GNF SymAtlas + NCI-60 cancer cell lines, human (Su, 2004; Ross, 2000)
Gene Symbol | Gene ID | Gene Info |
---|---|---|
MEIS2
|
ENSG00000134138.15 | Meis homeobox 2 |
Gene | Promoter | Pearson corr. coef. | P-value | Plot |
---|---|---|---|---|
MEIS2 | hg19_v2_chr15_-_37392086_37392116 | -0.17 | 9.9e-03 | Click! |
Promoter | Log-likelihood | Transcript | Gene | Gene Info |
---|---|---|---|---|
chr17_-_29648761 | 39.35 |
ENST00000247270.3
ENST00000462804.2 |
EVI2A
|
ecotropic viral integration site 2A |
chr6_-_33048483 | 32.16 |
ENST00000419277.1
|
HLA-DPA1
|
major histocompatibility complex, class II, DP alpha 1 |
chr22_-_27620603 | 31.62 |
ENST00000418271.1
ENST00000444114.1 |
RP5-1172A22.1
|
RP5-1172A22.1 |
chr4_-_88450244 | 30.36 |
ENST00000503414.1
|
SPARCL1
|
SPARC-like 1 (hevin) |
chr4_-_88450612 | 30.33 |
ENST00000418378.1
ENST00000282470.6 |
SPARCL1
|
SPARC-like 1 (hevin) |
chr11_-_5255696 | 30.14 |
ENST00000292901.3
ENST00000417377.1 |
HBD
|
hemoglobin, delta |
chr6_+_33043703 | 29.97 |
ENST00000418931.2
ENST00000535465.1 |
HLA-DPB1
|
major histocompatibility complex, class II, DP beta 1 |
chr11_-_5255861 | 28.09 |
ENST00000380299.3
|
HBD
|
hemoglobin, delta |
chr6_+_32407619 | 27.41 |
ENST00000395388.2
ENST00000374982.5 |
HLA-DRA
|
major histocompatibility complex, class II, DR alpha |
chr6_+_33048222 | 26.29 |
ENST00000428835.1
|
HLA-DPB1
|
major histocompatibility complex, class II, DP beta 1 |
chr11_-_111781610 | 25.81 |
ENST00000525823.1
|
CRYAB
|
crystallin, alpha B |
chr11_-_5248294 | 25.42 |
ENST00000335295.4
|
HBB
|
hemoglobin, beta |
chr6_-_32498046 | 23.20 |
ENST00000374975.3
|
HLA-DRB5
|
major histocompatibility complex, class II, DR beta 5 |
chr11_-_111781454 | 22.54 |
ENST00000533280.1
|
CRYAB
|
crystallin, alpha B |
chr13_-_67802549 | 22.18 |
ENST00000328454.5
ENST00000377865.2 |
PCDH9
|
protocadherin 9 |
chr11_-_111781554 | 21.77 |
ENST00000526167.1
ENST00000528961.1 |
CRYAB
|
crystallin, alpha B |
chr1_+_161185032 | 21.77 |
ENST00000367992.3
ENST00000289902.1 |
FCER1G
|
Fc fragment of IgE, high affinity I, receptor for; gamma polypeptide |
chr16_+_85061367 | 21.40 |
ENST00000538274.1
ENST00000258180.3 |
KIAA0513
|
KIAA0513 |
chr6_-_84418841 | 20.58 |
ENST00000369694.2
ENST00000195649.6 |
SNAP91
|
synaptosomal-associated protein, 91kDa |
chr15_+_81589254 | 20.58 |
ENST00000394652.2
|
IL16
|
interleukin 16 |
chr6_-_84418860 | 20.40 |
ENST00000521743.1
|
SNAP91
|
synaptosomal-associated protein, 91kDa |
chr16_+_2588012 | 19.09 |
ENST00000354836.5
ENST00000389224.3 |
PDPK1
|
3-phosphoinositide dependent protein kinase-1 |
chr16_+_30194916 | 18.77 |
ENST00000570045.1
ENST00000565497.1 ENST00000570244.1 |
CORO1A
|
coronin, actin binding protein, 1A |
chr11_-_111794446 | 17.64 |
ENST00000527950.1
|
CRYAB
|
crystallin, alpha B |
chr6_-_133084580 | 17.35 |
ENST00000525270.1
ENST00000530536.1 ENST00000524919.1 |
VNN2
|
vanin 2 |
chr6_-_33041378 | 17.16 |
ENST00000428995.1
|
HLA-DPA1
|
major histocompatibility complex, class II, DP alpha 1 |
chr9_-_136004782 | 16.85 |
ENST00000393157.3
|
RALGDS
|
ral guanine nucleotide dissociation stimulator |
chr18_-_47807829 | 16.35 |
ENST00000585672.1
ENST00000457839.2 ENST00000353909.3 ENST00000339998.6 ENST00000398493.1 |
MBD1
|
methyl-CpG binding domain protein 1 |
chr20_-_35580240 | 16.20 |
ENST00000262878.4
|
SAMHD1
|
SAM domain and HD domain 1 |
chr22_+_23264766 | 16.18 |
ENST00000390331.2
|
IGLC7
|
immunoglobulin lambda constant 7 |
chr19_-_10764509 | 16.06 |
ENST00000591501.1
|
ILF3-AS1
|
ILF3 antisense RNA 1 (head to head) |
chr17_+_41857793 | 15.97 |
ENST00000449302.3
|
C17orf105
|
chromosome 17 open reading frame 105 |
chr1_-_27961720 | 15.93 |
ENST00000545953.1
ENST00000374005.3 |
FGR
|
feline Gardner-Rasheed sarcoma viral oncogene homolog |
chr6_-_46293378 | 15.78 |
ENST00000330430.6
|
RCAN2
|
regulator of calcineurin 2 |
chr22_-_39151995 | 15.58 |
ENST00000405018.1
ENST00000438058.1 |
SUN2
|
Sad1 and UNC84 domain containing 2 |
chr5_-_178054105 | 15.58 |
ENST00000316308.4
|
CLK4
|
CDC-like kinase 4 |
chr16_+_6533380 | 15.56 |
ENST00000552089.1
|
RBFOX1
|
RNA binding protein, fox-1 homolog (C. elegans) 1 |
chr15_+_42696992 | 15.33 |
ENST00000561817.1
|
CAPN3
|
calpain 3, (p94) |
chr14_-_21492113 | 15.33 |
ENST00000554094.1
|
NDRG2
|
NDRG family member 2 |
chrX_-_92928557 | 15.21 |
ENST00000373079.3
ENST00000475430.2 |
NAP1L3
|
nucleosome assembly protein 1-like 3 |
chr17_+_80416050 | 15.08 |
ENST00000579198.1
ENST00000390006.4 ENST00000580296.1 |
NARF
|
nuclear prelamin A recognition factor |
chr1_+_66458072 | 15.00 |
ENST00000423207.2
|
PDE4B
|
phosphodiesterase 4B, cAMP-specific |
chr22_-_21213029 | 14.97 |
ENST00000572273.1
ENST00000255882.6 |
PI4KA
|
phosphatidylinositol 4-kinase, catalytic, alpha |
chr3_+_35722487 | 14.96 |
ENST00000441454.1
|
ARPP21
|
cAMP-regulated phosphoprotein, 21kDa |
chr15_+_42697018 | 14.93 |
ENST00000397204.4
|
CAPN3
|
calpain 3, (p94) |
chr8_-_134115118 | 14.87 |
ENST00000395352.3
ENST00000338087.5 |
SLA
|
Src-like-adaptor |
chr5_-_149792295 | 14.78 |
ENST00000518797.1
ENST00000524315.1 ENST00000009530.7 ENST00000377795.3 |
CD74
|
CD74 molecule, major histocompatibility complex, class II invariant chain |
chr22_-_39151947 | 14.63 |
ENST00000216064.4
|
SUN2
|
Sad1 and UNC84 domain containing 2 |
chr3_+_133465228 | 14.41 |
ENST00000482271.1
ENST00000264998.3 |
TF
|
transferrin |
chr16_+_30484021 | 14.31 |
ENST00000358164.5
|
ITGAL
|
integrin, alpha L (antigen CD11A (p180), lymphocyte function-associated antigen 1; alpha polypeptide) |
chr9_+_74526384 | 14.13 |
ENST00000334731.2
ENST00000377031.3 |
C9orf85
|
chromosome 9 open reading frame 85 |
chr12_-_109027643 | 13.91 |
ENST00000388962.3
ENST00000550948.1 |
SELPLG
|
selectin P ligand |
chr19_+_33182823 | 13.73 |
ENST00000397061.3
|
NUDT19
|
nudix (nucleoside diphosphate linked moiety X)-type motif 19 |
chr18_-_74701962 | 13.47 |
ENST00000585201.1
|
MBP
|
myelin basic protein |
chr16_+_30483962 | 13.39 |
ENST00000356798.6
|
ITGAL
|
integrin, alpha L (antigen CD11A (p180), lymphocyte function-associated antigen 1; alpha polypeptide) |
chrX_-_13835461 | 13.34 |
ENST00000316715.4
ENST00000356942.5 |
GPM6B
|
glycoprotein M6B |
chr7_+_149571045 | 13.30 |
ENST00000479613.1
ENST00000606024.1 ENST00000464662.1 ENST00000425642.2 |
ATP6V0E2
|
ATPase, H+ transporting V0 subunit e2 |
chr6_+_32709119 | 13.17 |
ENST00000374940.3
|
HLA-DQA2
|
major histocompatibility complex, class II, DQ alpha 2 |
chrX_+_16737718 | 13.12 |
ENST00000380155.3
|
SYAP1
|
synapse associated protein 1 |
chr8_-_134072593 | 13.10 |
ENST00000427060.2
|
SLA
|
Src-like-adaptor |
chr5_-_176057365 | 13.04 |
ENST00000310112.3
|
SNCB
|
synuclein, beta |
chr19_-_12662240 | 13.02 |
ENST00000416136.1
ENST00000428311.1 |
ZNF564
ZNF709
|
zinc finger protein 564 ZNF709 |
chr2_+_68962014 | 13.00 |
ENST00000467265.1
|
ARHGAP25
|
Rho GTPase activating protein 25 |
chr4_+_175204818 | 12.96 |
ENST00000503780.1
|
CEP44
|
centrosomal protein 44kDa |
chr2_+_68961934 | 12.91 |
ENST00000409202.3
|
ARHGAP25
|
Rho GTPase activating protein 25 |
chr6_-_112080256 | 12.90 |
ENST00000462856.2
ENST00000229471.4 |
FYN
|
FYN oncogene related to SRC, FGR, YES |
chr5_-_169725231 | 12.88 |
ENST00000046794.5
|
LCP2
|
lymphocyte cytosolic protein 2 (SH2 domain containing leukocyte protein of 76kDa) |
chr11_+_108093839 | 12.84 |
ENST00000452508.2
|
ATM
|
ataxia telangiectasia mutated |
chr1_-_160681593 | 12.82 |
ENST00000368045.3
ENST00000368046.3 |
CD48
|
CD48 molecule |
chr8_-_120685608 | 12.80 |
ENST00000427067.2
|
ENPP2
|
ectonucleotide pyrophosphatase/phosphodiesterase 2 |
chr3_-_18466026 | 12.66 |
ENST00000417717.2
|
SATB1
|
SATB homeobox 1 |
chr2_+_68961905 | 12.61 |
ENST00000295381.3
|
ARHGAP25
|
Rho GTPase activating protein 25 |
chr15_+_42696954 | 12.51 |
ENST00000337571.4
ENST00000569136.1 |
CAPN3
|
calpain 3, (p94) |
chr16_+_50776021 | 12.49 |
ENST00000566679.2
ENST00000564634.1 ENST00000398568.2 |
CYLD
|
cylindromatosis (turban tumor syndrome) |
chr2_-_87018784 | 12.46 |
ENST00000283635.3
ENST00000538832.1 |
CD8A
|
CD8a molecule |
chr11_-_125366089 | 12.45 |
ENST00000366139.3
ENST00000278919.3 |
FEZ1
|
fasciculation and elongation protein zeta 1 (zygin I) |
chr1_+_171810606 | 12.41 |
ENST00000358155.4
ENST00000367733.2 ENST00000355305.5 ENST00000367731.1 |
DNM3
|
dynamin 3 |
chr18_+_54318566 | 12.38 |
ENST00000589935.1
ENST00000357574.3 |
WDR7
|
WD repeat domain 7 |
chr1_-_236030216 | 12.35 |
ENST00000389794.3
ENST00000389793.2 |
LYST
|
lysosomal trafficking regulator |
chr2_+_24714729 | 12.25 |
ENST00000406961.1
ENST00000405141.1 |
NCOA1
|
nuclear receptor coactivator 1 |
chr14_-_21492251 | 12.23 |
ENST00000554398.1
|
NDRG2
|
NDRG family member 2 |
chr18_+_54318616 | 12.06 |
ENST00000254442.3
|
WDR7
|
WD repeat domain 7 |
chr18_-_52969844 | 12.02 |
ENST00000561831.3
|
TCF4
|
transcription factor 4 |
chr16_+_50775948 | 12.01 |
ENST00000569681.1
ENST00000569418.1 ENST00000540145.1 |
CYLD
|
cylindromatosis (turban tumor syndrome) |
chr1_-_204380919 | 11.99 |
ENST00000367188.4
|
PPP1R15B
|
protein phosphatase 1, regulatory subunit 15B |
chr12_+_8234807 | 11.97 |
ENST00000339754.5
|
NECAP1
|
NECAP endocytosis associated 1 |
chr9_-_93405352 | 11.94 |
ENST00000375765.3
|
DIRAS2
|
DIRAS family, GTP-binding RAS-like 2 |
chr3_+_50126341 | 11.87 |
ENST00000347869.3
ENST00000469838.1 ENST00000404526.2 ENST00000441305.1 |
RBM5
|
RNA binding motif protein 5 |
chr17_+_40610862 | 11.86 |
ENST00000393829.2
ENST00000546249.1 ENST00000537728.1 ENST00000264649.6 ENST00000585525.1 ENST00000343619.4 ENST00000544137.1 ENST00000589727.1 ENST00000587824.1 |
ATP6V0A1
|
ATPase, H+ transporting, lysosomal V0 subunit a1 |
chr8_-_27462822 | 11.74 |
ENST00000522098.1
|
CLU
|
clusterin |
chr21_-_32931290 | 11.70 |
ENST00000286827.3
|
TIAM1
|
T-cell lymphoma invasion and metastasis 1 |
chr2_+_89986318 | 11.67 |
ENST00000491977.1
|
IGKV2D-29
|
immunoglobulin kappa variable 2D-29 |
chrX_-_70331298 | 11.52 |
ENST00000456850.2
ENST00000473378.1 ENST00000487883.1 ENST00000374202.2 |
IL2RG
|
interleukin 2 receptor, gamma |
chr6_-_112115074 | 11.51 |
ENST00000368667.2
|
FYN
|
FYN oncogene related to SRC, FGR, YES |
chr1_-_153363452 | 11.48 |
ENST00000368732.1
ENST00000368733.3 |
S100A8
|
S100 calcium binding protein A8 |
chr10_-_73848531 | 11.47 |
ENST00000373109.2
|
SPOCK2
|
sparc/osteonectin, cwcv and kazal-like domains proteoglycan (testican) 2 |
chr6_-_166796461 | 11.42 |
ENST00000360961.6
ENST00000341756.6 |
MPC1
|
mitochondrial pyruvate carrier 1 |
chr5_-_139943830 | 11.40 |
ENST00000412920.3
ENST00000511201.2 ENST00000356738.2 ENST00000354402.5 ENST00000358580.5 ENST00000508496.2 |
APBB3
|
amyloid beta (A4) precursor protein-binding, family B, member 3 |
chr11_+_118938485 | 11.32 |
ENST00000300793.6
|
VPS11
|
vacuolar protein sorting 11 homolog (S. cerevisiae) |
chr9_+_132597722 | 11.27 |
ENST00000372429.3
ENST00000315480.4 ENST00000358355.1 |
USP20
|
ubiquitin specific peptidase 20 |
chr21_-_46340770 | 11.26 |
ENST00000397854.3
|
ITGB2
|
integrin, beta 2 (complement component 3 receptor 3 and 4 subunit) |
chr5_-_169694286 | 11.24 |
ENST00000521416.1
ENST00000520344.1 |
LCP2
|
lymphocyte cytosolic protein 2 (SH2 domain containing leukocyte protein of 76kDa) |
chr16_+_50775971 | 11.22 |
ENST00000311559.9
ENST00000564326.1 ENST00000566206.1 |
CYLD
|
cylindromatosis (turban tumor syndrome) |
chr19_+_1067271 | 11.21 |
ENST00000536472.1
ENST00000590214.1 |
HMHA1
|
histocompatibility (minor) HA-1 |
chr1_+_153330322 | 11.17 |
ENST00000368738.3
|
S100A9
|
S100 calcium binding protein A9 |
chr18_+_74240610 | 11.15 |
ENST00000578092.1
ENST00000578613.1 ENST00000583578.1 |
LINC00908
|
long intergenic non-protein coding RNA 908 |
chr2_-_89340242 | 11.08 |
ENST00000480492.1
|
IGKV1-12
|
immunoglobulin kappa variable 1-12 |
chr2_+_89901292 | 10.99 |
ENST00000448155.2
|
IGKV1D-39
|
immunoglobulin kappa variable 1D-39 |
chr16_+_23847339 | 10.99 |
ENST00000303531.7
|
PRKCB
|
protein kinase C, beta |
chr1_+_6845384 | 10.91 |
ENST00000303635.7
|
CAMTA1
|
calmodulin binding transcription activator 1 |
chr3_-_48936272 | 10.90 |
ENST00000544097.1
ENST00000430379.1 ENST00000319017.4 |
SLC25A20
|
solute carrier family 25 (carnitine/acylcarnitine translocase), member 20 |
chrX_+_103031421 | 10.89 |
ENST00000433491.1
ENST00000418604.1 ENST00000443502.1 |
PLP1
|
proteolipid protein 1 |
chr5_-_93447333 | 10.83 |
ENST00000395965.3
ENST00000505869.1 ENST00000509163.1 |
FAM172A
|
family with sequence similarity 172, member A |
chr14_-_81687197 | 10.70 |
ENST00000553612.1
|
GTF2A1
|
general transcription factor IIA, 1, 19/37kDa |
chr5_+_49962772 | 10.68 |
ENST00000281631.5
ENST00000513738.1 ENST00000503665.1 ENST00000514067.2 ENST00000503046.1 |
PARP8
|
poly (ADP-ribose) polymerase family, member 8 |
chr13_-_46716969 | 10.65 |
ENST00000435666.2
|
LCP1
|
lymphocyte cytosolic protein 1 (L-plastin) |
chr13_-_99959641 | 10.63 |
ENST00000376414.4
|
GPR183
|
G protein-coupled receptor 183 |
chr20_-_45035223 | 10.62 |
ENST00000450812.1
ENST00000290246.6 ENST00000439931.2 ENST00000396391.1 |
ELMO2
|
engulfment and cell motility 2 |
chr14_+_75746340 | 10.61 |
ENST00000555686.1
ENST00000555672.1 |
FOS
|
FBJ murine osteosarcoma viral oncogene homolog |
chrX_-_13956497 | 10.54 |
ENST00000398361.3
|
GPM6B
|
glycoprotein M6B |
chr9_-_98079965 | 10.53 |
ENST00000289081.3
|
FANCC
|
Fanconi anemia, complementation group C |
chrX_+_55478538 | 10.48 |
ENST00000342972.1
|
MAGEH1
|
melanoma antigen family H, 1 |
chr20_-_56195525 | 10.47 |
ENST00000371173.3
ENST00000395822.3 ENST00000340462.4 ENST00000343535.4 |
ZBP1
|
Z-DNA binding protein 1 |
chr8_-_90769422 | 10.45 |
ENST00000524190.1
ENST00000523859.1 |
RP11-37B2.1
|
RP11-37B2.1 |
chr3_-_58613323 | 10.39 |
ENST00000474531.1
ENST00000465970.1 |
FAM107A
|
family with sequence similarity 107, member A |
chr14_-_21490958 | 10.38 |
ENST00000554104.1
|
NDRG2
|
NDRG family member 2 |
chr6_-_152639479 | 10.34 |
ENST00000356820.4
|
SYNE1
|
spectrin repeat containing, nuclear envelope 1 |
chr22_+_35695793 | 10.34 |
ENST00000456128.1
ENST00000449058.2 ENST00000411850.1 ENST00000425375.1 ENST00000436462.2 ENST00000382034.5 |
TOM1
|
target of myb1 (chicken) |
chr17_-_56605341 | 10.29 |
ENST00000583114.1
|
SEPT4
|
septin 4 |
chr21_-_46340884 | 10.26 |
ENST00000302347.5
ENST00000517819.1 |
ITGB2
|
integrin, beta 2 (complement component 3 receptor 3 and 4 subunit) |
chr7_-_37024665 | 10.25 |
ENST00000396040.2
|
ELMO1
|
engulfment and cell motility 1 |
chr19_-_10679697 | 10.22 |
ENST00000335766.2
|
CDKN2D
|
cyclin-dependent kinase inhibitor 2D (p19, inhibits CDK4) |
chr2_-_89310012 | 10.21 |
ENST00000493819.1
|
IGKV1-9
|
immunoglobulin kappa variable 1-9 |
chr15_+_43809797 | 10.21 |
ENST00000399453.1
ENST00000300231.5 |
MAP1A
|
microtubule-associated protein 1A |
chr4_-_153274078 | 10.16 |
ENST00000263981.5
|
FBXW7
|
F-box and WD repeat domain containing 7, E3 ubiquitin protein ligase |
chr1_-_173793246 | 10.01 |
ENST00000345664.6
ENST00000367710.3 |
CENPL
|
centromere protein L |
chr15_+_84115868 | 10.00 |
ENST00000427482.2
|
SH3GL3
|
SH3-domain GRB2-like 3 |
chr6_-_32634425 | 9.96 |
ENST00000399082.3
ENST00000399079.3 ENST00000374943.4 ENST00000434651.2 |
HLA-DQB1
|
major histocompatibility complex, class II, DQ beta 1 |
chr14_+_100842735 | 9.95 |
ENST00000554998.1
ENST00000402312.3 ENST00000335290.6 ENST00000554175.1 |
WDR25
|
WD repeat domain 25 |
chr22_+_23247030 | 9.92 |
ENST00000390324.2
|
IGLJ3
|
immunoglobulin lambda joining 3 |
chr9_+_87285539 | 9.91 |
ENST00000359847.3
|
NTRK2
|
neurotrophic tyrosine kinase, receptor, type 2 |
chr2_+_90077680 | 9.91 |
ENST00000390270.2
|
IGKV3D-20
|
immunoglobulin kappa variable 3D-20 |
chr12_-_6580094 | 9.90 |
ENST00000361716.3
|
VAMP1
|
vesicle-associated membrane protein 1 (synaptobrevin 1) |
chr5_+_66124590 | 9.89 |
ENST00000490016.2
ENST00000403666.1 ENST00000450827.1 |
MAST4
|
microtubule associated serine/threonine kinase family member 4 |
chr16_+_2587998 | 9.88 |
ENST00000441549.3
ENST00000268673.7 |
PDPK1
|
3-phosphoinositide dependent protein kinase-1 |
chr8_-_9760839 | 9.87 |
ENST00000519461.1
ENST00000517675.1 |
LINC00599
|
long intergenic non-protein coding RNA 599 |
chr12_-_118810688 | 9.85 |
ENST00000542532.1
ENST00000392533.3 |
TAOK3
|
TAO kinase 3 |
chr5_+_156693091 | 9.82 |
ENST00000318218.6
ENST00000442283.2 ENST00000522463.1 ENST00000521420.1 |
CYFIP2
|
cytoplasmic FMR1 interacting protein 2 |
chr5_-_131330272 | 9.76 |
ENST00000379240.1
|
ACSL6
|
acyl-CoA synthetase long-chain family member 6 |
chr19_-_54784353 | 9.74 |
ENST00000391746.1
|
LILRB2
|
leukocyte immunoglobulin-like receptor, subfamily B (with TM and ITIM domains), member 2 |
chr14_-_106330458 | 9.67 |
ENST00000461719.1
|
IGHJ4
|
immunoglobulin heavy joining 4 |
chr4_+_166300084 | 9.67 |
ENST00000402744.4
|
CPE
|
carboxypeptidase E |
chr7_+_100136811 | 9.66 |
ENST00000300176.4
ENST00000262935.4 |
AGFG2
|
ArfGAP with FG repeats 2 |
chr2_-_8977714 | 9.65 |
ENST00000319688.5
ENST00000489024.1 ENST00000256707.3 ENST00000427284.1 ENST00000418530.1 ENST00000473731.1 |
KIDINS220
|
kinase D-interacting substrate, 220kDa |
chr12_-_42631529 | 9.56 |
ENST00000548917.1
|
YAF2
|
YY1 associated factor 2 |
chr22_+_23248512 | 9.50 |
ENST00000390325.2
|
IGLC3
|
immunoglobulin lambda constant 3 (Kern-Oz+ marker) |
chr5_-_176057518 | 9.49 |
ENST00000393693.2
|
SNCB
|
synuclein, beta |
chr4_+_156680153 | 9.47 |
ENST00000502959.1
ENST00000505764.1 ENST00000507146.1 ENST00000264424.8 ENST00000503520.1 |
GUCY1B3
|
guanylate cyclase 1, soluble, beta 3 |
chr5_+_67588391 | 9.47 |
ENST00000523872.1
|
PIK3R1
|
phosphoinositide-3-kinase, regulatory subunit 1 (alpha) |
chr17_+_53343577 | 9.45 |
ENST00000573945.1
|
HLF
|
hepatic leukemia factor |
chr5_+_156693159 | 9.44 |
ENST00000347377.6
|
CYFIP2
|
cytoplasmic FMR1 interacting protein 2 |
chr6_+_42531798 | 9.44 |
ENST00000372903.2
ENST00000372899.1 ENST00000372901.1 |
UBR2
|
ubiquitin protein ligase E3 component n-recognin 2 |
chr11_+_61717279 | 9.41 |
ENST00000378043.4
|
BEST1
|
bestrophin 1 |
chr4_+_47033607 | 9.40 |
ENST00000538619.1
|
GABRB1
|
gamma-aminobutyric acid (GABA) A receptor, beta 1 |
chr11_+_61717336 | 9.40 |
ENST00000378042.3
|
BEST1
|
bestrophin 1 |
chr19_+_45973120 | 9.35 |
ENST00000592811.1
ENST00000586615.1 |
FOSB
|
FBJ murine osteosarcoma viral oncogene homolog B |
chr4_-_174320687 | 9.34 |
ENST00000296506.3
|
SCRG1
|
stimulator of chondrogenesis 1 |
chr6_-_32557610 | 9.34 |
ENST00000360004.5
|
HLA-DRB1
|
major histocompatibility complex, class II, DR beta 1 |
chr6_-_24936170 | 9.28 |
ENST00000538035.1
|
FAM65B
|
family with sequence similarity 65, member B |
chr14_+_92980111 | 9.28 |
ENST00000216487.7
ENST00000557762.1 |
RIN3
|
Ras and Rab interactor 3 |
chr4_+_159593418 | 9.26 |
ENST00000507475.1
ENST00000307738.5 |
ETFDH
|
electron-transferring-flavoprotein dehydrogenase |
chr10_-_73848764 | 9.24 |
ENST00000317376.4
ENST00000412663.1 |
SPOCK2
|
sparc/osteonectin, cwcv and kazal-like domains proteoglycan (testican) 2 |
chr22_-_39151463 | 9.18 |
ENST00000405510.1
ENST00000433561.1 |
SUN2
|
Sad1 and UNC84 domain containing 2 |
chr16_+_58533951 | 9.07 |
ENST00000566192.1
ENST00000565088.1 ENST00000568640.1 ENST00000563978.1 ENST00000569923.1 ENST00000356752.4 ENST00000563799.1 ENST00000562999.1 ENST00000570248.1 ENST00000562731.1 ENST00000568424.1 |
NDRG4
|
NDRG family member 4 |
chr11_+_121447469 | 9.04 |
ENST00000532694.1
ENST00000534286.1 |
SORL1
|
sortilin-related receptor, L(DLR class) A repeats containing |
chr17_+_77681075 | 9.03 |
ENST00000397549.2
|
CTD-2116F7.1
|
CTD-2116F7.1 |
chr11_+_2323349 | 9.00 |
ENST00000381121.3
|
TSPAN32
|
tetraspanin 32 |
chr5_-_139944196 | 9.00 |
ENST00000357560.4
|
APBB3
|
amyloid beta (A4) precursor protein-binding, family B, member 3 |
chr4_-_46911248 | 9.00 |
ENST00000355591.3
ENST00000505102.1 |
COX7B2
|
cytochrome c oxidase subunit VIIb2 |
chr22_+_23237555 | 8.99 |
ENST00000390321.2
|
IGLC1
|
immunoglobulin lambda constant 1 (Mcg marker) |
chr12_-_133464151 | 8.97 |
ENST00000315585.7
ENST00000266880.7 ENST00000443047.2 ENST00000432561.2 ENST00000450056.2 |
CHFR
|
checkpoint with forkhead and ring finger domains, E3 ubiquitin protein ligase |
chr3_-_39323155 | 8.96 |
ENST00000358309.3
|
CX3CR1
|
chemokine (C-X3-C motif) receptor 1 |
chr19_+_1067492 | 8.96 |
ENST00000586866.1
|
HMHA1
|
histocompatibility (minor) HA-1 |
chr10_-_99393208 | 8.93 |
ENST00000307450.6
|
MORN4
|
MORN repeat containing 4 |
chr11_-_2323290 | 8.92 |
ENST00000381153.3
|
C11orf21
|
chromosome 11 open reading frame 21 |
chr9_+_137967366 | 8.88 |
ENST00000252854.4
|
OLFM1
|
olfactomedin 1 |
chr19_+_1067144 | 8.86 |
ENST00000313093.2
|
HMHA1
|
histocompatibility (minor) HA-1 |
chr1_+_151043070 | 8.84 |
ENST00000368918.3
ENST00000368917.1 |
GABPB2
|
GA binding protein transcription factor, beta subunit 2 |
chr10_-_99393242 | 8.81 |
ENST00000370635.3
ENST00000478953.1 ENST00000335628.3 |
MORN4
|
MORN repeat containing 4 |
chr16_+_75600247 | 8.80 |
ENST00000037243.2
ENST00000565057.1 ENST00000563744.1 |
GABARAPL2
|
GABA(A) receptor-associated protein-like 2 |
chr2_-_224467093 | 8.77 |
ENST00000305409.2
|
SCG2
|
secretogranin II |
chr7_+_80267973 | 8.76 |
ENST00000394788.3
ENST00000447544.2 |
CD36
|
CD36 molecule (thrombospondin receptor) |
chr20_+_10199468 | 8.74 |
ENST00000254976.2
ENST00000304886.2 |
SNAP25
|
synaptosomal-associated protein, 25kDa |
chr11_-_2906979 | 8.66 |
ENST00000380725.1
ENST00000313407.6 ENST00000430149.2 ENST00000440480.2 ENST00000414822.3 |
CDKN1C
|
cyclin-dependent kinase inhibitor 1C (p57, Kip2) |
chr5_-_131329918 | 8.61 |
ENST00000357096.1
ENST00000431707.1 ENST00000434099.1 |
ACSL6
|
acyl-CoA synthetase long-chain family member 6 |
chr7_+_150264365 | 8.60 |
ENST00000255945.2
ENST00000461940.1 |
GIMAP4
|
GTPase, IMAP family member 4 |
chr14_-_81687575 | 8.60 |
ENST00000434192.2
|
GTF2A1
|
general transcription factor IIA, 1, 19/37kDa |
chr17_-_5138099 | 8.59 |
ENST00000571800.1
ENST00000574081.1 ENST00000399600.4 ENST00000574297.1 |
SCIMP
|
SLP adaptor and CSK interacting membrane protein |
chr19_+_36266433 | 8.57 |
ENST00000314737.5
|
ARHGAP33
|
Rho GTPase activating protein 33 |
chr6_-_24911195 | 8.54 |
ENST00000259698.4
|
FAM65B
|
family with sequence similarity 65, member B |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
11.9 | 35.7 | GO:1990108 | protein linear deubiquitination(GO:1990108) |
9.1 | 27.2 | GO:0001812 | positive regulation of type I hypersensitivity(GO:0001812) |
9.0 | 44.8 | GO:0002399 | MHC class II protein complex assembly(GO:0002399) |
7.9 | 47.5 | GO:0070315 | G1 to G0 transition involved in cell differentiation(GO:0070315) |
7.3 | 7.3 | GO:2000520 | regulation of immunological synapse formation(GO:2000520) |
6.7 | 100.2 | GO:0015671 | oxygen transport(GO:0015671) |
6.4 | 19.3 | GO:1904882 | telomerase catalytic core complex assembly(GO:1904868) regulation of telomerase catalytic core complex assembly(GO:1904882) positive regulation of telomerase catalytic core complex assembly(GO:1904884) |
6.1 | 18.4 | GO:0035408 | histone H3-T6 phosphorylation(GO:0035408) |
5.6 | 33.3 | GO:0061502 | early endosome to recycling endosome transport(GO:0061502) |
5.6 | 55.5 | GO:0090292 | nuclear matrix anchoring at nuclear membrane(GO:0090292) |
5.3 | 21.2 | GO:2001193 | gamma-delta T cell activation involved in immune response(GO:0002290) negative regulation of interferon-beta secretion(GO:0035548) regulation of gamma-delta T cell activation involved in immune response(GO:2001191) positive regulation of gamma-delta T cell activation involved in immune response(GO:2001193) |
5.2 | 21.0 | GO:0045065 | cytotoxic T cell differentiation(GO:0045065) |
5.2 | 10.5 | GO:0032481 | positive regulation of type I interferon production(GO:0032481) |
5.2 | 15.6 | GO:1904395 | positive regulation of skeletal muscle acetylcholine-gated channel clustering(GO:1904395) |
5.2 | 15.5 | GO:0038060 | nitric oxide-cGMP-mediated signaling pathway(GO:0038060) |
5.1 | 91.6 | GO:0007021 | tubulin complex assembly(GO:0007021) |
4.8 | 14.5 | GO:0030886 | negative regulation of myeloid dendritic cell activation(GO:0030886) |
4.8 | 4.8 | GO:0060734 | regulation of endoplasmic reticulum stress-induced eIF2 alpha phosphorylation(GO:0060734) |
4.8 | 14.3 | GO:0036309 | protein localization to M-band(GO:0036309) protein localization to T-tubule(GO:0036371) |
4.7 | 4.7 | GO:0019367 | fatty acid elongation, saturated fatty acid(GO:0019367) fatty acid elongation, unsaturated fatty acid(GO:0019368) fatty acid elongation(GO:0030497) fatty acid elongation, monounsaturated fatty acid(GO:0034625) fatty acid elongation, polyunsaturated fatty acid(GO:0034626) very long-chain fatty acid biosynthetic process(GO:0042761) |
4.6 | 13.9 | GO:0050902 | leukocyte adhesive activation(GO:0050902) |
4.6 | 13.8 | GO:0045925 | positive regulation of female receptivity(GO:0045925) |
4.6 | 36.6 | GO:1990416 | cellular response to brain-derived neurotrophic factor stimulus(GO:1990416) |
4.4 | 4.4 | GO:0090286 | cytoskeletal anchoring at nuclear membrane(GO:0090286) |
4.3 | 4.3 | GO:0002625 | regulation of T cell antigen processing and presentation(GO:0002625) |
4.2 | 21.1 | GO:0099590 | neurotransmitter receptor internalization(GO:0099590) |
4.2 | 4.2 | GO:0051784 | negative regulation of nuclear division(GO:0051784) |
4.2 | 4.2 | GO:2000360 | negative regulation of binding of sperm to zona pellucida(GO:2000360) |
4.1 | 12.3 | GO:0033364 | mast cell secretory granule organization(GO:0033364) |
4.1 | 41.1 | GO:0051610 | negative regulation of neurotransmitter uptake(GO:0051581) serotonin uptake(GO:0051610) regulation of serotonin uptake(GO:0051611) negative regulation of serotonin uptake(GO:0051612) |
4.1 | 24.4 | GO:2000324 | positive regulation of glucocorticoid receptor signaling pathway(GO:2000324) |
4.1 | 16.2 | GO:0006203 | dGTP catabolic process(GO:0006203) |
4.0 | 32.3 | GO:0051388 | positive regulation of neurotrophin TRK receptor signaling pathway(GO:0051388) |
4.0 | 16.0 | GO:2001151 | regulation of renal water transport(GO:2001151) positive regulation of renal water transport(GO:2001153) |
3.8 | 30.6 | GO:0002291 | T cell activation via T cell receptor contact with antigen bound to MHC molecule on antigen presenting cell(GO:0002291) |
3.8 | 11.4 | GO:0060667 | fibroblast growth factor receptor signaling pathway involved in negative regulation of apoptotic process in bone marrow(GO:0035602) fibroblast growth factor receptor signaling pathway involved in hemopoiesis(GO:0035603) fibroblast growth factor receptor signaling pathway involved in positive regulation of cell proliferation in bone marrow(GO:0035604) fibroblast growth factor receptor signaling pathway involved in mammary gland specification(GO:0060595) mammary gland bud formation(GO:0060615) branch elongation involved in salivary gland morphogenesis(GO:0060667) mesenchymal cell differentiation involved in lung development(GO:0060915) |
3.8 | 22.6 | GO:1902996 | macrophage proliferation(GO:0061517) microglial cell proliferation(GO:0061518) regulation of neuronal signal transduction(GO:1902847) regulation of neurofibrillary tangle assembly(GO:1902996) positive regulation of neurofibrillary tangle assembly(GO:1902998) |
3.7 | 14.9 | GO:0050757 | thymidylate synthase biosynthetic process(GO:0050757) regulation of thymidylate synthase biosynthetic process(GO:0050758) |
3.7 | 11.1 | GO:0002904 | positive regulation of B cell apoptotic process(GO:0002904) |
3.7 | 14.7 | GO:0002774 | Fc receptor mediated inhibitory signaling pathway(GO:0002774) |
3.6 | 10.9 | GO:2000566 | positive regulation of CD8-positive, alpha-beta T cell proliferation(GO:2000566) |
3.5 | 10.6 | GO:0061470 | T follicular helper cell differentiation(GO:0061470) |
3.5 | 20.8 | GO:0070560 | protein secretion by platelet(GO:0070560) |
3.4 | 17.0 | GO:0002378 | immunoglobulin biosynthetic process(GO:0002378) |
3.4 | 30.2 | GO:2000343 | positive regulation of chemokine (C-X-C motif) ligand 2 production(GO:2000343) |
3.3 | 13.1 | GO:0050717 | positive regulation of interleukin-1 alpha secretion(GO:0050717) |
3.3 | 3.3 | GO:1990641 | response to iron ion starvation(GO:1990641) |
3.2 | 22.7 | GO:0032119 | sequestering of zinc ion(GO:0032119) |
3.2 | 6.3 | GO:0002125 | maternal aggressive behavior(GO:0002125) |
3.1 | 3.1 | GO:0033233 | regulation of protein sumoylation(GO:0033233) |
3.1 | 18.6 | GO:0052551 | response to defense-related nitric oxide production by other organism involved in symbiotic interaction(GO:0052551) response to defense-related host nitric oxide production(GO:0052565) |
3.0 | 3.0 | GO:0060037 | pharyngeal system development(GO:0060037) |
3.0 | 12.0 | GO:0071461 | cellular response to redox state(GO:0071461) |
3.0 | 9.0 | GO:0002881 | negative regulation of chronic inflammatory response to non-antigenic stimulus(GO:0002881) |
3.0 | 17.8 | GO:1902902 | negative regulation of autophagosome assembly(GO:1902902) |
2.9 | 8.7 | GO:0019417 | sulfur oxidation(GO:0019417) |
2.9 | 8.7 | GO:0002818 | intracellular defense response(GO:0002818) |
2.9 | 8.6 | GO:0007127 | meiosis I(GO:0007127) |
2.9 | 5.7 | GO:0050852 | T cell receptor signaling pathway(GO:0050852) |
2.8 | 11.3 | GO:0005986 | sucrose biosynthetic process(GO:0005986) |
2.8 | 8.4 | GO:0071494 | cellular response to UV-C(GO:0071494) |
2.8 | 22.3 | GO:0070236 | regulation of activation-induced cell death of T cells(GO:0070235) negative regulation of activation-induced cell death of T cells(GO:0070236) |
2.8 | 8.3 | GO:0003383 | apical constriction(GO:0003383) mesoderm migration involved in gastrulation(GO:0007509) |
2.8 | 27.8 | GO:1902951 | negative regulation of dendritic spine maintenance(GO:1902951) |
2.8 | 8.3 | GO:0045659 | regulation of neutrophil differentiation(GO:0045658) negative regulation of neutrophil differentiation(GO:0045659) |
2.8 | 2.8 | GO:0060594 | mammary gland specification(GO:0060594) |
2.7 | 8.2 | GO:1903697 | negative regulation of microvillus assembly(GO:1903697) |
2.7 | 8.2 | GO:0071409 | cellular response to cycloheximide(GO:0071409) |
2.7 | 19.0 | GO:0002220 | innate immune response activating cell surface receptor signaling pathway(GO:0002220) stimulatory C-type lectin receptor signaling pathway(GO:0002223) |
2.7 | 16.1 | GO:0098707 | ferrous iron import into cell(GO:0097460) ferrous iron import across plasma membrane(GO:0098707) |
2.6 | 7.9 | GO:0002727 | natural killer cell cytokine production(GO:0002370) regulation of natural killer cell cytokine production(GO:0002727) |
2.6 | 7.9 | GO:0070213 | protein auto-ADP-ribosylation(GO:0070213) |
2.6 | 21.1 | GO:0016191 | synaptic vesicle uncoating(GO:0016191) |
2.6 | 41.9 | GO:0090360 | platelet-derived growth factor production(GO:0090360) regulation of platelet-derived growth factor production(GO:0090361) |
2.6 | 2.6 | GO:0071168 | protein localization to chromatin(GO:0071168) |
2.6 | 7.8 | GO:1902988 | neurofibrillary tangle assembly(GO:1902988) |
2.5 | 7.6 | GO:0006982 | response to lipid hydroperoxide(GO:0006982) |
2.5 | 2.5 | GO:0002589 | regulation of antigen processing and presentation of peptide antigen via MHC class I(GO:0002589) negative regulation of antigen processing and presentation of peptide antigen via MHC class I(GO:0002590) |
2.5 | 9.8 | GO:0032053 | ciliary basal body organization(GO:0032053) |
2.5 | 7.4 | GO:0036079 | GDP-fucose transport(GO:0015783) purine nucleotide-sugar transport(GO:0036079) |
2.4 | 17.1 | GO:0038110 | interleukin-2-mediated signaling pathway(GO:0038110) |
2.4 | 12.2 | GO:0099538 | synaptic signaling via neuropeptide(GO:0099538) trans-synaptic signaling by neuropeptide(GO:0099540) trans-synaptic signaling by neuropeptide, modulating synaptic transmission(GO:0099551) |
2.4 | 7.3 | GO:0033693 | neurofilament bundle assembly(GO:0033693) |
2.4 | 24.2 | GO:2001199 | negative regulation of dendritic cell differentiation(GO:2001199) |
2.4 | 29.0 | GO:1901898 | negative regulation of relaxation of cardiac muscle(GO:1901898) |
2.4 | 2.4 | GO:0002353 | kinin cascade(GO:0002254) plasma kallikrein-kinin cascade(GO:0002353) |
2.4 | 7.2 | GO:0031587 | positive regulation of inositol 1,4,5-trisphosphate-sensitive calcium-release channel activity(GO:0031587) |
2.4 | 7.1 | GO:0032290 | peripheral nervous system myelin formation(GO:0032290) |
2.4 | 7.1 | GO:1902530 | regulation of protein linear polyubiquitination(GO:1902528) positive regulation of protein linear polyubiquitination(GO:1902530) |
2.4 | 11.8 | GO:0036369 | transcription factor catabolic process(GO:0036369) |
2.3 | 11.7 | GO:0033078 | extrathymic T cell differentiation(GO:0033078) |
2.3 | 9.4 | GO:0006072 | glycerol-3-phosphate metabolic process(GO:0006072) |
2.3 | 4.7 | GO:0006438 | valyl-tRNA aminoacylation(GO:0006438) |
2.3 | 7.0 | GO:1990502 | dense core granule maturation(GO:1990502) |
2.3 | 14.0 | GO:0072564 | blood microparticle formation(GO:0072564) regulation of blood microparticle formation(GO:2000332) positive regulation of blood microparticle formation(GO:2000334) |
2.3 | 4.6 | GO:1903526 | negative regulation of membrane tubulation(GO:1903526) |
2.3 | 4.6 | GO:1903347 | negative regulation of bicellular tight junction assembly(GO:1903347) |
2.3 | 11.4 | GO:0018230 | peptidyl-L-cysteine S-palmitoylation(GO:0018230) peptidyl-S-diacylglycerol-L-cysteine biosynthetic process from peptidyl-cysteine(GO:0018231) |
2.3 | 6.8 | GO:1902310 | positive regulation of peptidyl-serine dephosphorylation(GO:1902310) |
2.3 | 4.6 | GO:2001187 | positive regulation of CD8-positive, alpha-beta T cell activation(GO:2001187) |
2.3 | 6.8 | GO:0042137 | sequestering of neurotransmitter(GO:0042137) |
2.2 | 11.2 | GO:0033274 | response to vitamin B2(GO:0033274) heterochromatin maintenance(GO:0070829) |
2.2 | 8.9 | GO:0007525 | somatic muscle development(GO:0007525) |
2.2 | 22.2 | GO:0015939 | pantothenate metabolic process(GO:0015939) |
2.2 | 253.4 | GO:0031295 | T cell costimulation(GO:0031295) |
2.2 | 8.9 | GO:0006663 | platelet activating factor biosynthetic process(GO:0006663) |
2.2 | 2.2 | GO:0010807 | regulation of synaptic vesicle priming(GO:0010807) |
2.2 | 6.6 | GO:1902567 | negative regulation of eosinophil activation(GO:1902567) |
2.2 | 4.3 | GO:0046173 | polyol biosynthetic process(GO:0046173) |
2.1 | 6.4 | GO:0002309 | T cell proliferation involved in immune response(GO:0002309) |
2.1 | 17.2 | GO:0001661 | conditioned taste aversion(GO:0001661) |
2.1 | 6.4 | GO:0019074 | viral genome packaging(GO:0019072) viral RNA genome packaging(GO:0019074) |
2.1 | 14.8 | GO:1902746 | regulation of lens fiber cell differentiation(GO:1902746) |
2.1 | 14.6 | GO:0098989 | NMDA selective glutamate receptor signaling pathway(GO:0098989) |
2.1 | 10.3 | GO:0030382 | sperm mitochondrion organization(GO:0030382) |
2.1 | 2.1 | GO:0009404 | toxin metabolic process(GO:0009404) |
2.1 | 30.8 | GO:0048712 | negative regulation of astrocyte differentiation(GO:0048712) |
2.0 | 14.3 | GO:0051597 | response to methylmercury(GO:0051597) |
2.0 | 26.6 | GO:0030321 | transepithelial chloride transport(GO:0030321) |
2.0 | 10.2 | GO:0033029 | regulation of neutrophil apoptotic process(GO:0033029) |
2.0 | 10.2 | GO:2000639 | regulation of SREBP signaling pathway(GO:2000638) negative regulation of SREBP signaling pathway(GO:2000639) |
2.0 | 10.1 | GO:0048388 | endosomal lumen acidification(GO:0048388) |
2.0 | 14.1 | GO:0023041 | neuronal signal transduction(GO:0023041) |
2.0 | 2.0 | GO:0045404 | interleukin-4 biosynthetic process(GO:0042097) regulation of interleukin-4 biosynthetic process(GO:0045402) positive regulation of interleukin-4 biosynthetic process(GO:0045404) |
2.0 | 8.0 | GO:0033634 | positive regulation of cell-cell adhesion mediated by integrin(GO:0033634) |
2.0 | 15.9 | GO:0070544 | histone H3-K36 demethylation(GO:0070544) |
2.0 | 10.0 | GO:0071233 | cellular response to leucine(GO:0071233) |
2.0 | 2.0 | GO:0071896 | protein localization to adherens junction(GO:0071896) |
2.0 | 6.0 | GO:0033159 | negative regulation of protein import into nucleus, translocation(GO:0033159) |
2.0 | 49.5 | GO:2000369 | regulation of clathrin-mediated endocytosis(GO:2000369) |
2.0 | 2.0 | GO:1905167 | positive regulation of lysosomal protein catabolic process(GO:1905167) |
2.0 | 5.9 | GO:0009155 | purine deoxyribonucleotide catabolic process(GO:0009155) |
1.9 | 3.9 | GO:0070434 | positive regulation of nucleotide-binding oligomerization domain containing signaling pathway(GO:0070426) positive regulation of nucleotide-binding oligomerization domain containing 2 signaling pathway(GO:0070434) |
1.9 | 9.6 | GO:0030070 | insulin processing(GO:0030070) |
1.9 | 5.8 | GO:0015669 | gas transport(GO:0015669) |
1.9 | 3.8 | GO:0060700 | regulation of ribonuclease activity(GO:0060700) |
1.9 | 7.6 | GO:0050882 | voluntary musculoskeletal movement(GO:0050882) |
1.9 | 9.4 | GO:0048696 | regulation of collateral sprouting in absence of injury(GO:0048696) |
1.9 | 5.6 | GO:0034146 | toll-like receptor 5 signaling pathway(GO:0034146) |
1.9 | 5.6 | GO:0071109 | superior temporal gyrus development(GO:0071109) |
1.9 | 7.4 | GO:0003138 | primary heart field specification(GO:0003138) sinoatrial valve development(GO:0003172) sinoatrial valve morphogenesis(GO:0003185) |
1.9 | 11.1 | GO:1902731 | negative regulation of chondrocyte proliferation(GO:1902731) |
1.8 | 12.9 | GO:0010890 | positive regulation of sequestering of triglyceride(GO:0010890) |
1.8 | 18.4 | GO:0048102 | autophagic cell death(GO:0048102) |
1.8 | 7.2 | GO:0043983 | histone H4-K12 acetylation(GO:0043983) |
1.8 | 25.2 | GO:0043374 | CD8-positive, alpha-beta T cell differentiation(GO:0043374) |
1.8 | 7.2 | GO:0014052 | regulation of gamma-aminobutyric acid secretion(GO:0014052) |
1.8 | 17.8 | GO:2001135 | regulation of endocytic recycling(GO:2001135) |
1.8 | 8.8 | GO:1901725 | regulation of histone deacetylase activity(GO:1901725) |
1.8 | 36.9 | GO:0019800 | peptide cross-linking via chondroitin 4-sulfate glycosaminoglycan(GO:0019800) |
1.7 | 1.7 | GO:0010157 | response to chlorate(GO:0010157) |
1.7 | 5.1 | GO:1903070 | negative regulation of ER-associated ubiquitin-dependent protein catabolic process(GO:1903070) |
1.7 | 5.1 | GO:0097112 | gamma-aminobutyric acid receptor clustering(GO:0097112) |
1.7 | 5.1 | GO:0000738 | DNA catabolic process, exonucleolytic(GO:0000738) |
1.7 | 28.7 | GO:0042759 | long-chain fatty acid biosynthetic process(GO:0042759) |
1.7 | 10.1 | GO:0010732 | protein glutathionylation(GO:0010731) regulation of protein glutathionylation(GO:0010732) negative regulation of protein glutathionylation(GO:0010734) |
1.7 | 5.0 | GO:0045212 | negative regulation of synaptic transmission, cholinergic(GO:0032223) neurotransmitter receptor biosynthetic process(GO:0045212) |
1.7 | 6.7 | GO:0072658 | positive regulation of cell communication by electrical coupling(GO:0010650) maintenance of protein location in membrane(GO:0072658) maintenance of protein location in plasma membrane(GO:0072660) positive regulation of membrane depolarization during cardiac muscle cell action potential(GO:1900827) |
1.7 | 11.6 | GO:0009449 | gamma-aminobutyric acid biosynthetic process(GO:0009449) |
1.7 | 5.0 | GO:0043163 | cell envelope organization(GO:0043163) external encapsulating structure organization(GO:0045229) |
1.6 | 36.2 | GO:0050930 | induction of positive chemotaxis(GO:0050930) |
1.6 | 4.9 | GO:1904647 | response to rotenone(GO:1904647) |
1.6 | 6.5 | GO:0019276 | UDP-N-acetylgalactosamine metabolic process(GO:0019276) chondroitin sulfate proteoglycan biosynthetic process, polysaccharide chain biosynthetic process(GO:0050653) |
1.6 | 1.6 | GO:0070432 | regulation of nucleotide-binding oligomerization domain containing 2 signaling pathway(GO:0070432) |
1.6 | 3.2 | GO:0018242 | protein O-linked glycosylation via serine(GO:0018242) |
1.6 | 4.8 | GO:0090526 | regulation of gluconeogenesis involved in cellular glucose homeostasis(GO:0090526) |
1.6 | 4.7 | GO:0061034 | olfactory bulb mitral cell layer development(GO:0061034) |
1.6 | 6.3 | GO:1902361 | mitochondrial pyruvate transport(GO:0006850) mitochondrial pyruvate transmembrane transport(GO:1902361) |
1.6 | 1.6 | GO:0033625 | positive regulation of integrin activation(GO:0033625) |
1.6 | 6.3 | GO:0051866 | general adaptation syndrome(GO:0051866) |
1.6 | 11.0 | GO:0018344 | protein geranylgeranylation(GO:0018344) |
1.6 | 4.7 | GO:0097368 | establishment of Sertoli cell barrier(GO:0097368) |
1.6 | 4.7 | GO:0002317 | plasma cell differentiation(GO:0002317) |
1.5 | 7.7 | GO:0035694 | mitochondrial protein catabolic process(GO:0035694) |
1.5 | 7.7 | GO:0035936 | testosterone secretion(GO:0035936) regulation of testosterone secretion(GO:2000843) positive regulation of testosterone secretion(GO:2000845) |
1.5 | 4.6 | GO:0050859 | B-1 B cell differentiation(GO:0001923) negative regulation of B cell receptor signaling pathway(GO:0050859) |
1.5 | 6.1 | GO:0035616 | histone H2B conserved C-terminal lysine deubiquitination(GO:0035616) |
1.5 | 7.6 | GO:2000348 | regulation of CD40 signaling pathway(GO:2000348) |
1.5 | 3.0 | GO:0035411 | catenin import into nucleus(GO:0035411) |
1.5 | 1.5 | GO:0002634 | regulation of germinal center formation(GO:0002634) |
1.5 | 15.0 | GO:0034058 | endosomal vesicle fusion(GO:0034058) |
1.5 | 1.5 | GO:1902913 | positive regulation of neuroepithelial cell differentiation(GO:1902913) |
1.5 | 4.5 | GO:0072553 | terminal button organization(GO:0072553) |
1.5 | 4.4 | GO:1900169 | regulation of glucocorticoid mediated signaling pathway(GO:1900169) |
1.5 | 3.0 | GO:0006772 | thiamine metabolic process(GO:0006772) |
1.5 | 4.4 | GO:0019853 | L-ascorbic acid biosynthetic process(GO:0019853) negative regulation of DNA catabolic process(GO:1903625) |
1.5 | 4.4 | GO:0035915 | pore formation in membrane of other organism(GO:0035915) |
1.5 | 1.5 | GO:0002314 | germinal center B cell differentiation(GO:0002314) |
1.5 | 2.9 | GO:1990164 | histone H2A phosphorylation(GO:1990164) |
1.5 | 10.2 | GO:0000160 | phosphorelay signal transduction system(GO:0000160) |
1.5 | 4.4 | GO:0036058 | filtration diaphragm assembly(GO:0036058) slit diaphragm assembly(GO:0036060) |
1.5 | 5.8 | GO:0015942 | formate metabolic process(GO:0015942) |
1.4 | 1.4 | GO:0021692 | cerebellar Purkinje cell layer morphogenesis(GO:0021692) |
1.4 | 10.1 | GO:0015793 | glycerol transport(GO:0015793) |
1.4 | 2.9 | GO:0018352 | protein-pyridoxal-5-phosphate linkage(GO:0018352) |
1.4 | 8.6 | GO:2001300 | lipoxin metabolic process(GO:2001300) |
1.4 | 7.1 | GO:0046968 | peptide antigen transport(GO:0046968) |
1.4 | 4.3 | GO:0030885 | regulation of myeloid dendritic cell activation(GO:0030885) |
1.4 | 5.7 | GO:0045719 | negative regulation of glycogen biosynthetic process(GO:0045719) |
1.4 | 4.3 | GO:0002418 | immune response to tumor cell(GO:0002418) |
1.4 | 4.3 | GO:0046586 | regulation of calcium-dependent cell-cell adhesion(GO:0046586) |
1.4 | 15.6 | GO:0002286 | T cell activation involved in immune response(GO:0002286) |
1.4 | 8.5 | GO:0032483 | regulation of Rab protein signal transduction(GO:0032483) |
1.4 | 2.8 | GO:1901074 | regulation of engulfment of apoptotic cell(GO:1901074) |
1.4 | 18.1 | GO:0034638 | phosphatidylcholine catabolic process(GO:0034638) |
1.4 | 2.8 | GO:0001836 | release of cytochrome c from mitochondria(GO:0001836) |
1.4 | 90.3 | GO:0006910 | phagocytosis, recognition(GO:0006910) |
1.4 | 6.9 | GO:2000035 | regulation of stem cell division(GO:2000035) |
1.4 | 4.1 | GO:1903249 | regulation of cellular amine catabolic process(GO:0033241) negative regulation of cellular amine catabolic process(GO:0033242) negative regulation of the force of heart contraction(GO:0098736) regulation of arginine catabolic process(GO:1900081) negative regulation of arginine catabolic process(GO:1900082) regulation of adrenergic receptor signaling pathway involved in heart process(GO:1901204) negative regulation of adrenergic receptor signaling pathway involved in heart process(GO:1901205) regulation of citrulline biosynthetic process(GO:1903248) negative regulation of citrulline biosynthetic process(GO:1903249) negative regulation of cellular amino acid biosynthetic process(GO:2000283) |
1.4 | 4.1 | GO:0090045 | positive regulation of deacetylase activity(GO:0090045) |
1.4 | 6.8 | GO:0032264 | IMP salvage(GO:0032264) |
1.4 | 2.7 | GO:0044030 | regulation of DNA methylation(GO:0044030) |
1.3 | 1.3 | GO:0009826 | unidimensional cell growth(GO:0009826) |
1.3 | 4.0 | GO:0098746 | fast, calcium ion-dependent exocytosis of neurotransmitter(GO:0098746) |
1.3 | 4.0 | GO:0015888 | thiamine transport(GO:0015888) thiamine transmembrane transport(GO:0071934) |
1.3 | 13.3 | GO:0045647 | negative regulation of erythrocyte differentiation(GO:0045647) |
1.3 | 5.3 | GO:0042357 | thiamine diphosphate metabolic process(GO:0042357) |
1.3 | 5.3 | GO:0014738 | regulation of muscle hyperplasia(GO:0014738) |
1.3 | 3.9 | GO:0034154 | toll-like receptor 7 signaling pathway(GO:0034154) |
1.3 | 3.9 | GO:0030241 | skeletal muscle myosin thick filament assembly(GO:0030241) |
1.3 | 5.2 | GO:1900227 | positive regulation of NLRP3 inflammasome complex assembly(GO:1900227) |
1.3 | 3.8 | GO:0090219 | negative regulation of lipid kinase activity(GO:0090219) |
1.3 | 2.5 | GO:0032765 | positive regulation of mast cell cytokine production(GO:0032765) |
1.3 | 3.8 | GO:0038043 | interleukin-5-mediated signaling pathway(GO:0038043) |
1.3 | 2.5 | GO:0051386 | regulation of neurotrophin TRK receptor signaling pathway(GO:0051386) |
1.3 | 3.8 | GO:1903598 | positive regulation of gap junction assembly(GO:1903598) |
1.3 | 2.5 | GO:0070634 | transepithelial ammonium transport(GO:0070634) |
1.3 | 3.8 | GO:0060168 | positive regulation of adenosine receptor signaling pathway(GO:0060168) |
1.3 | 5.0 | GO:0097354 | protein prenylation(GO:0018342) protein farnesylation(GO:0018343) prenylation(GO:0097354) |
1.2 | 2.5 | GO:0042713 | sperm ejaculation(GO:0042713) |
1.2 | 4.9 | GO:0032049 | cardiolipin biosynthetic process(GO:0032049) |
1.2 | 2.4 | GO:0002584 | negative regulation of antigen processing and presentation of peptide antigen(GO:0002584) |
1.2 | 3.6 | GO:0042631 | cellular response to water deprivation(GO:0042631) |
1.2 | 3.6 | GO:0051725 | protein de-ADP-ribosylation(GO:0051725) |
1.2 | 2.4 | GO:0002384 | hepatic immune response(GO:0002384) |
1.2 | 12.0 | GO:0043950 | positive regulation of cAMP-mediated signaling(GO:0043950) |
1.2 | 2.4 | GO:0052331 | hemolysis by symbiont of host erythrocytes(GO:0019836) hemolysis in other organism(GO:0044179) hemolysis in other organism involved in symbiotic interaction(GO:0052331) |
1.2 | 3.6 | GO:0045409 | negative regulation of interleukin-6 biosynthetic process(GO:0045409) |
1.2 | 7.2 | GO:0035469 | determination of pancreatic left/right asymmetry(GO:0035469) determination of liver left/right asymmetry(GO:0071910) |
1.2 | 14.4 | GO:0070072 | proton-transporting V-type ATPase complex assembly(GO:0070070) vacuolar proton-transporting V-type ATPase complex assembly(GO:0070072) |
1.2 | 3.6 | GO:0006875 | cellular metal ion homeostasis(GO:0006875) |
1.2 | 3.5 | GO:2000341 | regulation of chemokine (C-X-C motif) ligand 2 production(GO:2000341) |
1.2 | 5.9 | GO:0031119 | tRNA pseudouridine synthesis(GO:0031119) |
1.2 | 11.8 | GO:0030889 | negative regulation of B cell proliferation(GO:0030889) |
1.2 | 9.4 | GO:0015705 | iodide transport(GO:0015705) |
1.2 | 15.2 | GO:0021702 | cerebellar Purkinje cell layer formation(GO:0021694) cerebellar Purkinje cell differentiation(GO:0021702) |
1.2 | 4.7 | GO:0090280 | positive regulation of calcium ion import(GO:0090280) |
1.2 | 2.3 | GO:0018243 | protein O-linked glycosylation via threonine(GO:0018243) |
1.2 | 3.5 | GO:0036118 | hyaluranon cable assembly(GO:0036118) regulation of hyaluranon cable assembly(GO:1900104) positive regulation of hyaluranon cable assembly(GO:1900106) |
1.2 | 1.2 | GO:0046666 | retinal cell programmed cell death(GO:0046666) regulation of retinal cell programmed cell death(GO:0046668) |
1.2 | 5.8 | GO:0006102 | isocitrate metabolic process(GO:0006102) |
1.2 | 5.8 | GO:2001181 | positive regulation of interleukin-10 secretion(GO:2001181) |
1.2 | 4.6 | GO:0072675 | multinuclear osteoclast differentiation(GO:0072674) osteoclast fusion(GO:0072675) |
1.2 | 10.4 | GO:0035799 | ureter maturation(GO:0035799) |
1.2 | 4.6 | GO:1902474 | positive regulation of protein localization to synapse(GO:1902474) |
1.2 | 11.5 | GO:0002430 | complement receptor mediated signaling pathway(GO:0002430) |
1.1 | 4.6 | GO:0097676 | histone H3-K36 dimethylation(GO:0097676) |
1.1 | 5.7 | GO:1904262 | negative regulation of TORC1 signaling(GO:1904262) |
1.1 | 1.1 | GO:0043308 | eosinophil activation involved in immune response(GO:0002278) eosinophil mediated immunity(GO:0002447) eosinophil activation(GO:0043307) eosinophil degranulation(GO:0043308) |
1.1 | 2.3 | GO:0030262 | apoptotic nuclear changes(GO:0030262) |
1.1 | 4.5 | GO:0006842 | tricarboxylic acid transport(GO:0006842) citrate transport(GO:0015746) |
1.1 | 1.1 | GO:0061153 | trachea submucosa development(GO:0061152) trachea gland development(GO:0061153) |
1.1 | 1.1 | GO:0032793 | positive regulation of CREB transcription factor activity(GO:0032793) |
1.1 | 20.2 | GO:0002523 | leukocyte migration involved in inflammatory response(GO:0002523) |
1.1 | 3.4 | GO:0007042 | lysosomal lumen acidification(GO:0007042) |
1.1 | 2.2 | GO:0042226 | interleukin-6 biosynthetic process(GO:0042226) |
1.1 | 3.3 | GO:0023016 | signal transduction by trans-phosphorylation(GO:0023016) |
1.1 | 3.3 | GO:1903800 | positive regulation of production of miRNAs involved in gene silencing by miRNA(GO:1903800) |
1.1 | 3.3 | GO:2000118 | regulation of sodium-dependent phosphate transport(GO:2000118) |
1.1 | 3.2 | GO:0006306 | DNA alkylation(GO:0006305) DNA methylation(GO:0006306) |
1.1 | 3.2 | GO:0060753 | regulation of mast cell chemotaxis(GO:0060753) |
1.1 | 1.1 | GO:0071286 | cellular response to magnesium ion(GO:0071286) |
1.1 | 3.2 | GO:2001034 | positive regulation of double-strand break repair via nonhomologous end joining(GO:2001034) |
1.1 | 5.3 | GO:0002315 | marginal zone B cell differentiation(GO:0002315) |
1.1 | 3.2 | GO:1903031 | regulation of microtubule plus-end binding(GO:1903031) positive regulation of microtubule plus-end binding(GO:1903033) |
1.1 | 24.2 | GO:0046339 | diacylglycerol metabolic process(GO:0046339) |
1.1 | 9.5 | GO:0044126 | regulation of growth of symbiont in host(GO:0044126) |
1.0 | 3.1 | GO:0036289 | peptidyl-serine autophosphorylation(GO:0036289) |
1.0 | 6.3 | GO:0061343 | cell adhesion involved in heart morphogenesis(GO:0061343) |
1.0 | 4.2 | GO:1904031 | positive regulation of cyclin-dependent protein kinase activity(GO:1904031) |
1.0 | 3.1 | GO:0045897 | positive regulation of transcription during mitosis(GO:0045897) |
1.0 | 5.2 | GO:1900004 | negative regulation of serine-type endopeptidase activity(GO:1900004) negative regulation of serine-type peptidase activity(GO:1902572) |
1.0 | 3.1 | GO:0010430 | fatty acid omega-oxidation(GO:0010430) |
1.0 | 4.1 | GO:0045591 | positive regulation of regulatory T cell differentiation(GO:0045591) |
1.0 | 3.1 | GO:0048213 | Golgi vesicle prefusion complex stabilization(GO:0048213) |
1.0 | 1.0 | GO:1900138 | negative regulation of phospholipase A2 activity(GO:1900138) |
1.0 | 9.2 | GO:2000143 | negative regulation of DNA-templated transcription, initiation(GO:2000143) |
1.0 | 23.4 | GO:0035338 | long-chain fatty-acyl-CoA biosynthetic process(GO:0035338) |
1.0 | 20.3 | GO:0090128 | regulation of synapse maturation(GO:0090128) |
1.0 | 3.0 | GO:1901052 | sarcosine metabolic process(GO:1901052) sarcosine catabolic process(GO:1901053) |
1.0 | 3.0 | GO:0003241 | growth involved in heart morphogenesis(GO:0003241) |
1.0 | 3.0 | GO:0009258 | 10-formyltetrahydrofolate catabolic process(GO:0009258) folic acid-containing compound catabolic process(GO:0009397) pteridine-containing compound catabolic process(GO:0042560) |
1.0 | 4.0 | GO:0001970 | positive regulation of activation of membrane attack complex(GO:0001970) |
1.0 | 6.0 | GO:0098535 | de novo centriole assembly(GO:0098535) |
1.0 | 5.0 | GO:0018101 | protein citrullination(GO:0018101) histone citrullination(GO:0036414) |
1.0 | 9.9 | GO:2001224 | positive regulation of neuron migration(GO:2001224) |
1.0 | 90.3 | GO:0006958 | complement activation, classical pathway(GO:0006958) |
1.0 | 3.0 | GO:0075044 | autophagy of host cells involved in interaction with symbiont(GO:0075044) autophagy involved in symbiotic interaction(GO:0075071) |
1.0 | 4.9 | GO:1904292 | regulation of ERAD pathway(GO:1904292) |
1.0 | 3.9 | GO:0010867 | positive regulation of triglyceride biosynthetic process(GO:0010867) |
1.0 | 2.0 | GO:1990418 | response to insulin-like growth factor stimulus(GO:1990418) |
1.0 | 3.9 | GO:0006740 | NADPH regeneration(GO:0006740) |
1.0 | 36.1 | GO:0048791 | calcium ion-regulated exocytosis of neurotransmitter(GO:0048791) |
1.0 | 4.9 | GO:0050885 | neuromuscular process controlling balance(GO:0050885) |
1.0 | 1.9 | GO:0035521 | monoubiquitinated histone deubiquitination(GO:0035521) monoubiquitinated histone H2A deubiquitination(GO:0035522) |
1.0 | 1.9 | GO:0009450 | gamma-aminobutyric acid catabolic process(GO:0009450) |
1.0 | 2.9 | GO:0061056 | sclerotome development(GO:0061056) |
1.0 | 1.9 | GO:0001575 | globoside metabolic process(GO:0001575) |
1.0 | 5.7 | GO:0045162 | clustering of voltage-gated sodium channels(GO:0045162) |
1.0 | 3.8 | GO:1903976 | negative regulation of glial cell migration(GO:1903976) |
1.0 | 9.5 | GO:0015074 | DNA integration(GO:0015074) |
0.9 | 2.8 | GO:1903244 | positive regulation of cardiac muscle adaptation(GO:0010615) positive regulation of cardiac muscle hypertrophy in response to stress(GO:1903244) |
0.9 | 4.7 | GO:0060136 | embryonic process involved in female pregnancy(GO:0060136) |
0.9 | 6.6 | GO:0098543 | detection of bacterium(GO:0016045) detection of other organism(GO:0098543) |
0.9 | 6.6 | GO:0048680 | positive regulation of axon regeneration(GO:0048680) |
0.9 | 2.8 | GO:0032700 | negative regulation of interleukin-17 production(GO:0032700) |
0.9 | 8.5 | GO:0071313 | cellular response to caffeine(GO:0071313) |
0.9 | 1.9 | GO:0072092 | ureteric bud invasion(GO:0072092) |
0.9 | 1.9 | GO:0014051 | gamma-aminobutyric acid secretion(GO:0014051) |
0.9 | 1.9 | GO:0008298 | intracellular mRNA localization(GO:0008298) |
0.9 | 2.8 | GO:0061055 | myotome development(GO:0061055) |
0.9 | 3.7 | GO:0090073 | positive regulation of protein homodimerization activity(GO:0090073) |
0.9 | 2.8 | GO:0051106 | positive regulation of DNA ligation(GO:0051106) |
0.9 | 2.8 | GO:0016476 | regulation of embryonic cell shape(GO:0016476) |
0.9 | 1.8 | GO:0007538 | primary sex determination(GO:0007538) |
0.9 | 3.6 | GO:0042048 | olfactory behavior(GO:0042048) |
0.9 | 2.7 | GO:0014807 | regulation of somitogenesis(GO:0014807) |
0.9 | 3.6 | GO:0070269 | pyroptosis(GO:0070269) |
0.9 | 5.3 | GO:0046689 | response to mercury ion(GO:0046689) |
0.9 | 7.1 | GO:0006216 | cytidine catabolic process(GO:0006216) cytidine deamination(GO:0009972) cytidine metabolic process(GO:0046087) |
0.9 | 5.3 | GO:0001867 | complement activation, lectin pathway(GO:0001867) |
0.9 | 2.6 | GO:1990168 | protein K33-linked deubiquitination(GO:1990168) |
0.9 | 1.7 | GO:0048312 | intracellular distribution of mitochondria(GO:0048312) |
0.9 | 5.2 | GO:0052422 | modulation by symbiont of host molecular function(GO:0052055) modulation of catalytic activity in other organism involved in symbiotic interaction(GO:0052203) modulation by host of symbiont catalytic activity(GO:0052422) |
0.9 | 6.1 | GO:0007217 | tachykinin receptor signaling pathway(GO:0007217) |
0.9 | 5.2 | GO:0018022 | peptidyl-lysine methylation(GO:0018022) |
0.9 | 2.6 | GO:0035621 | ER to Golgi ceramide transport(GO:0035621) |
0.9 | 2.6 | GO:0002949 | tRNA threonylcarbamoyladenosine modification(GO:0002949) |
0.9 | 8.6 | GO:0038180 | nerve growth factor signaling pathway(GO:0038180) |
0.9 | 4.3 | GO:0021510 | spinal cord development(GO:0021510) |
0.9 | 3.4 | GO:0001826 | inner cell mass cell differentiation(GO:0001826) |
0.8 | 5.9 | GO:0051533 | positive regulation of NFAT protein import into nucleus(GO:0051533) |
0.8 | 2.5 | GO:0098759 | response to interleukin-8(GO:0098758) cellular response to interleukin-8(GO:0098759) |
0.8 | 3.4 | GO:0002089 | lens morphogenesis in camera-type eye(GO:0002089) |
0.8 | 3.4 | GO:1902261 | positive regulation of delayed rectifier potassium channel activity(GO:1902261) |
0.8 | 1.7 | GO:0032849 | positive regulation of cellular pH reduction(GO:0032849) |
0.8 | 2.5 | GO:0071394 | cellular response to testosterone stimulus(GO:0071394) |
0.8 | 8.2 | GO:0001514 | selenocysteine incorporation(GO:0001514) translational readthrough(GO:0006451) |
0.8 | 8.2 | GO:1901374 | acetate ester transport(GO:1901374) |
0.8 | 7.4 | GO:0036066 | protein O-linked fucosylation(GO:0036066) |
0.8 | 2.5 | GO:2000296 | negative regulation of hydrogen peroxide catabolic process(GO:2000296) |
0.8 | 4.9 | GO:0048280 | vesicle fusion with Golgi apparatus(GO:0048280) |
0.8 | 2.5 | GO:1904924 | negative regulation of mitophagy in response to mitochondrial depolarization(GO:1904924) |
0.8 | 10.6 | GO:2000271 | positive regulation of fibroblast apoptotic process(GO:2000271) |
0.8 | 4.1 | GO:0019805 | quinolinate biosynthetic process(GO:0019805) |
0.8 | 2.4 | GO:0019605 | benzoate metabolic process(GO:0018874) butyrate metabolic process(GO:0019605) |
0.8 | 4.0 | GO:0097338 | response to clozapine(GO:0097338) |
0.8 | 3.2 | GO:1901509 | regulation of endothelial tube morphogenesis(GO:1901509) |
0.8 | 4.0 | GO:0051044 | positive regulation of membrane protein ectodomain proteolysis(GO:0051044) |
0.8 | 1.6 | GO:0045616 | regulation of keratinocyte differentiation(GO:0045616) |
0.8 | 4.8 | GO:0006196 | AMP catabolic process(GO:0006196) |
0.8 | 1.6 | GO:0045900 | negative regulation of translational elongation(GO:0045900) |
0.8 | 3.2 | GO:0010748 | regulation of plasma membrane long-chain fatty acid transport(GO:0010746) negative regulation of plasma membrane long-chain fatty acid transport(GO:0010748) |
0.8 | 1.6 | GO:0032661 | regulation of interleukin-18 production(GO:0032661) |
0.8 | 3.1 | GO:0007548 | sex differentiation(GO:0007548) |
0.8 | 21.9 | GO:0090383 | phagosome acidification(GO:0090383) |
0.8 | 2.3 | GO:0006421 | asparaginyl-tRNA aminoacylation(GO:0006421) |
0.8 | 3.9 | GO:0051791 | medium-chain fatty acid metabolic process(GO:0051791) |
0.8 | 1.5 | GO:1990253 | cellular response to leucine starvation(GO:1990253) |
0.8 | 3.1 | GO:0051970 | negative regulation of transmission of nerve impulse(GO:0051970) |
0.8 | 1.5 | GO:0051835 | positive regulation of synapse structural plasticity(GO:0051835) |
0.8 | 1.5 | GO:0000413 | protein peptidyl-prolyl isomerization(GO:0000413) |
0.8 | 7.7 | GO:1900745 | positive regulation of p38MAPK cascade(GO:1900745) |
0.8 | 6.9 | GO:1904781 | positive regulation of protein localization to centrosome(GO:1904781) |
0.8 | 6.1 | GO:0001574 | ganglioside biosynthetic process(GO:0001574) |
0.8 | 0.8 | GO:0046015 | regulation of transcription by glucose(GO:0046015) |
0.8 | 1.5 | GO:0021571 | rhombomere 5 development(GO:0021571) |
0.8 | 9.1 | GO:1900017 | positive regulation of cytokine production involved in inflammatory response(GO:1900017) |
0.8 | 4.5 | GO:0070777 | D-aspartate transport(GO:0070777) D-aspartate import(GO:0070779) |
0.8 | 2.3 | GO:0090370 | negative regulation of cholesterol efflux(GO:0090370) |
0.8 | 3.8 | GO:2000189 | positive regulation of cholesterol homeostasis(GO:2000189) |
0.8 | 8.3 | GO:0071688 | striated muscle myosin thick filament assembly(GO:0071688) |
0.7 | 0.7 | GO:2000969 | positive regulation of alpha-amino-3-hydroxy-5-methyl-4-isoxazole propionate selective glutamate receptor activity(GO:2000969) |
0.7 | 2.2 | GO:1900042 | positive regulation of interleukin-2 secretion(GO:1900042) |
0.7 | 11.2 | GO:0015874 | norepinephrine transport(GO:0015874) |
0.7 | 7.4 | GO:0048304 | positive regulation of isotype switching to IgG isotypes(GO:0048304) |
0.7 | 5.2 | GO:0046322 | negative regulation of fatty acid oxidation(GO:0046322) |
0.7 | 3.0 | GO:0072180 | mesonephric duct morphogenesis(GO:0072180) |
0.7 | 15.5 | GO:0071108 | protein K48-linked deubiquitination(GO:0071108) |
0.7 | 4.4 | GO:0003374 | dynamin polymerization involved in membrane fission(GO:0003373) dynamin polymerization involved in mitochondrial fission(GO:0003374) |
0.7 | 2.9 | GO:0006049 | UDP-N-acetylglucosamine catabolic process(GO:0006049) |
0.7 | 2.2 | GO:0010936 | negative regulation of macrophage cytokine production(GO:0010936) |
0.7 | 1.5 | GO:0070256 | negative regulation of circadian sleep/wake cycle, non-REM sleep(GO:0042323) negative regulation of mucus secretion(GO:0070256) |
0.7 | 2.9 | GO:0070306 | lens fiber cell differentiation(GO:0070306) |
0.7 | 2.9 | GO:0022027 | interkinetic nuclear migration(GO:0022027) |
0.7 | 1.4 | GO:0042320 | regulation of circadian sleep/wake cycle, REM sleep(GO:0042320) |
0.7 | 0.7 | GO:0006449 | regulation of translational termination(GO:0006449) |
0.7 | 0.7 | GO:0010966 | regulation of phosphate transport(GO:0010966) |
0.7 | 3.6 | GO:0006311 | meiotic gene conversion(GO:0006311) |
0.7 | 2.2 | GO:0051697 | protein delipidation(GO:0051697) |
0.7 | 10.7 | GO:0005513 | detection of calcium ion(GO:0005513) |
0.7 | 2.1 | GO:0043031 | negative regulation of macrophage activation(GO:0043031) |
0.7 | 3.5 | GO:0031642 | negative regulation of myelination(GO:0031642) |
0.7 | 3.5 | GO:0050966 | detection of mechanical stimulus involved in sensory perception of pain(GO:0050966) |
0.7 | 2.8 | GO:2001256 | regulation of store-operated calcium entry(GO:2001256) |
0.7 | 2.1 | GO:0048867 | stem cell fate determination(GO:0048867) |
0.7 | 0.7 | GO:0046533 | negative regulation of photoreceptor cell differentiation(GO:0046533) |
0.7 | 11.9 | GO:1902259 | regulation of delayed rectifier potassium channel activity(GO:1902259) |
0.7 | 3.5 | GO:0010212 | response to ionizing radiation(GO:0010212) |
0.7 | 2.1 | GO:0098501 | polynucleotide dephosphorylation(GO:0098501) |
0.7 | 4.9 | GO:0031998 | regulation of fatty acid beta-oxidation(GO:0031998) |
0.7 | 4.8 | GO:0007258 | JUN phosphorylation(GO:0007258) |
0.7 | 4.1 | GO:0060373 | regulation of ventricular cardiac muscle cell membrane depolarization(GO:0060373) |
0.7 | 2.0 | GO:2000786 | positive regulation of autophagosome assembly(GO:2000786) |
0.7 | 2.7 | GO:0060332 | positive regulation of response to interferon-gamma(GO:0060332) positive regulation of interferon-gamma-mediated signaling pathway(GO:0060335) |
0.7 | 1.4 | GO:0010572 | positive regulation of platelet activation(GO:0010572) |
0.7 | 10.8 | GO:0061025 | membrane fusion(GO:0061025) |
0.7 | 2.0 | GO:0060484 | lung-associated mesenchyme development(GO:0060484) |
0.7 | 12.8 | GO:0035090 | maintenance of apical/basal cell polarity(GO:0035090) maintenance of epithelial cell apical/basal polarity(GO:0045199) |
0.7 | 6.1 | GO:0007368 | determination of left/right symmetry(GO:0007368) |
0.7 | 3.4 | GO:1901906 | diadenosine polyphosphate catabolic process(GO:0015961) diphosphoinositol polyphosphate metabolic process(GO:0071543) diadenosine pentaphosphate metabolic process(GO:1901906) diadenosine pentaphosphate catabolic process(GO:1901907) diadenosine hexaphosphate metabolic process(GO:1901908) diadenosine hexaphosphate catabolic process(GO:1901909) adenosine 5'-(hexahydrogen pentaphosphate) metabolic process(GO:1901910) adenosine 5'-(hexahydrogen pentaphosphate) catabolic process(GO:1901911) |
0.7 | 8.1 | GO:0020027 | hemoglobin metabolic process(GO:0020027) |
0.7 | 1.3 | GO:0002865 | negative regulation of acute inflammatory response to antigenic stimulus(GO:0002865) |
0.7 | 6.7 | GO:0039536 | negative regulation of RIG-I signaling pathway(GO:0039536) |
0.7 | 4.0 | GO:0090043 | regulation of tubulin deacetylation(GO:0090043) |
0.7 | 2.7 | GO:2000544 | cell chemotaxis to fibroblast growth factor(GO:0035766) endothelial cell chemotaxis to fibroblast growth factor(GO:0035768) regulation of cell chemotaxis to fibroblast growth factor(GO:1904847) regulation of endothelial cell chemotaxis to fibroblast growth factor(GO:2000544) |
0.7 | 1.3 | GO:0031860 | telomeric 3' overhang formation(GO:0031860) |
0.7 | 4.7 | GO:0002741 | positive regulation of cytokine secretion involved in immune response(GO:0002741) |
0.7 | 1.3 | GO:0003220 | left ventricular cardiac muscle tissue morphogenesis(GO:0003220) cell proliferation involved in heart valve morphogenesis(GO:0003249) regulation of cell proliferation involved in heart valve morphogenesis(GO:0003250) kidney mesenchyme morphogenesis(GO:0072131) metanephric mesenchyme morphogenesis(GO:0072133) nephrogenic mesenchyme morphogenesis(GO:0072134) cell proliferation involved in heart valve development(GO:2000793) |
0.7 | 6.0 | GO:0034115 | negative regulation of heterotypic cell-cell adhesion(GO:0034115) regulation of cell-cell adhesion involved in gastrulation(GO:0070587) |
0.7 | 0.7 | GO:0048242 | regulation of epinephrine secretion(GO:0014060) epinephrine secretion(GO:0048242) |
0.7 | 3.3 | GO:0035063 | nuclear speck organization(GO:0035063) |
0.7 | 13.2 | GO:0071420 | cellular response to histamine(GO:0071420) |
0.7 | 4.0 | GO:0002860 | positive regulation of natural killer cell mediated immune response to tumor cell(GO:0002857) positive regulation of natural killer cell mediated cytotoxicity directed against tumor cell target(GO:0002860) |
0.7 | 3.3 | GO:0043117 | positive regulation of vascular permeability(GO:0043117) |
0.7 | 1.3 | GO:0002025 | vasodilation by norepinephrine-epinephrine involved in regulation of systemic arterial blood pressure(GO:0002025) |
0.7 | 0.7 | GO:0035026 | leading edge cell differentiation(GO:0035026) |
0.7 | 5.9 | GO:0045023 | G0 to G1 transition(GO:0045023) |
0.7 | 11.1 | GO:0090022 | regulation of neutrophil chemotaxis(GO:0090022) |
0.7 | 4.6 | GO:0016098 | monoterpenoid metabolic process(GO:0016098) |
0.7 | 0.7 | GO:0019254 | carnitine metabolic process, CoA-linked(GO:0019254) |
0.7 | 4.6 | GO:0006069 | ethanol oxidation(GO:0006069) |
0.6 | 12.3 | GO:0071397 | cellular response to cholesterol(GO:0071397) |
0.6 | 0.6 | GO:0060474 | positive regulation of sperm motility involved in capacitation(GO:0060474) |
0.6 | 4.5 | GO:0061179 | negative regulation of insulin secretion involved in cellular response to glucose stimulus(GO:0061179) |
0.6 | 1.9 | GO:0051684 | maintenance of Golgi location(GO:0051684) |
0.6 | 3.2 | GO:0090080 | positive regulation of MAPKKK cascade by fibroblast growth factor receptor signaling pathway(GO:0090080) |
0.6 | 2.6 | GO:0051026 | chiasma assembly(GO:0051026) |
0.6 | 3.2 | GO:0060718 | chorionic trophoblast cell differentiation(GO:0060718) |
0.6 | 10.9 | GO:0043562 | cellular response to nitrogen starvation(GO:0006995) cellular response to nitrogen levels(GO:0043562) |
0.6 | 3.8 | GO:0061737 | leukotriene signaling pathway(GO:0061737) |
0.6 | 4.4 | GO:1903690 | negative regulation of wound healing, spreading of epidermal cells(GO:1903690) |
0.6 | 0.6 | GO:0038095 | Fc-epsilon receptor signaling pathway(GO:0038095) |
0.6 | 2.5 | GO:0006127 | glycerophosphate shuttle(GO:0006127) |
0.6 | 34.9 | GO:0006501 | C-terminal protein lipidation(GO:0006501) |
0.6 | 1.9 | GO:1904823 | pyrimidine nucleobase transport(GO:0015855) purine nucleobase transmembrane transport(GO:1904823) |
0.6 | 1.9 | GO:0051102 | DNA ligation involved in DNA recombination(GO:0051102) |
0.6 | 12.4 | GO:0006884 | cell volume homeostasis(GO:0006884) |
0.6 | 1.8 | GO:0001973 | adenosine receptor signaling pathway(GO:0001973) |
0.6 | 1.8 | GO:0060018 | astrocyte fate commitment(GO:0060018) |
0.6 | 1.2 | GO:0040023 | nuclear migration(GO:0007097) establishment of nucleus localization(GO:0040023) |
0.6 | 6.7 | GO:0030502 | negative regulation of bone mineralization(GO:0030502) |
0.6 | 3.7 | GO:0021999 | neural plate anterior/posterior regionalization(GO:0021999) |
0.6 | 3.6 | GO:0046208 | spermine catabolic process(GO:0046208) |
0.6 | 2.4 | GO:0061762 | CAMKK-AMPK signaling cascade(GO:0061762) |
0.6 | 6.1 | GO:0036005 | response to macrophage colony-stimulating factor(GO:0036005) cellular response to macrophage colony-stimulating factor stimulus(GO:0036006) |
0.6 | 3.0 | GO:0061337 | cardiac conduction(GO:0061337) |
0.6 | 3.0 | GO:0006398 | mRNA 3'-end processing by stem-loop binding and cleavage(GO:0006398) |
0.6 | 4.2 | GO:0090141 | positive regulation of mitochondrial fission(GO:0090141) |
0.6 | 1.8 | GO:1900619 | acetylcholine metabolic process(GO:0008291) acetate ester metabolic process(GO:1900619) |
0.6 | 3.0 | GO:1903715 | regulation of aerobic respiration(GO:1903715) |
0.6 | 5.4 | GO:1903358 | regulation of Golgi organization(GO:1903358) |
0.6 | 4.8 | GO:0032020 | ISG15-protein conjugation(GO:0032020) |
0.6 | 1.8 | GO:0071140 | resolution of recombination intermediates(GO:0071139) resolution of mitotic recombination intermediates(GO:0071140) |
0.6 | 3.6 | GO:0060059 | embryonic retina morphogenesis in camera-type eye(GO:0060059) |
0.6 | 1.8 | GO:0044537 | regulation of circulating fibrinogen levels(GO:0044537) |
0.6 | 4.2 | GO:0001672 | regulation of chromatin assembly or disassembly(GO:0001672) |
0.6 | 14.2 | GO:0045063 | T-helper 1 cell differentiation(GO:0045063) |
0.6 | 4.1 | GO:0014877 | response to muscle inactivity involved in regulation of muscle adaptation(GO:0014877) response to denervation involved in regulation of muscle adaptation(GO:0014894) |
0.6 | 5.3 | GO:0050860 | negative regulation of T cell receptor signaling pathway(GO:0050860) |
0.6 | 8.8 | GO:0033005 | positive regulation of mast cell activation(GO:0033005) positive regulation of mast cell activation involved in immune response(GO:0033008) positive regulation of mast cell degranulation(GO:0043306) |
0.6 | 2.3 | GO:0097091 | synaptic vesicle clustering(GO:0097091) |
0.6 | 7.6 | GO:0033539 | fatty acid beta-oxidation using acyl-CoA dehydrogenase(GO:0033539) |
0.6 | 1.7 | GO:1902202 | regulation of hepatocyte growth factor receptor signaling pathway(GO:1902202) |
0.6 | 2.3 | GO:0042982 | amyloid precursor protein metabolic process(GO:0042982) |
0.6 | 5.2 | GO:0043653 | mitochondrial fragmentation involved in apoptotic process(GO:0043653) |
0.6 | 3.5 | GO:0006003 | fructose 2,6-bisphosphate metabolic process(GO:0006003) |
0.6 | 4.0 | GO:0045648 | positive regulation of erythrocyte differentiation(GO:0045648) |
0.6 | 1.7 | GO:0021919 | BMP signaling pathway involved in spinal cord dorsal/ventral patterning(GO:0021919) |
0.6 | 36.7 | GO:0031338 | regulation of vesicle fusion(GO:0031338) |
0.6 | 2.9 | GO:0050690 | regulation of defense response to virus by virus(GO:0050690) |
0.6 | 3.4 | GO:0046460 | neutral lipid biosynthetic process(GO:0046460) acylglycerol biosynthetic process(GO:0046463) |
0.6 | 11.4 | GO:0097503 | sialylation(GO:0097503) |
0.6 | 22.7 | GO:0050853 | B cell receptor signaling pathway(GO:0050853) |
0.6 | 2.8 | GO:2001106 | regulation of Rho guanyl-nucleotide exchange factor activity(GO:2001106) |
0.6 | 0.6 | GO:0007039 | protein catabolic process in the vacuole(GO:0007039) |
0.6 | 3.4 | GO:0050942 | positive regulation of pigment cell differentiation(GO:0050942) |
0.6 | 14.7 | GO:0051181 | cofactor transport(GO:0051181) |
0.6 | 1.7 | GO:0030860 | regulation of polarized epithelial cell differentiation(GO:0030860) specification of axis polarity(GO:0065001) |
0.6 | 5.6 | GO:0033299 | secretion of lysosomal enzymes(GO:0033299) |
0.6 | 2.8 | GO:0071374 | cellular response to parathyroid hormone stimulus(GO:0071374) |
0.6 | 3.9 | GO:0010623 | programmed cell death involved in cell development(GO:0010623) |
0.6 | 7.8 | GO:0035493 | SNARE complex assembly(GO:0035493) |
0.6 | 1.7 | GO:0007221 | positive regulation of transcription of Notch receptor target(GO:0007221) |
0.6 | 0.6 | GO:0002739 | regulation of cytokine secretion involved in immune response(GO:0002739) negative regulation of cytokine secretion involved in immune response(GO:0002740) |
0.6 | 1.1 | GO:0006662 | glycerol ether metabolic process(GO:0006662) ether metabolic process(GO:0018904) |
0.6 | 84.6 | GO:0007156 | homophilic cell adhesion via plasma membrane adhesion molecules(GO:0007156) |
0.6 | 2.2 | GO:1900190 | biofilm formation(GO:0042710) single-species biofilm formation(GO:0044010) single-species biofilm formation in or on host organism(GO:0044407) regulation of single-species biofilm formation(GO:1900190) negative regulation of single-species biofilm formation(GO:1900191) regulation of single-species biofilm formation in or on host organism(GO:1900228) negative regulation of single-species biofilm formation in or on host organism(GO:1900229) |
0.6 | 2.2 | GO:0010961 | cellular magnesium ion homeostasis(GO:0010961) |
0.6 | 1.1 | GO:0032972 | regulation of muscle filament sliding(GO:0032971) regulation of muscle filament sliding speed(GO:0032972) |
0.5 | 1.6 | GO:0002888 | positive regulation of myeloid leukocyte mediated immunity(GO:0002888) |
0.5 | 2.2 | GO:1904491 | protein localization to ciliary transition zone(GO:1904491) |
0.5 | 10.3 | GO:0006895 | Golgi to endosome transport(GO:0006895) |
0.5 | 1.6 | GO:0051956 | negative regulation of amino acid transport(GO:0051956) |
0.5 | 1.6 | GO:0090245 | axis elongation involved in somitogenesis(GO:0090245) |
0.5 | 3.2 | GO:1990001 | inhibition of cysteine-type endopeptidase activity involved in apoptotic process(GO:1990001) |
0.5 | 8.1 | GO:0043369 | CD4-positive or CD8-positive, alpha-beta T cell lineage commitment(GO:0043369) |
0.5 | 3.8 | GO:0071386 | cellular response to corticosterone stimulus(GO:0071386) |
0.5 | 1.6 | GO:0043153 | entrainment of circadian clock by photoperiod(GO:0043153) |
0.5 | 16.6 | GO:0034080 | CENP-A containing nucleosome assembly(GO:0034080) CENP-A containing chromatin organization(GO:0061641) |
0.5 | 1.1 | GO:0032621 | interleukin-18 production(GO:0032621) |
0.5 | 8.0 | GO:0060044 | negative regulation of cardiac muscle cell proliferation(GO:0060044) |
0.5 | 2.1 | GO:0034959 | substance P catabolic process(GO:0010814) calcitonin catabolic process(GO:0010816) endothelin maturation(GO:0034959) |
0.5 | 0.5 | GO:0070253 | somatostatin secretion(GO:0070253) |
0.5 | 11.0 | GO:0097484 | dendrite extension(GO:0097484) |
0.5 | 4.7 | GO:0042908 | xenobiotic transport(GO:0042908) |
0.5 | 3.7 | GO:0070206 | protein trimerization(GO:0070206) |
0.5 | 3.6 | GO:0015824 | proline transport(GO:0015824) |
0.5 | 3.1 | GO:0071421 | manganese ion transmembrane transport(GO:0071421) |
0.5 | 4.1 | GO:0010764 | negative regulation of fibroblast migration(GO:0010764) |
0.5 | 2.6 | GO:0032754 | positive regulation of interleukin-5 production(GO:0032754) |
0.5 | 3.1 | GO:0051414 | response to cortisol(GO:0051414) |
0.5 | 0.5 | GO:0046579 | positive regulation of Ras protein signal transduction(GO:0046579) |
0.5 | 4.1 | GO:0016556 | mRNA modification(GO:0016556) |
0.5 | 4.1 | GO:0034587 | piRNA metabolic process(GO:0034587) |
0.5 | 2.0 | GO:0055009 | atrial cardiac muscle tissue development(GO:0003228) atrial cardiac muscle tissue morphogenesis(GO:0055009) |
0.5 | 2.0 | GO:1901490 | regulation of lymphangiogenesis(GO:1901490) |
0.5 | 5.0 | GO:0003351 | epithelial cilium movement(GO:0003351) |
0.5 | 13.1 | GO:0047496 | vesicle transport along microtubule(GO:0047496) |
0.5 | 3.0 | GO:0021895 | cerebral cortex neuron differentiation(GO:0021895) |
0.5 | 4.5 | GO:0071830 | chylomicron remnant clearance(GO:0034382) triglyceride-rich lipoprotein particle clearance(GO:0071830) |
0.5 | 1.5 | GO:0042118 | endothelial cell activation(GO:0042118) |
0.5 | 4.5 | GO:0015747 | urate transport(GO:0015747) |
0.5 | 2.5 | GO:1902514 | regulation of calcium ion transmembrane transport via high voltage-gated calcium channel(GO:1902514) positive regulation of calcium ion transmembrane transport via high voltage-gated calcium channel(GO:1904879) |
0.5 | 4.0 | GO:0045954 | positive regulation of natural killer cell mediated immunity(GO:0002717) positive regulation of natural killer cell mediated cytotoxicity(GO:0045954) |
0.5 | 1.5 | GO:0070781 | response to biotin(GO:0070781) |
0.5 | 3.9 | GO:0071526 | semaphorin-plexin signaling pathway(GO:0071526) |
0.5 | 3.5 | GO:0035092 | sperm chromatin condensation(GO:0035092) |
0.5 | 9.9 | GO:0006646 | phosphatidylethanolamine biosynthetic process(GO:0006646) phosphatidylethanolamine metabolic process(GO:0046337) |
0.5 | 3.4 | GO:0007256 | activation of JNKK activity(GO:0007256) |
0.5 | 7.4 | GO:0035970 | peptidyl-threonine dephosphorylation(GO:0035970) |
0.5 | 1.0 | GO:0009566 | fertilization(GO:0009566) |
0.5 | 1.0 | GO:0071104 | response to interleukin-9(GO:0071104) |
0.5 | 2.4 | GO:0050857 | positive regulation of antigen receptor-mediated signaling pathway(GO:0050857) |
0.5 | 3.9 | GO:0071260 | cellular response to mechanical stimulus(GO:0071260) |
0.5 | 5.8 | GO:0042355 | fucose catabolic process(GO:0019317) L-fucose metabolic process(GO:0042354) L-fucose catabolic process(GO:0042355) |
0.5 | 12.5 | GO:0016601 | Rac protein signal transduction(GO:0016601) |
0.5 | 7.7 | GO:0098743 | cell aggregation(GO:0098743) |
0.5 | 1.0 | GO:0033326 | cerebrospinal fluid secretion(GO:0033326) |
0.5 | 2.4 | GO:0044266 | angiotensin catabolic process in blood(GO:0002005) multicellular organismal protein catabolic process(GO:0044254) protein digestion(GO:0044256) multicellular organismal macromolecule catabolic process(GO:0044266) |
0.5 | 1.9 | GO:0046952 | ketone body catabolic process(GO:0046952) |
0.5 | 4.8 | GO:0051412 | response to corticosterone(GO:0051412) |
0.5 | 7.7 | GO:0050651 | dermatan sulfate proteoglycan biosynthetic process(GO:0050651) |
0.5 | 4.8 | GO:0002052 | positive regulation of neuroblast proliferation(GO:0002052) |
0.5 | 5.3 | GO:0098789 | pre-mRNA cleavage required for polyadenylation(GO:0098789) |
0.5 | 1.9 | GO:0035425 | autocrine signaling(GO:0035425) |
0.5 | 0.9 | GO:0060371 | regulation of atrial cardiac muscle cell membrane depolarization(GO:0060371) |
0.5 | 1.4 | GO:0071043 | CUT catabolic process(GO:0071034) CUT metabolic process(GO:0071043) |
0.5 | 1.4 | GO:2000491 | positive regulation of hepatic stellate cell activation(GO:2000491) |
0.5 | 1.4 | GO:1904996 | positive regulation of leukocyte adhesion to vascular endothelial cell(GO:1904996) |
0.5 | 5.2 | GO:0046949 | fatty-acyl-CoA biosynthetic process(GO:0046949) |
0.5 | 2.3 | GO:0006741 | NADP biosynthetic process(GO:0006741) |
0.5 | 2.8 | GO:0017121 | phospholipid scrambling(GO:0017121) |
0.5 | 5.1 | GO:0045986 | negative regulation of smooth muscle contraction(GO:0045986) |
0.5 | 2.3 | GO:0090208 | positive regulation of triglyceride metabolic process(GO:0090208) |
0.5 | 1.4 | GO:0051135 | positive regulation of NK T cell activation(GO:0051135) |
0.5 | 3.2 | GO:0043587 | tongue morphogenesis(GO:0043587) |
0.5 | 0.5 | GO:1900747 | negative regulation of vascular endothelial growth factor signaling pathway(GO:1900747) negative regulation of cellular response to vascular endothelial growth factor stimulus(GO:1902548) |
0.5 | 0.9 | GO:2001013 | epithelial cell proliferation involved in renal tubule morphogenesis(GO:2001013) |
0.5 | 2.3 | GO:0070212 | protein poly-ADP-ribosylation(GO:0070212) |
0.5 | 1.4 | GO:0060023 | soft palate development(GO:0060023) |
0.5 | 113.4 | GO:0002250 | adaptive immune response(GO:0002250) |
0.5 | 14.2 | GO:0035235 | ionotropic glutamate receptor signaling pathway(GO:0035235) |
0.5 | 3.2 | GO:0019509 | L-methionine biosynthetic process from methylthioadenosine(GO:0019509) |
0.5 | 4.1 | GO:0036158 | outer dynein arm assembly(GO:0036158) |
0.5 | 3.7 | GO:0034088 | maintenance of sister chromatid cohesion(GO:0034086) maintenance of mitotic sister chromatid cohesion(GO:0034088) |
0.5 | 3.2 | GO:0071447 | cellular response to hydroperoxide(GO:0071447) |
0.5 | 5.0 | GO:0072017 | distal tubule development(GO:0072017) |
0.5 | 6.8 | GO:0045475 | locomotor rhythm(GO:0045475) |
0.4 | 2.2 | GO:0035977 | protein deglycosylation involved in glycoprotein catabolic process(GO:0035977) glycoprotein ERAD pathway(GO:0097466) mannose trimming involved in glycoprotein ERAD pathway(GO:1904382) |
0.4 | 2.6 | GO:0017185 | peptidyl-lysine hydroxylation(GO:0017185) |
0.4 | 0.4 | GO:0051461 | positive regulation of corticotropin secretion(GO:0051461) |
0.4 | 2.2 | GO:0030916 | otic vesicle formation(GO:0030916) |
0.4 | 16.6 | GO:0038083 | peptidyl-tyrosine autophosphorylation(GO:0038083) |
0.4 | 10.0 | GO:0045948 | positive regulation of translational initiation(GO:0045948) |
0.4 | 2.2 | GO:0033353 | S-adenosylmethionine cycle(GO:0033353) |
0.4 | 3.5 | GO:0007175 | negative regulation of epidermal growth factor-activated receptor activity(GO:0007175) |
0.4 | 2.2 | GO:2000766 | negative regulation of cytoplasmic translation(GO:2000766) |
0.4 | 2.2 | GO:0061314 | Notch signaling involved in heart development(GO:0061314) |
0.4 | 1.3 | GO:0038001 | paracrine signaling(GO:0038001) |
0.4 | 2.6 | GO:0097411 | hypoxia-inducible factor-1alpha signaling pathway(GO:0097411) |
0.4 | 1.7 | GO:0018094 | protein polyglycylation(GO:0018094) |
0.4 | 6.4 | GO:0006681 | galactosylceramide metabolic process(GO:0006681) galactolipid metabolic process(GO:0019374) |
0.4 | 3.4 | GO:0021527 | spinal cord association neuron differentiation(GO:0021527) |
0.4 | 2.5 | GO:0032287 | peripheral nervous system myelin maintenance(GO:0032287) |
0.4 | 5.9 | GO:0006068 | ethanol metabolic process(GO:0006067) ethanol catabolic process(GO:0006068) |
0.4 | 0.8 | GO:0035754 | B cell chemotaxis(GO:0035754) |
0.4 | 9.6 | GO:0007398 | ectoderm development(GO:0007398) |
0.4 | 2.9 | GO:0072079 | nephron tubule formation(GO:0072079) |
0.4 | 2.8 | GO:0044245 | polysaccharide digestion(GO:0044245) |
0.4 | 0.8 | GO:0032286 | central nervous system myelin maintenance(GO:0032286) |
0.4 | 2.0 | GO:0008272 | sulfate transport(GO:0008272) |
0.4 | 3.6 | GO:0070814 | hydrogen sulfide biosynthetic process(GO:0070814) |
0.4 | 4.0 | GO:0005981 | regulation of glycogen catabolic process(GO:0005981) |
0.4 | 0.4 | GO:0032058 | positive regulation of translational initiation in response to stress(GO:0032058) |
0.4 | 4.0 | GO:0021854 | hypothalamus development(GO:0021854) |
0.4 | 3.2 | GO:0034260 | negative regulation of GTPase activity(GO:0034260) |
0.4 | 15.2 | GO:0006968 | cellular defense response(GO:0006968) |
0.4 | 4.0 | GO:0006600 | creatine metabolic process(GO:0006600) |
0.4 | 3.6 | GO:0043406 | positive regulation of MAP kinase activity(GO:0043406) |
0.4 | 1.6 | GO:0019086 | late viral transcription(GO:0019086) |
0.4 | 3.1 | GO:0030575 | nuclear body organization(GO:0030575) |
0.4 | 2.7 | GO:0032516 | positive regulation of phosphoprotein phosphatase activity(GO:0032516) |
0.4 | 2.7 | GO:0035865 | cellular response to potassium ion(GO:0035865) |
0.4 | 0.8 | GO:0032639 | TRAIL production(GO:0032639) regulation of TRAIL production(GO:0032679) positive regulation of TRAIL production(GO:0032759) |
0.4 | 12.7 | GO:0018149 | peptide cross-linking(GO:0018149) |
0.4 | 5.0 | GO:0061756 | leukocyte adhesion to vascular endothelial cell(GO:0061756) |
0.4 | 6.9 | GO:0006904 | vesicle docking involved in exocytosis(GO:0006904) |
0.4 | 6.1 | GO:0035640 | exploration behavior(GO:0035640) |
0.4 | 1.1 | GO:0006422 | aspartyl-tRNA aminoacylation(GO:0006422) |
0.4 | 4.1 | GO:0034656 | nucleobase-containing small molecule catabolic process(GO:0034656) |
0.4 | 3.7 | GO:0018026 | peptidyl-lysine monomethylation(GO:0018026) |
0.4 | 1.5 | GO:0018377 | protein myristoylation(GO:0018377) |
0.4 | 3.0 | GO:0006013 | mannose metabolic process(GO:0006013) |
0.4 | 5.6 | GO:0032728 | positive regulation of interferon-beta production(GO:0032728) |
0.4 | 5.2 | GO:0007202 | activation of phospholipase C activity(GO:0007202) |
0.4 | 2.6 | GO:0008343 | adult feeding behavior(GO:0008343) |
0.4 | 1.9 | GO:0010761 | fibroblast migration(GO:0010761) |
0.4 | 1.5 | GO:0060741 | prostate gland stromal morphogenesis(GO:0060741) |
0.4 | 2.5 | GO:1990845 | adaptive thermogenesis(GO:1990845) |
0.4 | 2.2 | GO:0036342 | post-anal tail morphogenesis(GO:0036342) |
0.4 | 4.7 | GO:0034393 | positive regulation of smooth muscle cell apoptotic process(GO:0034393) |
0.4 | 4.0 | GO:0098719 | sodium ion import(GO:0097369) sodium ion import across plasma membrane(GO:0098719) sodium ion import into cell(GO:1990118) |
0.4 | 4.0 | GO:0045008 | depyrimidination(GO:0045008) |
0.4 | 3.2 | GO:0000395 | mRNA 5'-splice site recognition(GO:0000395) |
0.4 | 8.6 | GO:0042417 | dopamine metabolic process(GO:0042417) |
0.4 | 1.8 | GO:1901090 | regulation of protein tetramerization(GO:1901090) negative regulation of protein tetramerization(GO:1901091) regulation of protein homotetramerization(GO:1901093) negative regulation of protein homotetramerization(GO:1901094) |
0.4 | 6.7 | GO:0035590 | purinergic nucleotide receptor signaling pathway(GO:0035590) |
0.4 | 1.8 | GO:0015812 | gamma-aminobutyric acid transport(GO:0015812) |
0.4 | 2.1 | GO:0032411 | positive regulation of transporter activity(GO:0032411) |
0.4 | 3.5 | GO:0044804 | nucleophagy(GO:0044804) |
0.4 | 1.8 | GO:0032025 | response to cobalt ion(GO:0032025) |
0.4 | 2.5 | GO:0043523 | regulation of neuron apoptotic process(GO:0043523) |
0.4 | 2.1 | GO:0032026 | response to magnesium ion(GO:0032026) |
0.4 | 8.4 | GO:0014047 | glutamate secretion(GO:0014047) |
0.3 | 4.9 | GO:0016558 | protein import into peroxisome matrix(GO:0016558) |
0.3 | 4.5 | GO:0006491 | N-glycan processing(GO:0006491) |
0.3 | 8.7 | GO:0007214 | gamma-aminobutyric acid signaling pathway(GO:0007214) |
0.3 | 2.8 | GO:0007028 | cytoplasm organization(GO:0007028) |
0.3 | 6.2 | GO:0061003 | positive regulation of dendritic spine morphogenesis(GO:0061003) |
0.3 | 1.0 | GO:0038193 | thromboxane A2 signaling pathway(GO:0038193) |
0.3 | 1.0 | GO:0060296 | negative regulation of appetite by leptin-mediated signaling pathway(GO:0038108) regulation of cilium movement involved in cell motility(GO:0060295) regulation of cilium beat frequency involved in ciliary motility(GO:0060296) regulation of cilium-dependent cell motility(GO:1902019) |
0.3 | 1.7 | GO:0035774 | positive regulation of insulin secretion involved in cellular response to glucose stimulus(GO:0035774) |
0.3 | 2.0 | GO:0051152 | positive regulation of smooth muscle cell differentiation(GO:0051152) |
0.3 | 1.0 | GO:1901842 | negative regulation of high voltage-gated calcium channel activity(GO:1901842) |
0.3 | 1.4 | GO:0006848 | pyruvate transport(GO:0006848) pyruvate transmembrane transport(GO:1901475) |
0.3 | 1.4 | GO:0060075 | regulation of resting membrane potential(GO:0060075) |
0.3 | 2.4 | GO:0034983 | peptidyl-lysine deacetylation(GO:0034983) |
0.3 | 3.7 | GO:0043046 | DNA methylation involved in gamete generation(GO:0043046) |
0.3 | 3.3 | GO:0010990 | regulation of SMAD protein complex assembly(GO:0010990) negative regulation of SMAD protein complex assembly(GO:0010991) |
0.3 | 3.3 | GO:0032364 | oxygen homeostasis(GO:0032364) |
0.3 | 15.3 | GO:0001510 | RNA methylation(GO:0001510) |
0.3 | 0.3 | GO:0072677 | eosinophil migration(GO:0072677) |
0.3 | 3.0 | GO:1904152 | regulation of retrograde protein transport, ER to cytosol(GO:1904152) |
0.3 | 0.7 | GO:0006447 | regulation of translational initiation by iron(GO:0006447) positive regulation of translational initiation by iron(GO:0045994) |
0.3 | 1.3 | GO:0090084 | negative regulation of inclusion body assembly(GO:0090084) |
0.3 | 0.3 | GO:0031055 | chromatin remodeling at centromere(GO:0031055) |
0.3 | 1.6 | GO:0048535 | lymph node development(GO:0048535) |
0.3 | 1.0 | GO:0043456 | regulation of pentose-phosphate shunt(GO:0043456) |
0.3 | 1.3 | GO:0060546 | negative regulation of necroptotic process(GO:0060546) negative regulation of necrotic cell death(GO:0060547) |
0.3 | 1.6 | GO:0032929 | negative regulation of superoxide anion generation(GO:0032929) |
0.3 | 1.6 | GO:0021853 | cerebral cortex GABAergic interneuron migration(GO:0021853) interneuron migration(GO:1904936) |
0.3 | 6.6 | GO:1903846 | positive regulation of transforming growth factor beta receptor signaling pathway(GO:0030511) positive regulation of cellular response to transforming growth factor beta stimulus(GO:1903846) |
0.3 | 0.6 | GO:0030299 | intestinal cholesterol absorption(GO:0030299) intestinal lipid absorption(GO:0098856) |
0.3 | 0.6 | GO:0006145 | purine nucleobase catabolic process(GO:0006145) |
0.3 | 8.8 | GO:0072600 | establishment of protein localization to Golgi(GO:0072600) |
0.3 | 6.9 | GO:0044803 | multi-organism membrane organization(GO:0044803) |
0.3 | 0.3 | GO:0044339 | canonical Wnt signaling pathway involved in osteoblast differentiation(GO:0044339) |
0.3 | 0.6 | GO:0045348 | positive regulation of MHC class II biosynthetic process(GO:0045348) |
0.3 | 10.3 | GO:0045744 | negative regulation of G-protein coupled receptor protein signaling pathway(GO:0045744) |
0.3 | 2.2 | GO:0060158 | phospholipase C-activating dopamine receptor signaling pathway(GO:0060158) |
0.3 | 1.9 | GO:1903898 | negative regulation of PERK-mediated unfolded protein response(GO:1903898) |
0.3 | 0.6 | GO:0006388 | tRNA splicing, via endonucleolytic cleavage and ligation(GO:0006388) |
0.3 | 1.5 | GO:0010735 | positive regulation of transcription via serum response element binding(GO:0010735) |
0.3 | 7.0 | GO:0031663 | lipopolysaccharide-mediated signaling pathway(GO:0031663) |
0.3 | 1.5 | GO:0010886 | positive regulation of cholesterol storage(GO:0010886) |
0.3 | 15.2 | GO:0050911 | detection of chemical stimulus involved in sensory perception of smell(GO:0050911) |
0.3 | 2.1 | GO:0050974 | detection of mechanical stimulus involved in sensory perception(GO:0050974) |
0.3 | 1.2 | GO:0007320 | insemination(GO:0007320) |
0.3 | 2.1 | GO:0048012 | hepatocyte growth factor receptor signaling pathway(GO:0048012) |
0.3 | 4.2 | GO:0006590 | thyroid hormone generation(GO:0006590) |
0.3 | 0.6 | GO:1903371 | regulation of endoplasmic reticulum tubular network organization(GO:1903371) |
0.3 | 5.7 | GO:0007257 | activation of JUN kinase activity(GO:0007257) |
0.3 | 2.1 | GO:0002021 | response to dietary excess(GO:0002021) |
0.3 | 2.1 | GO:0035331 | negative regulation of hippo signaling(GO:0035331) |
0.3 | 13.2 | GO:2000649 | regulation of sodium ion transmembrane transporter activity(GO:2000649) |
0.3 | 7.3 | GO:0006198 | cAMP catabolic process(GO:0006198) |
0.3 | 3.8 | GO:0018298 | protein-chromophore linkage(GO:0018298) |
0.3 | 0.9 | GO:2000346 | negative regulation of hepatocyte proliferation(GO:2000346) |
0.3 | 4.3 | GO:0001558 | regulation of cell growth(GO:0001558) |
0.3 | 0.6 | GO:0001777 | T cell homeostatic proliferation(GO:0001777) regulation of T cell homeostatic proliferation(GO:0046013) |
0.3 | 4.0 | GO:0042100 | B cell proliferation(GO:0042100) |
0.3 | 0.3 | GO:0045852 | pH elevation(GO:0045852) intracellular pH elevation(GO:0051454) |
0.3 | 5.9 | GO:0015695 | organic cation transport(GO:0015695) |
0.3 | 1.4 | GO:0010763 | positive regulation of fibroblast migration(GO:0010763) |
0.3 | 2.2 | GO:0072592 | oxygen metabolic process(GO:0072592) |
0.3 | 2.0 | GO:0010606 | positive regulation of cytoplasmic mRNA processing body assembly(GO:0010606) |
0.3 | 2.2 | GO:2000251 | positive regulation of actin cytoskeleton reorganization(GO:2000251) |
0.3 | 1.7 | GO:0060453 | regulation of gastric acid secretion(GO:0060453) |
0.3 | 0.3 | GO:2000253 | positive regulation of feeding behavior(GO:2000253) |
0.3 | 1.7 | GO:0036444 | calcium ion transmembrane import into mitochondrion(GO:0036444) |
0.3 | 1.4 | GO:0000301 | retrograde transport, vesicle recycling within Golgi(GO:0000301) |
0.3 | 1.4 | GO:0009233 | menaquinone metabolic process(GO:0009233) |
0.3 | 5.8 | GO:0042462 | eye photoreceptor cell development(GO:0042462) |
0.3 | 0.6 | GO:0002933 | lipid hydroxylation(GO:0002933) |
0.3 | 1.1 | GO:0090050 | positive regulation of cell migration involved in sprouting angiogenesis(GO:0090050) |
0.3 | 1.7 | GO:0046855 | inositol phosphate dephosphorylation(GO:0046855) inositol phosphate catabolic process(GO:0071545) |
0.3 | 3.5 | GO:0007205 | protein kinase C-activating G-protein coupled receptor signaling pathway(GO:0007205) |
0.3 | 2.2 | GO:0042423 | catechol-containing compound biosynthetic process(GO:0009713) catecholamine biosynthetic process(GO:0042423) |
0.3 | 0.8 | GO:1902630 | regulation of membrane hyperpolarization(GO:1902630) |
0.3 | 5.6 | GO:0033344 | cholesterol efflux(GO:0033344) |
0.3 | 0.5 | GO:0010972 | negative regulation of G2/M transition of mitotic cell cycle(GO:0010972) negative regulation of cell cycle G2/M phase transition(GO:1902750) |
0.3 | 3.4 | GO:0034063 | stress granule assembly(GO:0034063) |
0.3 | 1.6 | GO:0034314 | Arp2/3 complex-mediated actin nucleation(GO:0034314) |
0.3 | 0.8 | GO:0051781 | positive regulation of cell division(GO:0051781) |
0.3 | 2.1 | GO:0035809 | regulation of urine volume(GO:0035809) |
0.3 | 6.4 | GO:0046928 | regulation of neurotransmitter secretion(GO:0046928) |
0.3 | 3.1 | GO:0050482 | arachidonic acid secretion(GO:0050482) arachidonate transport(GO:1903963) |
0.3 | 1.0 | GO:0030037 | actin filament reorganization involved in cell cycle(GO:0030037) |
0.3 | 4.1 | GO:0031954 | positive regulation of protein autophosphorylation(GO:0031954) |
0.3 | 6.3 | GO:0010107 | potassium ion import(GO:0010107) |
0.3 | 5.8 | GO:0050806 | positive regulation of synaptic transmission(GO:0050806) |
0.3 | 8.3 | GO:0045576 | mast cell activation(GO:0045576) |
0.3 | 1.8 | GO:0034383 | low-density lipoprotein particle clearance(GO:0034383) |
0.2 | 7.7 | GO:0030593 | neutrophil chemotaxis(GO:0030593) |
0.2 | 1.2 | GO:0010836 | negative regulation of protein ADP-ribosylation(GO:0010836) |
0.2 | 3.5 | GO:0007130 | synaptonemal complex assembly(GO:0007130) |
0.2 | 1.2 | GO:0010757 | negative regulation of plasminogen activation(GO:0010757) |
0.2 | 1.2 | GO:0006824 | cobalt ion transport(GO:0006824) |
0.2 | 0.7 | GO:0061536 | glycine secretion(GO:0061536) glycine secretion, neurotransmission(GO:0061537) |
0.2 | 4.9 | GO:0032012 | regulation of ARF protein signal transduction(GO:0032012) |
0.2 | 2.0 | GO:0018195 | peptidyl-arginine modification(GO:0018195) |
0.2 | 4.9 | GO:0016254 | preassembly of GPI anchor in ER membrane(GO:0016254) |
0.2 | 1.5 | GO:0043435 | response to corticotropin-releasing hormone(GO:0043435) cellular response to corticotropin-releasing hormone stimulus(GO:0071376) |
0.2 | 0.5 | GO:0051560 | mitochondrial calcium ion homeostasis(GO:0051560) |
0.2 | 0.7 | GO:0021913 | regulation of transcription from RNA polymerase II promoter involved in ventral spinal cord interneuron specification(GO:0021913) |
0.2 | 5.5 | GO:0070098 | chemokine-mediated signaling pathway(GO:0070098) |
0.2 | 1.4 | GO:2000288 | positive regulation of myoblast proliferation(GO:2000288) |
0.2 | 1.9 | GO:0045717 | negative regulation of fatty acid biosynthetic process(GO:0045717) |
0.2 | 0.7 | GO:0097194 | execution phase of apoptosis(GO:0097194) |
0.2 | 3.5 | GO:0046606 | negative regulation of centrosome cycle(GO:0046606) |
0.2 | 1.4 | GO:0051546 | keratinocyte migration(GO:0051546) |
0.2 | 1.9 | GO:0097167 | circadian regulation of translation(GO:0097167) |
0.2 | 1.2 | GO:0016446 | somatic hypermutation of immunoglobulin genes(GO:0016446) |
0.2 | 0.9 | GO:0035897 | proteolysis in other organism(GO:0035897) |
0.2 | 1.6 | GO:1903608 | protein localization to cytoplasmic stress granule(GO:1903608) |
0.2 | 0.9 | GO:0042472 | inner ear morphogenesis(GO:0042472) |
0.2 | 4.1 | GO:0030101 | natural killer cell activation(GO:0030101) |
0.2 | 5.5 | GO:0008045 | motor neuron axon guidance(GO:0008045) |
0.2 | 3.0 | GO:0007141 | male meiosis I(GO:0007141) |
0.2 | 3.4 | GO:0099601 | regulation of neurotransmitter receptor activity(GO:0099601) |
0.2 | 1.1 | GO:0000707 | meiotic DNA recombinase assembly(GO:0000707) |
0.2 | 4.4 | GO:0045494 | photoreceptor cell maintenance(GO:0045494) |
0.2 | 1.1 | GO:0000393 | spliceosomal conformational changes to generate catalytic conformation(GO:0000393) |
0.2 | 1.5 | GO:0016079 | synaptic vesicle exocytosis(GO:0016079) |
0.2 | 5.3 | GO:0044818 | mitotic G2/M transition checkpoint(GO:0044818) |
0.2 | 1.3 | GO:0042904 | 9-cis-retinoic acid biosynthetic process(GO:0042904) 9-cis-retinoic acid metabolic process(GO:0042905) |
0.2 | 0.9 | GO:0031116 | positive regulation of microtubule polymerization(GO:0031116) |
0.2 | 2.3 | GO:0071044 | histone mRNA catabolic process(GO:0071044) |
0.2 | 0.4 | GO:0030157 | pancreatic juice secretion(GO:0030157) |
0.2 | 3.4 | GO:0007191 | adenylate cyclase-activating dopamine receptor signaling pathway(GO:0007191) |
0.2 | 0.4 | GO:0001994 | norepinephrine-epinephrine vasoconstriction involved in regulation of systemic arterial blood pressure(GO:0001994) |
0.2 | 1.9 | GO:0007220 | Notch receptor processing(GO:0007220) |
0.2 | 1.3 | GO:0002720 | positive regulation of cytokine production involved in immune response(GO:0002720) |
0.2 | 2.1 | GO:0070914 | UV-damage excision repair(GO:0070914) |
0.2 | 0.8 | GO:0090230 | regulation of centromere complex assembly(GO:0090230) regulation of kinetochore assembly(GO:0090234) |
0.2 | 4.4 | GO:1903779 | regulation of cardiac conduction(GO:1903779) |
0.2 | 2.9 | GO:0006833 | water transport(GO:0006833) |
0.2 | 2.9 | GO:0050779 | RNA destabilization(GO:0050779) |
0.2 | 4.5 | GO:0030818 | negative regulation of cAMP biosynthetic process(GO:0030818) |
0.2 | 2.0 | GO:0035025 | positive regulation of Rho protein signal transduction(GO:0035025) |
0.2 | 1.2 | GO:0072102 | glomerulus morphogenesis(GO:0072102) |
0.2 | 10.9 | GO:0000381 | regulation of alternative mRNA splicing, via spliceosome(GO:0000381) |
0.2 | 0.4 | GO:0000712 | resolution of meiotic recombination intermediates(GO:0000712) |
0.2 | 4.6 | GO:0006359 | regulation of transcription from RNA polymerase III promoter(GO:0006359) |
0.2 | 1.4 | GO:0010561 | negative regulation of glycoprotein biosynthetic process(GO:0010561) |
0.2 | 1.2 | GO:0006776 | vitamin A metabolic process(GO:0006776) |
0.2 | 2.0 | GO:0016042 | lipid catabolic process(GO:0016042) |
0.2 | 5.0 | GO:0003407 | neural retina development(GO:0003407) |
0.2 | 1.7 | GO:0035372 | protein localization to microtubule(GO:0035372) |
0.2 | 2.2 | GO:0016242 | negative regulation of macroautophagy(GO:0016242) |
0.2 | 0.9 | GO:0014911 | positive regulation of smooth muscle cell migration(GO:0014911) |
0.2 | 0.7 | GO:0044057 | regulation of system process(GO:0044057) |
0.2 | 0.6 | GO:2000049 | positive regulation of cell-cell adhesion mediated by cadherin(GO:2000049) |
0.2 | 1.3 | GO:1990592 | protein ufmylation(GO:0071569) protein polyufmylation(GO:1990564) protein K69-linked ufmylation(GO:1990592) |
0.2 | 2.9 | GO:0031532 | actin cytoskeleton reorganization(GO:0031532) |
0.2 | 1.3 | GO:2000179 | positive regulation of neural precursor cell proliferation(GO:2000179) |
0.2 | 2.0 | GO:0006957 | complement activation, alternative pathway(GO:0006957) |
0.2 | 0.5 | GO:0038092 | nodal signaling pathway(GO:0038092) |
0.2 | 0.5 | GO:0002367 | cytokine production involved in immune response(GO:0002367) |
0.2 | 3.8 | GO:0042059 | negative regulation of epidermal growth factor receptor signaling pathway(GO:0042059) |
0.2 | 1.2 | GO:0033234 | negative regulation of protein sumoylation(GO:0033234) |
0.2 | 1.5 | GO:0045721 | negative regulation of gluconeogenesis(GO:0045721) |
0.2 | 0.3 | GO:0039534 | negative regulation of MDA-5 signaling pathway(GO:0039534) |
0.2 | 1.2 | GO:0060143 | positive regulation of syncytium formation by plasma membrane fusion(GO:0060143) |
0.2 | 10.0 | GO:0048010 | vascular endothelial growth factor receptor signaling pathway(GO:0048010) |
0.2 | 1.0 | GO:0030263 | apoptotic chromosome condensation(GO:0030263) |
0.2 | 2.8 | GO:0045662 | negative regulation of myoblast differentiation(GO:0045662) |
0.2 | 0.5 | GO:0048250 | mitochondrial iron ion transport(GO:0048250) |
0.2 | 0.3 | GO:0060349 | bone morphogenesis(GO:0060349) |
0.2 | 2.1 | GO:0042552 | myelination(GO:0042552) |
0.2 | 1.1 | GO:0006489 | dolichyl diphosphate biosynthetic process(GO:0006489) dolichyl diphosphate metabolic process(GO:0046465) |
0.2 | 4.4 | GO:0007274 | neuromuscular synaptic transmission(GO:0007274) |
0.1 | 0.6 | GO:1902231 | positive regulation of intrinsic apoptotic signaling pathway in response to DNA damage(GO:1902231) |
0.1 | 0.9 | GO:0042487 | regulation of odontogenesis of dentin-containing tooth(GO:0042487) |
0.1 | 1.2 | GO:0090140 | regulation of mitochondrial fission(GO:0090140) |
0.1 | 0.6 | GO:0071300 | cellular response to retinoic acid(GO:0071300) |
0.1 | 0.3 | GO:0001842 | neural fold formation(GO:0001842) |
0.1 | 0.1 | GO:0031649 | heat generation(GO:0031649) |
0.1 | 0.6 | GO:0008380 | RNA splicing(GO:0008380) |
0.1 | 1.1 | GO:0007064 | mitotic sister chromatid cohesion(GO:0007064) |
0.1 | 3.7 | GO:0006953 | acute-phase response(GO:0006953) |
0.1 | 0.8 | GO:0061525 | hindgut morphogenesis(GO:0007442) hindgut development(GO:0061525) |
0.1 | 5.2 | GO:0001578 | microtubule bundle formation(GO:0001578) |
0.1 | 1.1 | GO:0006874 | cellular calcium ion homeostasis(GO:0006874) |
0.1 | 0.9 | GO:0006942 | regulation of striated muscle contraction(GO:0006942) |
0.1 | 0.1 | GO:0000255 | allantoin metabolic process(GO:0000255) |
0.1 | 4.5 | GO:0015701 | bicarbonate transport(GO:0015701) |
0.1 | 0.3 | GO:0042756 | drinking behavior(GO:0042756) |
0.1 | 0.3 | GO:0015791 | polyol transport(GO:0015791) |
0.1 | 0.4 | GO:0060047 | heart process(GO:0003015) heart contraction(GO:0060047) |
0.1 | 0.6 | GO:0002098 | tRNA wobble uridine modification(GO:0002098) |
0.1 | 1.2 | GO:0022011 | myelination in peripheral nervous system(GO:0022011) peripheral nervous system axon ensheathment(GO:0032292) |
0.1 | 0.1 | GO:0071880 | adenylate cyclase-activating adrenergic receptor signaling pathway(GO:0071880) |
0.1 | 1.4 | GO:0010457 | centriole-centriole cohesion(GO:0010457) |
0.1 | 1.2 | GO:0090435 | protein localization to nuclear envelope(GO:0090435) |
0.1 | 0.6 | GO:0014886 | transition between slow and fast fiber(GO:0014886) |
0.1 | 1.4 | GO:0071625 | vocalization behavior(GO:0071625) |
0.1 | 0.7 | GO:1900029 | positive regulation of ruffle assembly(GO:1900029) |
0.1 | 0.8 | GO:0045879 | negative regulation of smoothened signaling pathway(GO:0045879) |
0.1 | 2.7 | GO:0086010 | membrane depolarization during action potential(GO:0086010) |
0.1 | 0.6 | GO:0043152 | induction of bacterial agglutination(GO:0043152) |
0.1 | 1.5 | GO:0022900 | electron transport chain(GO:0022900) |
0.1 | 0.7 | GO:0006544 | glycine metabolic process(GO:0006544) |
0.1 | 0.9 | GO:0043517 | positive regulation of DNA damage response, signal transduction by p53 class mediator(GO:0043517) |
0.1 | 0.3 | GO:0006420 | arginyl-tRNA aminoacylation(GO:0006420) |
0.1 | 3.0 | GO:0006836 | neurotransmitter transport(GO:0006836) |
0.1 | 1.4 | GO:0042554 | superoxide anion generation(GO:0042554) |
0.1 | 0.4 | GO:0010968 | regulation of microtubule nucleation(GO:0010968) |
0.1 | 3.8 | GO:0050771 | negative regulation of axonogenesis(GO:0050771) |
0.1 | 1.1 | GO:0042220 | response to cocaine(GO:0042220) |
0.1 | 0.2 | GO:0032962 | regulation of inositol trisphosphate biosynthetic process(GO:0032960) positive regulation of inositol trisphosphate biosynthetic process(GO:0032962) |
0.1 | 0.8 | GO:0035162 | embryonic hemopoiesis(GO:0035162) |
0.1 | 0.8 | GO:0045668 | negative regulation of osteoblast differentiation(GO:0045668) |
0.1 | 2.1 | GO:0060828 | regulation of canonical Wnt signaling pathway(GO:0060828) |
0.1 | 0.7 | GO:0045176 | apical protein localization(GO:0045176) |
0.1 | 0.2 | GO:0002155 | thyroid hormone mediated signaling pathway(GO:0002154) regulation of thyroid hormone mediated signaling pathway(GO:0002155) |
0.1 | 0.9 | GO:0007171 | activation of transmembrane receptor protein tyrosine kinase activity(GO:0007171) |
0.1 | 0.7 | GO:0007140 | male meiosis(GO:0007140) |
0.1 | 0.8 | GO:0097264 | self proteolysis(GO:0097264) |
0.1 | 0.9 | GO:0001676 | long-chain fatty acid metabolic process(GO:0001676) |
0.1 | 2.8 | GO:0046889 | positive regulation of lipid biosynthetic process(GO:0046889) |
0.1 | 0.2 | GO:0002830 | positive regulation of type 2 immune response(GO:0002830) |
0.1 | 3.6 | GO:0042073 | intraciliary transport(GO:0042073) |
0.1 | 0.3 | GO:1900383 | regulation of synaptic plasticity by receptor localization to synapse(GO:1900383) |
0.1 | 0.5 | GO:0043651 | linoleic acid metabolic process(GO:0043651) |
0.1 | 0.2 | GO:0060088 | auditory receptor cell morphogenesis(GO:0002093) auditory receptor cell stereocilium organization(GO:0060088) |
0.1 | 0.3 | GO:0070493 | thrombin receptor signaling pathway(GO:0070493) |
0.1 | 0.3 | GO:0034505 | tooth mineralization(GO:0034505) |
0.1 | 0.6 | GO:0016048 | detection of temperature stimulus(GO:0016048) |
0.1 | 0.6 | GO:0008212 | mineralocorticoid biosynthetic process(GO:0006705) mineralocorticoid metabolic process(GO:0008212) |
0.1 | 0.2 | GO:0048247 | lymphocyte chemotaxis(GO:0048247) |
0.1 | 0.6 | GO:0031284 | positive regulation of guanylate cyclase activity(GO:0031284) |
0.1 | 0.2 | GO:0097211 | response to gonadotropin-releasing hormone(GO:0097210) cellular response to gonadotropin-releasing hormone(GO:0097211) |
0.1 | 0.4 | GO:0060244 | negative regulation of cell proliferation involved in contact inhibition(GO:0060244) |
0.1 | 1.0 | GO:0017187 | peptidyl-glutamic acid carboxylation(GO:0017187) protein carboxylation(GO:0018214) |
0.1 | 0.5 | GO:0031086 | nuclear-transcribed mRNA catabolic process, deadenylation-independent decay(GO:0031086) deadenylation-independent decapping of nuclear-transcribed mRNA(GO:0031087) |
0.1 | 1.3 | GO:0006891 | intra-Golgi vesicle-mediated transport(GO:0006891) |
0.1 | 2.1 | GO:0042475 | odontogenesis of dentin-containing tooth(GO:0042475) |
0.1 | 0.5 | GO:0030207 | chondroitin sulfate catabolic process(GO:0030207) |
0.1 | 0.2 | GO:0010921 | regulation of phosphatase activity(GO:0010921) |
0.1 | 0.3 | GO:0032218 | riboflavin transport(GO:0032218) |
0.1 | 2.6 | GO:0016266 | O-glycan processing(GO:0016266) |
0.1 | 0.4 | GO:0060397 | JAK-STAT cascade involved in growth hormone signaling pathway(GO:0060397) |
0.1 | 1.1 | GO:0090110 | cargo loading into COPII-coated vesicle(GO:0090110) |
0.1 | 0.2 | GO:0048861 | leukemia inhibitory factor signaling pathway(GO:0048861) |
0.1 | 0.2 | GO:0060392 | negative regulation of SMAD protein import into nucleus(GO:0060392) |
0.1 | 1.5 | GO:0043550 | regulation of lipid kinase activity(GO:0043550) |
0.1 | 0.3 | GO:0016926 | protein desumoylation(GO:0016926) |
0.1 | 0.1 | GO:0005988 | lactose metabolic process(GO:0005988) lactose biosynthetic process(GO:0005989) |
0.1 | 0.2 | GO:0006542 | glutamine biosynthetic process(GO:0006542) |
0.1 | 0.3 | GO:0042758 | long-chain fatty acid catabolic process(GO:0042758) |
0.1 | 0.5 | GO:0006030 | chitin metabolic process(GO:0006030) chitin catabolic process(GO:0006032) |
0.1 | 0.3 | GO:0050884 | neuromuscular process controlling posture(GO:0050884) |
0.1 | 0.6 | GO:0046688 | response to copper ion(GO:0046688) |
0.1 | 0.1 | GO:0046066 | dGDP metabolic process(GO:0046066) |
0.1 | 0.3 | GO:0051601 | exocyst localization(GO:0051601) |
0.1 | 0.3 | GO:0019323 | pentose catabolic process(GO:0019323) |
0.1 | 1.3 | GO:1904659 | hexose transmembrane transport(GO:0035428) glucose transmembrane transport(GO:1904659) |
0.1 | 0.9 | GO:0046627 | negative regulation of insulin receptor signaling pathway(GO:0046627) |
0.1 | 1.1 | GO:0030317 | sperm motility(GO:0030317) |
0.1 | 0.6 | GO:0090200 | positive regulation of release of cytochrome c from mitochondria(GO:0090200) |
0.0 | 0.5 | GO:0060326 | cell chemotaxis(GO:0060326) |
0.0 | 0.2 | GO:0030277 | maintenance of gastrointestinal epithelium(GO:0030277) |
0.0 | 0.3 | GO:0006065 | UDP-glucuronate biosynthetic process(GO:0006065) |
0.0 | 9.1 | GO:0051056 | regulation of small GTPase mediated signal transduction(GO:0051056) |
0.0 | 0.3 | GO:0071763 | nuclear membrane organization(GO:0071763) |
0.0 | 1.7 | GO:0006879 | cellular iron ion homeostasis(GO:0006879) |
0.0 | 0.2 | GO:1990822 | basic amino acid transmembrane transport(GO:1990822) |
0.0 | 0.9 | GO:0016486 | peptide hormone processing(GO:0016486) |
0.0 | 0.6 | GO:0010259 | multicellular organism aging(GO:0010259) |
0.0 | 0.5 | GO:0070584 | mitochondrion morphogenesis(GO:0070584) |
0.0 | 0.1 | GO:0038044 | transforming growth factor-beta secretion(GO:0038044) |
0.0 | 0.4 | GO:0016540 | protein autoprocessing(GO:0016540) |
0.0 | 0.1 | GO:0034344 | type III interferon production(GO:0034343) regulation of type III interferon production(GO:0034344) |
0.0 | 2.2 | GO:0007286 | spermatid development(GO:0007286) |
0.0 | 0.3 | GO:0045124 | regulation of bone resorption(GO:0045124) |
0.0 | 0.0 | GO:0036378 | calcitriol biosynthetic process from calciol(GO:0036378) vitamin D3 metabolic process(GO:0070640) |
0.0 | 0.6 | GO:0006517 | protein deglycosylation(GO:0006517) |
0.0 | 0.3 | GO:0030206 | chondroitin sulfate biosynthetic process(GO:0030206) |
0.0 | 0.7 | GO:0032456 | endocytic recycling(GO:0032456) |
0.0 | 0.2 | GO:0060523 | prostate epithelial cord elongation(GO:0060523) prostate gland morphogenetic growth(GO:0060737) |
0.0 | 0.2 | GO:0050919 | negative chemotaxis(GO:0050919) |
0.0 | 0.1 | GO:0044314 | protein K27-linked ubiquitination(GO:0044314) |
0.0 | 0.2 | GO:0055057 | neuronal stem cell division(GO:0036445) neuroblast division(GO:0055057) |
0.0 | 0.1 | GO:1901503 | ether lipid biosynthetic process(GO:0008611) glycerol ether biosynthetic process(GO:0046504) ether biosynthetic process(GO:1901503) |
0.0 | 0.2 | GO:0031018 | endocrine pancreas development(GO:0031018) |
0.0 | 0.4 | GO:0061512 | protein localization to cilium(GO:0061512) |
0.0 | 0.2 | GO:0007212 | dopamine receptor signaling pathway(GO:0007212) |
0.0 | 0.4 | GO:0001895 | retina homeostasis(GO:0001895) |
0.0 | 0.3 | GO:0006383 | transcription from RNA polymerase III promoter(GO:0006383) |
0.0 | 0.1 | GO:0021615 | glossopharyngeal nerve morphogenesis(GO:0021615) |
0.0 | 0.1 | GO:0015693 | magnesium ion transport(GO:0015693) |
0.0 | 0.3 | GO:0031648 | protein destabilization(GO:0031648) |
0.0 | 0.2 | GO:0097576 | vacuole fusion(GO:0097576) |
0.0 | 0.3 | GO:0045197 | establishment or maintenance of epithelial cell apical/basal polarity(GO:0045197) |
0.0 | 0.3 | GO:0045824 | negative regulation of innate immune response(GO:0045824) |
0.0 | 0.2 | GO:0051593 | response to folic acid(GO:0051593) |
0.0 | 0.1 | GO:0006657 | CDP-choline pathway(GO:0006657) |
0.0 | 0.1 | GO:0035791 | platelet-derived growth factor receptor-beta signaling pathway(GO:0035791) |
0.0 | 0.1 | GO:1900028 | negative regulation of ruffle assembly(GO:1900028) |
0.0 | 0.1 | GO:0031118 | rRNA pseudouridine synthesis(GO:0031118) |
0.0 | 0.1 | GO:0042136 | neurotransmitter biosynthetic process(GO:0042136) |
0.0 | 0.0 | GO:0061113 | pancreas morphogenesis(GO:0061113) |
0.0 | 0.0 | GO:0007635 | chemosensory behavior(GO:0007635) |
0.0 | 0.1 | GO:0006458 | 'de novo' protein folding(GO:0006458) |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
10.9 | 229.1 | GO:0042613 | MHC class II protein complex(GO:0042613) |
8.2 | 49.2 | GO:0034687 | integrin alphaL-beta2 complex(GO:0034687) |
7.1 | 99.5 | GO:0005833 | hemoglobin complex(GO:0005833) |
6.5 | 103.5 | GO:0097512 | cardiac myofibril(GO:0097512) |
6.0 | 24.1 | GO:1990578 | perinuclear endoplasmic reticulum membrane(GO:1990578) |
4.8 | 24.1 | GO:0036398 | TCR signalosome(GO:0036398) |
4.8 | 14.5 | GO:0044609 | DBIRD complex(GO:0044609) |
4.7 | 23.6 | GO:0098843 | postsynaptic endocytic zone(GO:0098843) |
4.7 | 14.0 | GO:0019034 | viral replication complex(GO:0019034) |
3.9 | 50.6 | GO:0034993 | microtubule organizing center attachment site(GO:0034992) LINC complex(GO:0034993) |
3.6 | 14.3 | GO:0070032 | synaptobrevin 2-SNAP-25-syntaxin-1a-complexin I complex(GO:0070032) |
3.5 | 21.1 | GO:0031232 | extrinsic component of external side of plasma membrane(GO:0031232) |
3.4 | 23.6 | GO:0019815 | B cell receptor complex(GO:0019815) |
3.0 | 3.0 | GO:0005953 | CAAX-protein geranylgeranyltransferase complex(GO:0005953) |
2.9 | 55.9 | GO:0001891 | phagocytic cup(GO:0001891) |
2.9 | 22.9 | GO:0005672 | transcription factor TFIIA complex(GO:0005672) |
2.6 | 7.8 | GO:0020005 | symbiont-containing vacuole(GO:0020003) symbiont-containing vacuole membrane(GO:0020005) |
2.5 | 27.5 | GO:0042105 | alpha-beta T cell receptor complex(GO:0042105) |
2.4 | 12.2 | GO:0097179 | protease inhibitor complex(GO:0097179) |
2.3 | 20.4 | GO:0005638 | lamin filament(GO:0005638) |
2.2 | 2.2 | GO:0070044 | synaptobrevin 2-SNAP-25-syntaxin-1a complex(GO:0070044) |
2.0 | 2.0 | GO:0097025 | MPP7-DLG1-LIN7 complex(GO:0097025) |
1.9 | 13.5 | GO:0033269 | internode region of axon(GO:0033269) |
1.9 | 29.9 | GO:0097418 | neurofibrillary tangle(GO:0097418) |
1.8 | 25.6 | GO:0033179 | proton-transporting V-type ATPase, V0 domain(GO:0033179) |
1.8 | 10.9 | GO:0060203 | clathrin-sculpted glutamate transport vesicle(GO:0060199) clathrin-sculpted glutamate transport vesicle membrane(GO:0060203) |
1.8 | 88.5 | GO:0042571 | immunoglobulin complex(GO:0019814) immunoglobulin complex, circulating(GO:0042571) |
1.7 | 7.0 | GO:0005968 | Rab-protein geranylgeranyltransferase complex(GO:0005968) |
1.7 | 5.1 | GO:0016935 | glycine-gated chloride channel complex(GO:0016935) |
1.7 | 35.5 | GO:0044295 | axonal growth cone(GO:0044295) |
1.6 | 29.4 | GO:0042101 | T cell receptor complex(GO:0042101) |
1.6 | 19.4 | GO:0032045 | guanyl-nucleotide exchange factor complex(GO:0032045) |
1.6 | 39.8 | GO:0071565 | nBAF complex(GO:0071565) |
1.6 | 4.7 | GO:0034657 | GID complex(GO:0034657) |
1.5 | 10.8 | GO:0043240 | Fanconi anaemia nuclear complex(GO:0043240) |
1.5 | 10.6 | GO:0097013 | phagocytic vesicle lumen(GO:0097013) |
1.5 | 5.9 | GO:0016939 | kinesin II complex(GO:0016939) |
1.5 | 30.6 | GO:0014731 | spectrin-associated cytoskeleton(GO:0014731) |
1.5 | 10.2 | GO:1990452 | Parkin-FBXW7-Cul1 ubiquitin ligase complex(GO:1990452) |
1.4 | 4.3 | GO:0098536 | deuterosome(GO:0098536) |
1.4 | 11.3 | GO:0035976 | AP1 complex(GO:0035976) |
1.4 | 27.9 | GO:0031254 | uropod(GO:0001931) cell trailing edge(GO:0031254) |
1.3 | 14.8 | GO:0005641 | nuclear envelope lumen(GO:0005641) |
1.3 | 3.9 | GO:0071595 | Nem1-Spo7 phosphatase complex(GO:0071595) |
1.3 | 18.0 | GO:0030897 | HOPS complex(GO:0030897) |
1.3 | 2.6 | GO:0005967 | mitochondrial pyruvate dehydrogenase complex(GO:0005967) |
1.3 | 6.4 | GO:0005602 | complement component C1 complex(GO:0005602) |
1.3 | 7.6 | GO:0005955 | calcineurin complex(GO:0005955) |
1.3 | 5.0 | GO:0032144 | 4-aminobutyrate transaminase complex(GO:0032144) |
1.3 | 5.0 | GO:0005965 | protein farnesyltransferase complex(GO:0005965) |
1.2 | 5.0 | GO:0032937 | SREBP-SCAP-Insig complex(GO:0032937) |
1.2 | 7.5 | GO:0000015 | phosphopyruvate hydratase complex(GO:0000015) |
1.2 | 2.5 | GO:0031838 | haptoglobin-hemoglobin complex(GO:0031838) |
1.2 | 7.3 | GO:0097442 | CA3 pyramidal cell dendrite(GO:0097442) |
1.2 | 1.2 | GO:0043541 | UDP-N-acetylglucosamine transferase complex(GO:0043541) |
1.2 | 10.8 | GO:0000421 | autophagosome membrane(GO:0000421) |
1.2 | 4.8 | GO:1990745 | EARP complex(GO:1990745) |
1.2 | 7.2 | GO:0032010 | phagolysosome(GO:0032010) |
1.2 | 10.6 | GO:0070652 | HAUS complex(GO:0070652) |
1.1 | 11.5 | GO:0097427 | microtubule bundle(GO:0097427) |
1.1 | 47.4 | GO:0097542 | ciliary tip(GO:0097542) |
1.1 | 13.4 | GO:1990712 | HFE-transferrin receptor complex(GO:1990712) |
1.1 | 3.3 | GO:0060053 | neurofilament cytoskeleton(GO:0060053) |
1.1 | 4.3 | GO:0044194 | cytolytic granule(GO:0044194) |
1.0 | 4.2 | GO:0070876 | SOSS complex(GO:0070876) |
1.0 | 8.3 | GO:0045179 | apical cortex(GO:0045179) |
1.0 | 25.8 | GO:0008074 | guanylate cyclase complex, soluble(GO:0008074) |
1.0 | 1.0 | GO:1902636 | kinociliary basal body(GO:1902636) |
1.0 | 5.0 | GO:0001652 | granular component(GO:0001652) |
1.0 | 7.0 | GO:1990812 | growth cone filopodium(GO:1990812) |
1.0 | 3.0 | GO:0097123 | cyclin A1-CDK2 complex(GO:0097123) |
1.0 | 15.4 | GO:0031045 | dense core granule(GO:0031045) |
1.0 | 1.9 | GO:0097443 | sorting endosome(GO:0097443) |
1.0 | 75.5 | GO:0030315 | T-tubule(GO:0030315) |
0.9 | 3.8 | GO:1990604 | IRE1-TRAF2-ASK1 complex(GO:1990604) |
0.9 | 0.9 | GO:0071439 | clathrin complex(GO:0071439) |
0.9 | 2.8 | GO:0043291 | RAVE complex(GO:0043291) |
0.9 | 12.2 | GO:0016471 | vacuolar proton-transporting V-type ATPase complex(GO:0016471) |
0.9 | 4.6 | GO:0044308 | axonal spine(GO:0044308) |
0.9 | 4.5 | GO:0030673 | axolemma(GO:0030673) |
0.9 | 1.7 | GO:0098592 | cytoplasmic side of apical plasma membrane(GO:0098592) |
0.9 | 6.0 | GO:0002178 | palmitoyltransferase complex(GO:0002178) |
0.9 | 4.3 | GO:0031233 | intrinsic component of external side of plasma membrane(GO:0031233) |
0.8 | 6.7 | GO:0043194 | axon initial segment(GO:0043194) |
0.8 | 3.3 | GO:0032009 | early phagosome(GO:0032009) |
0.8 | 5.7 | GO:0061700 | GATOR2 complex(GO:0061700) |
0.8 | 6.5 | GO:0035253 | ciliary rootlet(GO:0035253) |
0.8 | 1.6 | GO:0033017 | sarcoplasmic reticulum membrane(GO:0033017) |
0.8 | 71.1 | GO:0043195 | terminal bouton(GO:0043195) |
0.8 | 2.4 | GO:0036396 | MIS complex(GO:0036396) mRNA editing complex(GO:0045293) |
0.8 | 56.5 | GO:0101003 | ficolin-1-rich granule membrane(GO:0101003) |
0.8 | 2.3 | GO:0030981 | cortical microtubule cytoskeleton(GO:0030981) |
0.8 | 5.4 | GO:0005742 | mitochondrial outer membrane translocase complex(GO:0005742) |
0.8 | 4.6 | GO:0070776 | H3 histone acetyltransferase complex(GO:0070775) MOZ/MORF histone acetyltransferase complex(GO:0070776) |
0.8 | 0.8 | GO:0002079 | inner acrosomal membrane(GO:0002079) |
0.7 | 2.2 | GO:0030314 | junctional membrane complex(GO:0030314) |
0.7 | 3.6 | GO:0030121 | AP-1 adaptor complex(GO:0030121) |
0.7 | 4.4 | GO:0009331 | glycerol-3-phosphate dehydrogenase complex(GO:0009331) |
0.7 | 3.6 | GO:0070110 | ciliary neurotrophic factor receptor complex(GO:0070110) |
0.7 | 5.7 | GO:0097425 | smooth endoplasmic reticulum membrane(GO:0030868) smooth endoplasmic reticulum part(GO:0097425) |
0.7 | 7.8 | GO:0012506 | vesicle membrane(GO:0012506) |
0.7 | 5.6 | GO:0030130 | clathrin coat of trans-Golgi network vesicle(GO:0030130) |
0.7 | 5.6 | GO:0033010 | paranodal junction(GO:0033010) |
0.7 | 4.2 | GO:1990682 | CSF1-CSF1R complex(GO:1990682) |
0.7 | 12.5 | GO:0044298 | neuronal cell body membrane(GO:0032809) cell body membrane(GO:0044298) |
0.7 | 3.5 | GO:0000801 | central element(GO:0000801) |
0.7 | 13.1 | GO:0032591 | dendritic spine membrane(GO:0032591) |
0.7 | 4.0 | GO:0002080 | acrosomal membrane(GO:0002080) |
0.7 | 3.3 | GO:0071008 | U2-type post-mRNA release spliceosomal complex(GO:0071008) |
0.7 | 23.2 | GO:1902711 | GABA-A receptor complex(GO:1902711) |
0.7 | 6.6 | GO:0033270 | paranode region of axon(GO:0033270) |
0.7 | 6.6 | GO:0042587 | glycogen granule(GO:0042587) |
0.7 | 2.0 | GO:1990393 | 3M complex(GO:1990393) |
0.6 | 3.9 | GO:0032839 | dendrite cytoplasm(GO:0032839) |
0.6 | 4.4 | GO:0036021 | endolysosome lumen(GO:0036021) |
0.6 | 8.8 | GO:0005589 | collagen type VI trimer(GO:0005589) collagen beaded filament(GO:0098647) |
0.6 | 3.0 | GO:0005947 | mitochondrial alpha-ketoglutarate dehydrogenase complex(GO:0005947) |
0.6 | 1.8 | GO:0035354 | Toll-like receptor 1-Toll-like receptor 2 protein complex(GO:0035354) |
0.6 | 7.8 | GO:0008385 | IkappaB kinase complex(GO:0008385) |
0.6 | 2.4 | GO:0032777 | Piccolo NuA4 histone acetyltransferase complex(GO:0032777) |
0.6 | 3.6 | GO:0071014 | post-mRNA release spliceosomal complex(GO:0071014) |
0.6 | 5.9 | GO:0043083 | synaptic cleft(GO:0043083) |
0.6 | 7.0 | GO:0097440 | apical dendrite(GO:0097440) |
0.6 | 4.1 | GO:0098554 | cytoplasmic side of endoplasmic reticulum membrane(GO:0098554) |
0.6 | 19.3 | GO:0048786 | presynaptic active zone(GO:0048786) |
0.6 | 1.2 | GO:0005927 | muscle tendon junction(GO:0005927) |
0.6 | 0.6 | GO:0031300 | intrinsic component of organelle membrane(GO:0031300) |
0.6 | 3.4 | GO:0033391 | chromatoid body(GO:0033391) |
0.6 | 1.7 | GO:0030895 | apolipoprotein B mRNA editing enzyme complex(GO:0030895) |
0.6 | 10.7 | GO:0031201 | SNARE complex(GO:0031201) |
0.6 | 13.0 | GO:0034451 | centriolar satellite(GO:0034451) |
0.6 | 1.7 | GO:0070382 | exocytic vesicle(GO:0070382) |
0.5 | 7.7 | GO:0000788 | nuclear nucleosome(GO:0000788) |
0.5 | 19.1 | GO:0034707 | chloride channel complex(GO:0034707) |
0.5 | 6.0 | GO:0000164 | protein phosphatase type 1 complex(GO:0000164) |
0.5 | 9.7 | GO:0032281 | AMPA glutamate receptor complex(GO:0032281) |
0.5 | 4.8 | GO:0035102 | PRC1 complex(GO:0035102) |
0.5 | 2.1 | GO:0031302 | intrinsic component of endosome membrane(GO:0031302) |
0.5 | 3.2 | GO:0043196 | varicosity(GO:0043196) |
0.5 | 0.5 | GO:0042612 | MHC class I protein complex(GO:0042612) |
0.5 | 7.9 | GO:0031235 | intrinsic component of the cytoplasmic side of the plasma membrane(GO:0031235) |
0.5 | 2.6 | GO:0030061 | mitochondrial crista(GO:0030061) |
0.5 | 8.9 | GO:0031083 | BLOC-1 complex(GO:0031083) |
0.5 | 3.1 | GO:0005577 | fibrinogen complex(GO:0005577) |
0.5 | 12.9 | GO:0005721 | pericentric heterochromatin(GO:0005721) |
0.5 | 9.8 | GO:0044224 | juxtaparanode region of axon(GO:0044224) |
0.5 | 3.6 | GO:0001518 | voltage-gated sodium channel complex(GO:0001518) |
0.5 | 6.1 | GO:0030133 | transport vesicle(GO:0030133) |
0.5 | 54.9 | GO:0043204 | perikaryon(GO:0043204) |
0.5 | 2.5 | GO:0032389 | MutLalpha complex(GO:0032389) |
0.5 | 1.5 | GO:0016938 | kinesin I complex(GO:0016938) |
0.5 | 2.0 | GO:0097208 | alveolar lamellar body(GO:0097208) |
0.5 | 5.0 | GO:0043190 | ATP-binding cassette (ABC) transporter complex(GO:0043190) |
0.5 | 8.3 | GO:0045277 | respiratory chain complex IV(GO:0045277) |
0.5 | 2.9 | GO:0033063 | DNA recombinase mediator complex(GO:0033061) Rad51B-Rad51C-Rad51D-XRCC2 complex(GO:0033063) |
0.5 | 2.4 | GO:0044352 | pinosome(GO:0044352) macropinosome(GO:0044354) |
0.5 | 1.4 | GO:0005944 | phosphatidylinositol 3-kinase complex, class IB(GO:0005944) |
0.5 | 1.4 | GO:0030906 | retromer, cargo-selective complex(GO:0030906) |
0.5 | 0.5 | GO:0030891 | VCB complex(GO:0030891) |
0.5 | 2.3 | GO:0010370 | perinucleolar chromocenter(GO:0010370) |
0.4 | 1.3 | GO:1990876 | cytoplasmic side of nuclear pore(GO:1990876) |
0.4 | 2.7 | GO:0097433 | dense body(GO:0097433) |
0.4 | 16.0 | GO:0008305 | integrin complex(GO:0008305) |
0.4 | 2.7 | GO:0016600 | flotillin complex(GO:0016600) |
0.4 | 3.1 | GO:0032593 | insulin-responsive compartment(GO:0032593) |
0.4 | 1.8 | GO:0043293 | apoptosome(GO:0043293) |
0.4 | 0.4 | GO:0051286 | cell tip(GO:0051286) |
0.4 | 10.9 | GO:0000930 | gamma-tubulin complex(GO:0000930) |
0.4 | 5.2 | GO:1990909 | Wnt signalosome(GO:1990909) |
0.4 | 2.2 | GO:0005594 | collagen type IX trimer(GO:0005594) |
0.4 | 3.9 | GO:0042788 | polysomal ribosome(GO:0042788) |
0.4 | 1.7 | GO:1990246 | uniplex complex(GO:1990246) |
0.4 | 9.1 | GO:0005720 | nuclear heterochromatin(GO:0005720) |
0.4 | 9.9 | GO:0000795 | synaptonemal complex(GO:0000795) |
0.4 | 5.4 | GO:0048188 | Set1C/COMPASS complex(GO:0048188) |
0.4 | 3.2 | GO:0097486 | multivesicular body lumen(GO:0097486) |
0.4 | 5.2 | GO:0034518 | mRNA cap binding complex(GO:0005845) RNA cap binding complex(GO:0034518) |
0.4 | 2.4 | GO:0044614 | nuclear pore cytoplasmic filaments(GO:0044614) |
0.4 | 14.7 | GO:0044306 | neuron projection terminus(GO:0044306) |
0.4 | 1.6 | GO:0070436 | Grb2-EGFR complex(GO:0070436) |
0.4 | 5.1 | GO:0031462 | Cul2-RING ubiquitin ligase complex(GO:0031462) |
0.4 | 2.3 | GO:0097165 | nuclear stress granule(GO:0097165) |
0.4 | 1.2 | GO:0097058 | CRLF-CLCF1 complex(GO:0097058) |
0.4 | 30.9 | GO:0005905 | clathrin-coated pit(GO:0005905) |
0.4 | 0.8 | GO:0034673 | inhibin-betaglycan-ActRII complex(GO:0034673) |
0.4 | 3.4 | GO:0030118 | clathrin coat(GO:0030118) |
0.4 | 61.8 | GO:0009897 | external side of plasma membrane(GO:0009897) |
0.4 | 1.5 | GO:0005899 | insulin receptor complex(GO:0005899) |
0.4 | 13.1 | GO:0005859 | muscle myosin complex(GO:0005859) |
0.4 | 0.4 | GO:0014701 | junctional sarcoplasmic reticulum membrane(GO:0014701) |
0.4 | 3.5 | GO:0005767 | secondary lysosome(GO:0005767) |
0.4 | 2.8 | GO:0043235 | receptor complex(GO:0043235) |
0.4 | 1.4 | GO:0000322 | storage vacuole(GO:0000322) |
0.4 | 2.1 | GO:0030877 | beta-catenin destruction complex(GO:0030877) |
0.3 | 5.9 | GO:0070821 | tertiary granule membrane(GO:0070821) |
0.3 | 3.1 | GO:0097546 | ciliary base(GO:0097546) |
0.3 | 1.4 | GO:0072536 | interleukin-23 receptor complex(GO:0072536) |
0.3 | 7.1 | GO:0001772 | immunological synapse(GO:0001772) |
0.3 | 2.7 | GO:0031931 | TORC1 complex(GO:0031931) |
0.3 | 28.7 | GO:0016234 | inclusion body(GO:0016234) |
0.3 | 51.0 | GO:0072562 | blood microparticle(GO:0072562) |
0.3 | 2.0 | GO:0045334 | clathrin-coated endocytic vesicle(GO:0045334) |
0.3 | 3.2 | GO:0000242 | pericentriolar material(GO:0000242) |
0.3 | 15.6 | GO:0030665 | clathrin-coated vesicle membrane(GO:0030665) |
0.3 | 7.2 | GO:0031092 | platelet alpha granule membrane(GO:0031092) |
0.3 | 21.8 | GO:0034705 | voltage-gated potassium channel complex(GO:0008076) potassium channel complex(GO:0034705) |
0.3 | 1.9 | GO:0032807 | DNA ligase IV complex(GO:0032807) |
0.3 | 15.3 | GO:0030672 | synaptic vesicle membrane(GO:0030672) exocytic vesicle membrane(GO:0099501) |
0.3 | 2.4 | GO:0071204 | U7 snRNP(GO:0005683) histone pre-mRNA 3'end processing complex(GO:0071204) |
0.3 | 4.5 | GO:0005869 | dynactin complex(GO:0005869) |
0.3 | 1.5 | GO:0000836 | Hrd1p ubiquitin ligase complex(GO:0000836) |
0.3 | 41.3 | GO:0030427 | site of polarized growth(GO:0030427) |
0.3 | 41.8 | GO:0031225 | anchored component of membrane(GO:0031225) |
0.3 | 1.7 | GO:0042824 | MHC class I peptide loading complex(GO:0042824) TAP complex(GO:0042825) |
0.3 | 1.4 | GO:0042406 | extrinsic component of endoplasmic reticulum membrane(GO:0042406) |
0.3 | 3.4 | GO:0005847 | mRNA cleavage and polyadenylation specificity factor complex(GO:0005847) |
0.3 | 3.1 | GO:0017119 | Golgi transport complex(GO:0017119) |
0.3 | 0.8 | GO:0097342 | ripoptosome(GO:0097342) |
0.3 | 8.8 | GO:0000159 | protein phosphatase type 2A complex(GO:0000159) |
0.3 | 3.5 | GO:0097225 | sperm midpiece(GO:0097225) |
0.3 | 2.4 | GO:0005964 | phosphorylase kinase complex(GO:0005964) |
0.3 | 160.8 | GO:0045202 | synapse(GO:0045202) |
0.3 | 0.8 | GO:0000308 | cytoplasmic cyclin-dependent protein kinase holoenzyme complex(GO:0000308) |
0.3 | 1.3 | GO:0070826 | paraferritin complex(GO:0070826) |
0.2 | 24.0 | GO:0055037 | recycling endosome(GO:0055037) |
0.2 | 6.8 | GO:0080008 | Cul4-RING E3 ubiquitin ligase complex(GO:0080008) |
0.2 | 1.7 | GO:0072487 | MSL complex(GO:0072487) |
0.2 | 2.6 | GO:0005952 | cAMP-dependent protein kinase complex(GO:0005952) |
0.2 | 0.2 | GO:0000835 | ER ubiquitin ligase complex(GO:0000835) |
0.2 | 1.3 | GO:0032444 | activin responsive factor complex(GO:0032444) |
0.2 | 5.5 | GO:0005581 | collagen trimer(GO:0005581) |
0.2 | 2.0 | GO:0030015 | CCR4-NOT core complex(GO:0030015) |
0.2 | 10.6 | GO:0035577 | azurophil granule membrane(GO:0035577) |
0.2 | 0.4 | GO:0030430 | host cell cytoplasm(GO:0030430) host cell cytoplasm part(GO:0033655) |
0.2 | 2.7 | GO:0097227 | sperm annulus(GO:0097227) |
0.2 | 1.7 | GO:1990111 | spermatoproteasome complex(GO:1990111) |
0.2 | 1.0 | GO:0036157 | outer dynein arm(GO:0036157) |
0.2 | 0.6 | GO:0043198 | dendritic shaft(GO:0043198) |
0.2 | 12.4 | GO:0005796 | Golgi lumen(GO:0005796) |
0.2 | 0.6 | GO:0072558 | NLRP1 inflammasome complex(GO:0072558) |
0.2 | 8.8 | GO:0030666 | endocytic vesicle membrane(GO:0030666) |
0.2 | 4.0 | GO:0005801 | cis-Golgi network(GO:0005801) |
0.2 | 1.9 | GO:0005687 | U4 snRNP(GO:0005687) |
0.2 | 8.7 | GO:0001533 | cornified envelope(GO:0001533) |
0.2 | 12.8 | GO:0032587 | ruffle membrane(GO:0032587) |
0.2 | 2.1 | GO:0031528 | microvillus membrane(GO:0031528) |
0.2 | 48.4 | GO:0005788 | endoplasmic reticulum lumen(GO:0005788) |
0.2 | 1.4 | GO:0071682 | endocytic vesicle lumen(GO:0071682) |
0.2 | 10.9 | GO:0031463 | Cul3-RING ubiquitin ligase complex(GO:0031463) |
0.2 | 3.2 | GO:0035869 | ciliary transition zone(GO:0035869) |
0.2 | 8.3 | GO:0005834 | heterotrimeric G-protein complex(GO:0005834) |
0.2 | 4.8 | GO:0090545 | NuRD complex(GO:0016581) CHD-type complex(GO:0090545) |
0.1 | 4.2 | GO:0016324 | apical plasma membrane(GO:0016324) |
0.1 | 1.6 | GO:0000346 | transcription export complex(GO:0000346) |
0.1 | 0.6 | GO:0036128 | CatSper complex(GO:0036128) |
0.1 | 6.1 | GO:0097014 | axoneme(GO:0005930) ciliary plasm(GO:0097014) |
0.1 | 0.4 | GO:0016011 | dystroglycan complex(GO:0016011) sarcoglycan complex(GO:0016012) |
0.1 | 0.9 | GO:0045252 | oxoglutarate dehydrogenase complex(GO:0045252) |
0.1 | 7.6 | GO:0009898 | cytoplasmic side of plasma membrane(GO:0009898) |
0.1 | 7.9 | GO:0017053 | transcriptional repressor complex(GO:0017053) |
0.1 | 0.8 | GO:0032391 | photoreceptor connecting cilium(GO:0032391) |
0.1 | 1.3 | GO:0036064 | ciliary basal body(GO:0036064) |
0.1 | 0.6 | GO:0034363 | intermediate-density lipoprotein particle(GO:0034363) |
0.1 | 5.8 | GO:0001750 | photoreceptor outer segment(GO:0001750) |
0.1 | 6.3 | GO:0015030 | Cajal body(GO:0015030) |
0.1 | 0.3 | GO:0033596 | TSC1-TSC2 complex(GO:0033596) |
0.1 | 0.9 | GO:0097038 | perinuclear endoplasmic reticulum(GO:0097038) |
0.1 | 2.7 | GO:0031304 | intrinsic component of mitochondrial inner membrane(GO:0031304) integral component of mitochondrial inner membrane(GO:0031305) |
0.1 | 9.8 | GO:0045121 | membrane raft(GO:0045121) membrane microdomain(GO:0098857) |
0.1 | 0.2 | GO:0030485 | smooth muscle contractile fiber(GO:0030485) |
0.1 | 0.8 | GO:0061702 | inflammasome complex(GO:0061702) |
0.1 | 0.3 | GO:0033565 | ESCRT-0 complex(GO:0033565) |
0.1 | 0.9 | GO:0005853 | eukaryotic translation elongation factor 1 complex(GO:0005853) |
0.1 | 0.7 | GO:0000243 | commitment complex(GO:0000243) |
0.1 | 3.1 | GO:0030173 | integral component of Golgi membrane(GO:0030173) |
0.1 | 0.9 | GO:0016602 | CCAAT-binding factor complex(GO:0016602) |
0.1 | 0.7 | GO:0043020 | NADPH oxidase complex(GO:0043020) |
0.1 | 13.3 | GO:0016323 | basolateral plasma membrane(GO:0016323) |
0.1 | 0.5 | GO:0097539 | ciliary transition fiber(GO:0097539) |
0.1 | 0.4 | GO:0031904 | endosome lumen(GO:0031904) |
0.1 | 1.3 | GO:0034045 | pre-autophagosomal structure membrane(GO:0034045) |
0.1 | 0.3 | GO:1990131 | EGO complex(GO:0034448) Gtr1-Gtr2 GTPase complex(GO:1990131) |
0.1 | 0.3 | GO:0000408 | EKC/KEOPS complex(GO:0000408) |
0.1 | 1.9 | GO:0005903 | brush border(GO:0005903) |
0.1 | 1.2 | GO:0035579 | specific granule membrane(GO:0035579) |
0.1 | 2.1 | GO:0019005 | SCF ubiquitin ligase complex(GO:0019005) |
0.1 | 0.2 | GO:0034098 | VCP-NPL4-UFD1 AAA ATPase complex(GO:0034098) |
0.1 | 2.6 | GO:0001726 | ruffle(GO:0001726) |
0.0 | 0.3 | GO:0030688 | preribosome, small subunit precursor(GO:0030688) |
0.0 | 0.3 | GO:0005790 | smooth endoplasmic reticulum(GO:0005790) |
0.0 | 0.3 | GO:0033162 | melanosome membrane(GO:0033162) chitosome(GO:0045009) |
0.0 | 0.7 | GO:0042629 | mast cell granule(GO:0042629) |
0.0 | 0.7 | GO:1904115 | axon cytoplasm(GO:1904115) |
0.0 | 0.4 | GO:0031332 | RISC complex(GO:0016442) RNAi effector complex(GO:0031332) |
0.0 | 0.3 | GO:0016529 | sarcoplasmic reticulum(GO:0016529) |
0.0 | 0.6 | GO:0016459 | myosin complex(GO:0016459) |
0.0 | 0.8 | GO:0035145 | exon-exon junction complex(GO:0035145) |
0.0 | 28.7 | GO:0005887 | integral component of plasma membrane(GO:0005887) |
0.0 | 0.1 | GO:0072357 | PTW/PP1 phosphatase complex(GO:0072357) |
0.0 | 0.2 | GO:0005854 | nascent polypeptide-associated complex(GO:0005854) |
0.0 | 0.3 | GO:0005922 | connexon complex(GO:0005922) |
0.0 | 0.1 | GO:0035859 | Seh1-associated complex(GO:0035859) Iml1 complex(GO:1990130) |
0.0 | 0.2 | GO:0044291 | cell-cell contact zone(GO:0044291) |
0.0 | 0.1 | GO:0090543 | Flemming body(GO:0090543) |
0.0 | 5.1 | GO:0016607 | nuclear speck(GO:0016607) |
0.0 | 0.7 | GO:0005814 | centriole(GO:0005814) |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
12.1 | 36.4 | GO:0004676 | 3-phosphoinositide-dependent protein kinase activity(GO:0004676) |
8.3 | 116.7 | GO:0032395 | MHC class II receptor activity(GO:0032395) |
8.2 | 24.6 | GO:0035662 | Toll-like receptor 4 binding(GO:0035662) |
7.7 | 100.2 | GO:0005344 | oxygen transporter activity(GO:0005344) |
7.4 | 51.7 | GO:0030369 | ICAM-3 receptor activity(GO:0030369) |
6.1 | 18.4 | GO:0035403 | histone kinase activity (H3-T6 specific)(GO:0035403) |
5.3 | 21.2 | GO:0030107 | HLA-A specific inhibitory MHC class I receptor activity(GO:0030107) |
5.1 | 20.4 | GO:0047391 | alkylglycerophosphoethanolamine phosphodiesterase activity(GO:0047391) |
5.0 | 40.2 | GO:0031802 | type 5 metabotropic glutamate receptor binding(GO:0031802) |
4.8 | 14.4 | GO:0015091 | ferric iron transmembrane transporter activity(GO:0015091) trivalent inorganic cation transmembrane transporter activity(GO:0072510) |
4.8 | 19.1 | GO:0042289 | MHC class II protein binding(GO:0042289) |
4.5 | 13.4 | GO:0015199 | amino-acid betaine transmembrane transporter activity(GO:0015199) carnitine transmembrane transporter activity(GO:0015226) |
4.4 | 22.2 | GO:0017159 | pantetheine hydrolase activity(GO:0017159) |
4.3 | 17.1 | GO:0019976 | interleukin-2 receptor activity(GO:0004911) interleukin-2 binding(GO:0019976) |
4.2 | 59.1 | GO:0031432 | titin binding(GO:0031432) |
4.2 | 41.7 | GO:0061578 | Lys63-specific deubiquitinase activity(GO:0061578) |
4.1 | 16.5 | GO:0043812 | phosphatidylinositol-4-phosphate phosphatase activity(GO:0043812) |
4.0 | 15.9 | GO:0034988 | Fc-gamma receptor I complex binding(GO:0034988) |
4.0 | 23.7 | GO:0019763 | immunoglobulin receptor activity(GO:0019763) |
3.7 | 14.7 | GO:0032396 | inhibitory MHC class I receptor activity(GO:0032396) |
3.6 | 3.6 | GO:0001054 | RNA polymerase I activity(GO:0001054) |
3.4 | 106.5 | GO:0005212 | structural constituent of eye lens(GO:0005212) |
3.2 | 13.0 | GO:0035373 | chondroitin sulfate proteoglycan binding(GO:0035373) |
3.2 | 91.9 | GO:0042605 | peptide antigen binding(GO:0042605) |
3.0 | 35.9 | GO:0019911 | structural constituent of myelin sheath(GO:0019911) |
3.0 | 9.0 | GO:0016495 | C-X3-C chemokine receptor activity(GO:0016495) |
2.9 | 2.9 | GO:0005272 | sodium channel activity(GO:0005272) |
2.9 | 14.5 | GO:0001132 | RNA polymerase II transcription factor activity, TBP-class protein binding, involved in preinitiation complex assembly(GO:0001129) RNA polymerase II transcription factor activity, TBP-class protein binding(GO:0001132) |
2.9 | 28.9 | GO:0036312 | phosphatidylinositol 3-kinase regulatory subunit binding(GO:0036312) |
2.9 | 2.9 | GO:0005534 | galactose binding(GO:0005534) |
2.8 | 11.3 | GO:0042132 | fructose 1,6-bisphosphate 1-phosphatase activity(GO:0042132) |
2.8 | 72.0 | GO:0005521 | lamin binding(GO:0005521) |
2.7 | 32.9 | GO:0019864 | IgG binding(GO:0019864) |
2.7 | 8.2 | GO:0005150 | interleukin-1, Type I receptor binding(GO:0005150) |
2.7 | 35.5 | GO:0001011 | transcription factor activity, sequence-specific DNA binding, RNA polymerase recruiting(GO:0001011) transcription factor activity, TFIIB-class binding(GO:0001087) |
2.7 | 10.9 | GO:0042030 | ATPase inhibitor activity(GO:0042030) |
2.7 | 8.1 | GO:0019959 | interleukin-8 binding(GO:0019959) |
2.7 | 16.0 | GO:0042577 | lipid phosphatase activity(GO:0042577) |
2.6 | 10.5 | GO:0003726 | double-stranded RNA adenosine deaminase activity(GO:0003726) |
2.6 | 2.6 | GO:0047631 | ADP-ribose diphosphatase activity(GO:0047631) |
2.6 | 15.4 | GO:0008597 | calcium-dependent protein serine/threonine phosphatase regulator activity(GO:0008597) |
2.6 | 12.8 | GO:0070728 | leucine binding(GO:0070728) |
2.6 | 10.2 | GO:0030492 | hemoglobin binding(GO:0030492) |
2.5 | 7.5 | GO:0047192 | 1-alkylglycerophosphocholine O-acetyltransferase activity(GO:0047192) |
2.5 | 15.0 | GO:0004430 | 1-phosphatidylinositol 4-kinase activity(GO:0004430) |
2.5 | 29.9 | GO:1903136 | cuprous ion binding(GO:1903136) |
2.5 | 17.3 | GO:0008142 | oxysterol binding(GO:0008142) |
2.5 | 7.4 | GO:0005457 | GDP-fucose transmembrane transporter activity(GO:0005457) purine nucleotide-sugar transmembrane transporter activity(GO:0036080) |
2.4 | 4.9 | GO:0047184 | 1-acylglycerophosphocholine O-acyltransferase activity(GO:0047184) |
2.4 | 12.2 | GO:0060175 | brain-derived neurotrophic factor-activated receptor activity(GO:0060175) |
2.3 | 14.0 | GO:0070892 | lipoteichoic acid receptor activity(GO:0070892) |
2.3 | 7.0 | GO:0016314 | phosphatidylinositol-3,4,5-trisphosphate 3-phosphatase activity(GO:0016314) |
2.3 | 9.3 | GO:0015254 | glycerol channel activity(GO:0015254) |
2.3 | 9.3 | GO:0055131 | C3HC4-type RING finger domain binding(GO:0055131) |
2.3 | 6.8 | GO:0005174 | CD40 receptor binding(GO:0005174) |
2.2 | 11.2 | GO:0004489 | methylenetetrahydrofolate reductase (NAD(P)H) activity(GO:0004489) |
2.2 | 6.6 | GO:0008502 | melatonin receptor activity(GO:0008502) |
2.2 | 8.8 | GO:0070290 | N-acylphosphatidylethanolamine-specific phospholipase D activity(GO:0070290) |
2.2 | 6.5 | GO:0008955 | peptidoglycan glycosyltransferase activity(GO:0008955) |
2.2 | 10.9 | GO:0004982 | N-formyl peptide receptor activity(GO:0004982) |
2.1 | 10.6 | GO:0017153 | sodium:dicarboxylate symporter activity(GO:0017153) |
2.1 | 4.2 | GO:0019912 | cyclin-dependent protein kinase activating kinase activity(GO:0019912) |
2.0 | 12.2 | GO:0048039 | ubiquinone binding(GO:0048039) |
2.0 | 6.1 | GO:0047696 | beta-adrenergic receptor kinase activity(GO:0047696) |
2.0 | 15.9 | GO:0051864 | histone demethylase activity (H3-K36 specific)(GO:0051864) |
2.0 | 23.8 | GO:0010385 | double-stranded methylated DNA binding(GO:0010385) |
2.0 | 5.9 | GO:0045322 | unmethylated CpG binding(GO:0045322) |
2.0 | 21.5 | GO:0008430 | selenium binding(GO:0008430) |
1.9 | 7.8 | GO:0099609 | microtubule lateral binding(GO:0099609) |
1.9 | 5.8 | GO:0003953 | NAD+ nucleosidase activity(GO:0003953) NAD(P)+ nucleosidase activity(GO:0050135) |
1.9 | 5.7 | GO:0080130 | L-phenylalanine aminotransferase activity(GO:0070546) L-phenylalanine:2-oxoglutarate aminotransferase activity(GO:0080130) |
1.9 | 9.5 | GO:0048248 | CXCR3 chemokine receptor binding(GO:0048248) |
1.9 | 3.8 | GO:0015111 | iodide transmembrane transporter activity(GO:0015111) |
1.9 | 9.5 | GO:0061665 | SUMO ligase activity(GO:0061665) |
1.9 | 9.4 | GO:0005333 | norepinephrine transmembrane transporter activity(GO:0005333) |
1.9 | 13.1 | GO:0032554 | purine deoxyribonucleotide binding(GO:0032554) |
1.9 | 16.8 | GO:0043426 | MRF binding(GO:0043426) |
1.9 | 11.1 | GO:0008440 | inositol-1,4,5-trisphosphate 3-kinase activity(GO:0008440) |
1.8 | 7.4 | GO:0051120 | hepoxilin A3 synthase activity(GO:0051120) |
1.8 | 3.7 | GO:0034648 | histone demethylase activity (H3-dimethyl-K4 specific)(GO:0034648) |
1.8 | 7.3 | GO:0097001 | ceramide binding(GO:0097001) |
1.8 | 7.2 | GO:0052812 | phosphatidylinositol-3,4-bisphosphate 5-kinase activity(GO:0052812) |
1.8 | 32.3 | GO:0102391 | decanoate--CoA ligase activity(GO:0102391) |
1.7 | 5.2 | GO:0051139 | metal ion:proton antiporter activity(GO:0051139) |
1.7 | 6.9 | GO:0042954 | lipoprotein transporter activity(GO:0042954) |
1.7 | 13.7 | GO:0008318 | protein prenyltransferase activity(GO:0008318) |
1.7 | 6.8 | GO:0015319 | sodium:inorganic phosphate symporter activity(GO:0015319) |
1.7 | 10.2 | GO:0000155 | phosphorelay sensor kinase activity(GO:0000155) |
1.7 | 5.1 | GO:0008859 | exoribonuclease II activity(GO:0008859) |
1.7 | 5.1 | GO:0000822 | inositol hexakisphosphate binding(GO:0000822) |
1.7 | 6.7 | GO:0017040 | ceramidase activity(GO:0017040) |
1.7 | 38.7 | GO:0005545 | 1-phosphatidylinositol binding(GO:0005545) |
1.7 | 84.8 | GO:0034987 | immunoglobulin receptor binding(GO:0034987) |
1.7 | 8.3 | GO:0070097 | delta-catenin binding(GO:0070097) |
1.7 | 3.3 | GO:0031545 | peptidyl-proline dioxygenase activity(GO:0031543) peptidyl-proline 4-dioxygenase activity(GO:0031545) |
1.6 | 6.6 | GO:0004505 | phenylalanine 4-monooxygenase activity(GO:0004505) |
1.6 | 4.9 | GO:0008321 | Ral guanyl-nucleotide exchange factor activity(GO:0008321) |
1.6 | 14.6 | GO:0042608 | T cell receptor binding(GO:0042608) |
1.6 | 6.5 | GO:0047288 | monosialoganglioside sialyltransferase activity(GO:0047288) |
1.6 | 4.8 | GO:0016262 | protein N-acetylglucosaminyltransferase activity(GO:0016262) |
1.6 | 4.8 | GO:0004694 | eukaryotic translation initiation factor 2alpha kinase activity(GO:0004694) |
1.6 | 1.6 | GO:0035379 | carbon dioxide transmembrane transporter activity(GO:0035379) |
1.6 | 11.1 | GO:0015501 | glutamate:sodium symporter activity(GO:0015501) |
1.6 | 3.2 | GO:0001784 | phosphotyrosine binding(GO:0001784) |
1.6 | 4.7 | GO:0016838 | carbon-oxygen lyase activity, acting on phosphates(GO:0016838) |
1.6 | 6.3 | GO:0061714 | folic acid receptor activity(GO:0061714) |
1.6 | 9.4 | GO:0004522 | ribonuclease A activity(GO:0004522) |
1.6 | 7.8 | GO:0004468 | lysine N-acetyltransferase activity, acting on acetyl phosphate as donor(GO:0004468) |
1.6 | 4.7 | GO:0004832 | valine-tRNA ligase activity(GO:0004832) |
1.5 | 6.1 | GO:0005220 | inositol 1,4,5-trisphosphate-sensitive calcium-release channel activity(GO:0005220) |
1.5 | 25.9 | GO:0004861 | cyclin-dependent protein serine/threonine kinase inhibitor activity(GO:0004861) |
1.5 | 9.0 | GO:0004705 | JUN kinase activity(GO:0004705) SAP kinase activity(GO:0016909) |
1.5 | 22.3 | GO:0005229 | intracellular calcium activated chloride channel activity(GO:0005229) |
1.5 | 8.8 | GO:0072320 | volume-sensitive chloride channel activity(GO:0072320) |
1.5 | 1.5 | GO:0016401 | palmitoyl-CoA oxidase activity(GO:0016401) |
1.5 | 4.4 | GO:0051377 | mannose-ethanolamine phosphotransferase activity(GO:0051377) |
1.4 | 25.4 | GO:0004143 | diacylglycerol kinase activity(GO:0004143) |
1.4 | 4.2 | GO:0016435 | rRNA (guanine) methyltransferase activity(GO:0016435) |
1.4 | 5.6 | GO:0004449 | isocitrate dehydrogenase (NAD+) activity(GO:0004449) |
1.4 | 2.8 | GO:0017128 | phospholipid scramblase activity(GO:0017128) |
1.4 | 29.0 | GO:0050811 | GABA receptor binding(GO:0050811) |
1.4 | 4.1 | GO:0036487 | nitric-oxide synthase inhibitor activity(GO:0036487) |
1.4 | 6.8 | GO:0004647 | phosphoserine phosphatase activity(GO:0004647) |
1.4 | 2.7 | GO:0052811 | 1-phosphatidylinositol-3-phosphate 4-kinase activity(GO:0052811) |
1.4 | 4.1 | GO:0008798 | beta-aspartyl-peptidase activity(GO:0008798) |
1.3 | 20.2 | GO:0032036 | myosin heavy chain binding(GO:0032036) |
1.3 | 9.4 | GO:0001515 | opioid peptide activity(GO:0001515) |
1.3 | 5.4 | GO:0005314 | high-affinity glutamate transmembrane transporter activity(GO:0005314) |
1.3 | 2.7 | GO:0004723 | calcium-dependent protein serine/threonine phosphatase activity(GO:0004723) calmodulin-dependent protein phosphatase activity(GO:0033192) |
1.3 | 4.0 | GO:0015234 | thiamine transmembrane transporter activity(GO:0015234) thiamine uptake transmembrane transporter activity(GO:0015403) |
1.3 | 185.4 | GO:0003823 | antigen binding(GO:0003823) |
1.3 | 23.6 | GO:0005522 | profilin binding(GO:0005522) |
1.3 | 17.0 | GO:0019957 | C-C chemokine binding(GO:0019957) |
1.3 | 11.8 | GO:0005025 | transforming growth factor beta receptor activity, type I(GO:0005025) |
1.3 | 5.2 | GO:0034236 | protein kinase A catalytic subunit binding(GO:0034236) |
1.3 | 6.4 | GO:0030911 | TPR domain binding(GO:0030911) |
1.3 | 3.8 | GO:0050501 | hyaluronan synthase activity(GO:0050501) |
1.3 | 5.1 | GO:0004727 | prenylated protein tyrosine phosphatase activity(GO:0004727) |
1.3 | 7.7 | GO:0004024 | alcohol dehydrogenase activity, zinc-dependent(GO:0004024) |
1.3 | 7.6 | GO:0004677 | DNA-dependent protein kinase activity(GO:0004677) |
1.3 | 3.8 | GO:0004914 | interleukin-5 receptor activity(GO:0004914) |
1.3 | 89.9 | GO:0001540 | beta-amyloid binding(GO:0001540) |
1.3 | 21.5 | GO:0001103 | RNA polymerase II repressing transcription factor binding(GO:0001103) |
1.3 | 5.0 | GO:0032145 | 4-aminobutyrate transaminase activity(GO:0003867) succinate-semialdehyde dehydrogenase binding(GO:0032145) (S)-3-amino-2-methylpropionate transaminase activity(GO:0047298) |
1.2 | 7.5 | GO:0004634 | phosphopyruvate hydratase activity(GO:0004634) |
1.2 | 4.9 | GO:0001588 | dopamine neurotransmitter receptor activity, coupled via Gs(GO:0001588) |
1.2 | 3.7 | GO:0043183 | vascular endothelial growth factor receptor 1 binding(GO:0043183) |
1.2 | 3.7 | GO:0047223 | beta-1,3-galactosyl-O-glycosyl-glycoprotein beta-1,3-N-acetylglucosaminyltransferase activity(GO:0047223) |
1.2 | 9.8 | GO:0003876 | AMP deaminase activity(GO:0003876) adenosine-phosphate deaminase activity(GO:0047623) |
1.2 | 3.7 | GO:0015439 | heme-transporting ATPase activity(GO:0015439) |
1.2 | 3.6 | GO:0052894 | norspermine:oxygen oxidoreductase activity(GO:0052894) N1-acetylspermine:oxygen oxidoreductase (N1-acetylspermidine-forming) activity(GO:0052895) |
1.2 | 15.8 | GO:0017162 | aryl hydrocarbon receptor binding(GO:0017162) |
1.2 | 6.1 | GO:0000179 | rRNA (adenine-N6,N6-)-dimethyltransferase activity(GO:0000179) |
1.2 | 13.3 | GO:0035612 | AP-2 adaptor complex binding(GO:0035612) |
1.2 | 9.7 | GO:0004176 | ATP-dependent peptidase activity(GO:0004176) |
1.2 | 7.2 | GO:0070016 | armadillo repeat domain binding(GO:0070016) |
1.2 | 3.6 | GO:0019981 | interleukin-6 receptor activity(GO:0004915) interleukin-6 binding(GO:0019981) |
1.2 | 7.1 | GO:0035368 | selenocysteine insertion sequence binding(GO:0035368) |
1.2 | 2.4 | GO:0030272 | 5-formyltetrahydrofolate cyclo-ligase activity(GO:0030272) |
1.2 | 5.8 | GO:0017060 | 3-galactosyl-N-acetylglucosaminide 4-alpha-L-fucosyltransferase activity(GO:0017060) |
1.2 | 15.0 | GO:0033691 | sialic acid binding(GO:0033691) |
1.1 | 3.4 | GO:0016714 | oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen, reduced pteridine as one donor, and incorporation of one atom of oxygen(GO:0016714) |
1.1 | 11.4 | GO:0005007 | fibroblast growth factor-activated receptor activity(GO:0005007) |
1.1 | 3.4 | GO:0019841 | retinol binding(GO:0019841) |
1.1 | 6.7 | GO:0003998 | acylphosphatase activity(GO:0003998) |
1.1 | 79.1 | GO:0050840 | extracellular matrix binding(GO:0050840) |
1.1 | 4.5 | GO:0001632 | leukotriene B4 receptor activity(GO:0001632) |
1.1 | 29.9 | GO:0004016 | adenylate cyclase activity(GO:0004016) phosphorus-oxygen lyase activity(GO:0016849) |
1.1 | 4.4 | GO:1990430 | extracellular matrix protein binding(GO:1990430) |
1.1 | 3.3 | GO:0031727 | CCR2 chemokine receptor binding(GO:0031727) |
1.1 | 4.3 | GO:0050265 | RNA uridylyltransferase activity(GO:0050265) |
1.1 | 5.4 | GO:0086006 | voltage-gated sodium channel activity involved in cardiac muscle cell action potential(GO:0086006) |
1.1 | 7.5 | GO:0017077 | oxidative phosphorylation uncoupler activity(GO:0017077) |
1.1 | 3.2 | GO:0030158 | protein xylosyltransferase activity(GO:0030158) |
1.1 | 10.6 | GO:0009374 | biotin binding(GO:0009374) |
1.1 | 38.2 | GO:0004115 | 3',5'-cyclic-AMP phosphodiesterase activity(GO:0004115) |
1.1 | 7.4 | GO:0031726 | CCR1 chemokine receptor binding(GO:0031726) |
1.1 | 5.3 | GO:0005219 | ryanodine-sensitive calcium-release channel activity(GO:0005219) |
1.0 | 5.2 | GO:0031893 | vasopressin receptor binding(GO:0031893) |
1.0 | 11.3 | GO:0031681 | G-protein beta-subunit binding(GO:0031681) |
1.0 | 4.1 | GO:0030215 | semaphorin receptor binding(GO:0030215) |
1.0 | 15.3 | GO:0005247 | voltage-gated chloride channel activity(GO:0005247) |
1.0 | 7.1 | GO:0004126 | cytidine deaminase activity(GO:0004126) |
1.0 | 3.0 | GO:0046997 | sarcosine dehydrogenase activity(GO:0008480) oxidoreductase activity, acting on the CH-NH group of donors, flavin as acceptor(GO:0046997) |
1.0 | 5.1 | GO:0008934 | inositol monophosphate 1-phosphatase activity(GO:0008934) inositol monophosphate 3-phosphatase activity(GO:0052832) inositol monophosphate 4-phosphatase activity(GO:0052833) inositol monophosphate phosphatase activity(GO:0052834) |
1.0 | 15.2 | GO:0047617 | acyl-CoA hydrolase activity(GO:0047617) |
1.0 | 7.1 | GO:0050682 | AF-2 domain binding(GO:0050682) |
1.0 | 3.0 | GO:0003863 | alpha-ketoacid dehydrogenase activity(GO:0003826) 3-methyl-2-oxobutanoate dehydrogenase (2-methylpropanoyl-transferring) activity(GO:0003863) |
1.0 | 3.0 | GO:0016155 | formyltetrahydrofolate dehydrogenase activity(GO:0016155) |
1.0 | 5.0 | GO:0004668 | protein-arginine deiminase activity(GO:0004668) |
1.0 | 3.0 | GO:0004040 | amidase activity(GO:0004040) |
1.0 | 3.0 | GO:0035473 | lipase binding(GO:0035473) |
1.0 | 3.0 | GO:0004802 | transketolase activity(GO:0004802) |
1.0 | 2.9 | GO:0034353 | RNA pyrophosphohydrolase activity(GO:0034353) |
1.0 | 7.7 | GO:0050833 | pyruvate transmembrane transporter activity(GO:0050833) |
1.0 | 4.8 | GO:0016933 | extracellular-glycine-gated ion channel activity(GO:0016933) extracellular-glycine-gated chloride channel activity(GO:0016934) |
1.0 | 14.3 | GO:0005068 | transmembrane receptor protein tyrosine kinase adaptor activity(GO:0005068) |
0.9 | 4.7 | GO:0004591 | oxoglutarate dehydrogenase (succinyl-transferring) activity(GO:0004591) |
0.9 | 3.8 | GO:0008410 | CoA-transferase activity(GO:0008410) |
0.9 | 2.8 | GO:0005152 | interleukin-1 receptor antagonist activity(GO:0005152) |
0.9 | 2.8 | GO:0030226 | apolipoprotein receptor activity(GO:0030226) apolipoprotein A-I receptor activity(GO:0034188) phosphatidylserine-translocating ATPase activity(GO:0090556) |
0.9 | 3.8 | GO:0008422 | beta-glucosidase activity(GO:0008422) |
0.9 | 5.6 | GO:0043533 | inositol 1,3,4,5 tetrakisphosphate binding(GO:0043533) |
0.9 | 2.8 | GO:0001181 | transcription factor activity, core RNA polymerase I binding(GO:0001181) |
0.9 | 19.2 | GO:0030676 | Rac guanyl-nucleotide exchange factor activity(GO:0030676) |
0.9 | 3.7 | GO:0016160 | amylase activity(GO:0016160) |
0.9 | 4.6 | GO:0003956 | NAD(P)+-protein-arginine ADP-ribosyltransferase activity(GO:0003956) |
0.9 | 4.6 | GO:0008113 | peptide-methionine (S)-S-oxide reductase activity(GO:0008113) |
0.9 | 14.6 | GO:0038191 | neuropilin binding(GO:0038191) |
0.9 | 1.8 | GO:0035663 | Toll-like receptor 2 binding(GO:0035663) |
0.9 | 41.5 | GO:0030507 | spectrin binding(GO:0030507) |
0.9 | 11.7 | GO:0043274 | phospholipase binding(GO:0043274) |
0.9 | 1.8 | GO:0048403 | brain-derived neurotrophic factor binding(GO:0048403) |
0.9 | 8.9 | GO:0005094 | Rho GDP-dissociation inhibitor activity(GO:0005094) |
0.9 | 13.3 | GO:0016918 | retinal binding(GO:0016918) |
0.9 | 12.4 | GO:0042043 | neurexin family protein binding(GO:0042043) |
0.9 | 2.6 | GO:0050698 | proteoglycan sulfotransferase activity(GO:0050698) |
0.9 | 3.4 | GO:0004706 | JUN kinase kinase kinase activity(GO:0004706) |
0.9 | 3.4 | GO:0016841 | ammonia-lyase activity(GO:0016841) |
0.9 | 1.7 | GO:0046977 | peptide antigen-transporting ATPase activity(GO:0015433) TAP binding(GO:0046977) TAP1 binding(GO:0046978) |
0.9 | 1.7 | GO:0043559 | insulin binding(GO:0043559) |
0.9 | 2.6 | GO:0033878 | hormone-sensitive lipase activity(GO:0033878) |
0.8 | 3.4 | GO:0052798 | beta-galactoside alpha-2,3-sialyltransferase activity(GO:0052798) |
0.8 | 1.7 | GO:0004998 | transferrin receptor activity(GO:0004998) |
0.8 | 10.2 | GO:0097027 | ubiquitin-protein transferase activator activity(GO:0097027) |
0.8 | 16.8 | GO:0043014 | alpha-tubulin binding(GO:0043014) |
0.8 | 5.8 | GO:0004920 | interleukin-10 receptor activity(GO:0004920) |
0.8 | 2.5 | GO:1990380 | Lys48-specific deubiquitinase activity(GO:1990380) |
0.8 | 4.1 | GO:0004771 | sterol esterase activity(GO:0004771) |
0.8 | 21.5 | GO:0005001 | transmembrane receptor protein tyrosine phosphatase activity(GO:0005001) transmembrane receptor protein phosphatase activity(GO:0019198) |
0.8 | 23.1 | GO:0046961 | proton-transporting ATPase activity, rotational mechanism(GO:0046961) |
0.8 | 12.3 | GO:0042609 | CD4 receptor binding(GO:0042609) |
0.8 | 2.4 | GO:0004947 | bradykinin receptor activity(GO:0004947) |
0.8 | 17.1 | GO:0042288 | MHC class I protein binding(GO:0042288) |
0.8 | 2.4 | GO:0071209 | U7 snRNA binding(GO:0071209) |
0.8 | 3.2 | GO:0004740 | pyruvate dehydrogenase (acetyl-transferring) kinase activity(GO:0004740) |
0.8 | 12.1 | GO:0008409 | 5'-3' exonuclease activity(GO:0008409) |
0.8 | 4.0 | GO:0004111 | creatine kinase activity(GO:0004111) |
0.8 | 4.8 | GO:0042296 | ISG15 transferase activity(GO:0042296) |
0.8 | 2.4 | GO:0016422 | mRNA (2'-O-methyladenosine-N6-)-methyltransferase activity(GO:0016422) |
0.8 | 2.4 | GO:0015018 | galactosylgalactosylxylosylprotein 3-beta-glucuronosyltransferase activity(GO:0015018) |
0.8 | 11.8 | GO:0009881 | photoreceptor activity(GO:0009881) |
0.8 | 2.3 | GO:1990841 | promoter-specific chromatin binding(GO:1990841) |
0.8 | 2.3 | GO:0004045 | aminoacyl-tRNA hydrolase activity(GO:0004045) |
0.8 | 4.7 | GO:0015185 | gamma-aminobutyric acid:sodium symporter activity(GO:0005332) gamma-aminobutyric acid transmembrane transporter activity(GO:0015185) |
0.8 | 4.6 | GO:0004741 | [pyruvate dehydrogenase (lipoamide)] phosphatase activity(GO:0004741) |
0.8 | 3.1 | GO:0022850 | serotonin-gated cation channel activity(GO:0022850) |
0.8 | 6.2 | GO:0070181 | small ribosomal subunit rRNA binding(GO:0070181) |
0.8 | 6.9 | GO:0004321 | fatty-acyl-CoA synthase activity(GO:0004321) |
0.8 | 3.0 | GO:0046625 | sphingolipid binding(GO:0046625) |
0.8 | 8.3 | GO:0016423 | tRNA (guanine) methyltransferase activity(GO:0016423) |
0.8 | 3.0 | GO:0008889 | glycerophosphodiester phosphodiesterase activity(GO:0008889) |
0.7 | 3.0 | GO:0060422 | peptidyl-dipeptidase inhibitor activity(GO:0060422) |
0.7 | 2.9 | GO:0097603 | temperature-gated ion channel activity(GO:0097603) |
0.7 | 2.9 | GO:0003827 | alpha-1,3-mannosylglycoprotein 2-beta-N-acetylglucosaminyltransferase activity(GO:0003827) |
0.7 | 2.2 | GO:0032184 | SUMO polymer binding(GO:0032184) |
0.7 | 2.9 | GO:0001025 | RNA polymerase III transcription factor binding(GO:0001025) |
0.7 | 11.6 | GO:0005326 | neurotransmitter transporter activity(GO:0005326) |
0.7 | 10.0 | GO:0050700 | CARD domain binding(GO:0050700) |
0.7 | 2.9 | GO:0042500 | aspartic endopeptidase activity, intramembrane cleaving(GO:0042500) |
0.7 | 5.7 | GO:0008559 | xenobiotic-transporting ATPase activity(GO:0008559) |
0.7 | 1.4 | GO:0099529 | neurotransmitter receptor activity involved in regulation of postsynaptic membrane potential(GO:0099529) transmitter-gated ion channel activity involved in regulation of postsynaptic membrane potential(GO:1904315) |
0.7 | 6.3 | GO:0004499 | N,N-dimethylaniline monooxygenase activity(GO:0004499) |
0.7 | 3.5 | GO:0070573 | metallodipeptidase activity(GO:0070573) |
0.7 | 2.1 | GO:0008192 | RNA guanylyltransferase activity(GO:0008192) |
0.7 | 3.5 | GO:0004815 | aspartate-tRNA ligase activity(GO:0004815) |
0.7 | 6.9 | GO:1901702 | urate transmembrane transporter activity(GO:0015143) salt transmembrane transporter activity(GO:1901702) |
0.7 | 6.9 | GO:0031433 | telethonin binding(GO:0031433) |
0.7 | 4.7 | GO:0097322 | 7SK snRNA binding(GO:0097322) |
0.7 | 3.4 | GO:0052841 | endopolyphosphatase activity(GO:0000298) diphosphoinositol-polyphosphate diphosphatase activity(GO:0008486) bis(5'-adenosyl)-hexaphosphatase activity(GO:0034431) bis(5'-adenosyl)-pentaphosphatase activity(GO:0034432) inositol diphosphate tetrakisphosphate diphosphatase activity(GO:0052840) inositol bisdiphosphate tetrakisphosphate diphosphatase activity(GO:0052841) inositol diphosphate pentakisphosphate diphosphatase activity(GO:0052842) inositol-1-diphosphate-2,3,4,5,6-pentakisphosphate diphosphatase activity(GO:0052843) inositol-3-diphosphate-1,2,4,5,6-pentakisphosphate diphosphatase activity(GO:0052844) inositol-5-diphosphate-1,2,3,4,6-pentakisphosphate diphosphatase activity(GO:0052845) inositol-1,5-bisdiphosphate-2,3,4,6-tetrakisphosphate 1-diphosphatase activity(GO:0052846) inositol-1,5-bisdiphosphate-2,3,4,6-tetrakisphosphate 5-diphosphatase activity(GO:0052847) inositol-3,5-bisdiphosphate-2,3,4,6-tetrakisphosphate 5-diphosphatase activity(GO:0052848) |
0.7 | 9.2 | GO:0004691 | cAMP-dependent protein kinase activity(GO:0004691) |
0.7 | 2.0 | GO:0004711 | ribosomal protein S6 kinase activity(GO:0004711) |
0.7 | 1.3 | GO:0004939 | beta-adrenergic receptor activity(GO:0004939) |
0.6 | 3.9 | GO:0061649 | ubiquitinated histone binding(GO:0061649) |
0.6 | 2.6 | GO:0005134 | interleukin-2 receptor binding(GO:0005134) |
0.6 | 16.7 | GO:0005104 | fibroblast growth factor receptor binding(GO:0005104) |
0.6 | 15.4 | GO:0004708 | MAP kinase kinase activity(GO:0004708) |
0.6 | 7.7 | GO:0015250 | water channel activity(GO:0015250) |
0.6 | 4.4 | GO:0050294 | steroid sulfotransferase activity(GO:0050294) |
0.6 | 2.5 | GO:0052590 | sn-glycerol-3-phosphate:ubiquinone oxidoreductase activity(GO:0052590) sn-glycerol-3-phosphate:ubiquinone-8 oxidoreductase activity(GO:0052591) |
0.6 | 3.1 | GO:0097199 | cysteine-type endopeptidase activity involved in apoptotic signaling pathway(GO:0097199) |
0.6 | 1.9 | GO:0005350 | pyrimidine nucleobase transmembrane transporter activity(GO:0005350) |
0.6 | 3.7 | GO:0008467 | [heparan sulfate]-glucosamine 3-sulfotransferase 1 activity(GO:0008467) |
0.6 | 2.5 | GO:0098821 | BMP receptor activity(GO:0098821) |
0.6 | 3.1 | GO:0018024 | histone-lysine N-methyltransferase activity(GO:0018024) |
0.6 | 3.1 | GO:0004306 | ethanolamine-phosphate cytidylyltransferase activity(GO:0004306) |
0.6 | 4.9 | GO:0030306 | ADP-ribosylation factor binding(GO:0030306) |
0.6 | 4.9 | GO:0034235 | GPI anchor binding(GO:0034235) |
0.6 | 17.1 | GO:0003950 | NAD+ ADP-ribosyltransferase activity(GO:0003950) |
0.6 | 27.3 | GO:0005484 | SNAP receptor activity(GO:0005484) |
0.6 | 6.7 | GO:0031683 | G-protein beta/gamma-subunit complex binding(GO:0031683) |
0.6 | 6.6 | GO:0052629 | phosphatidylinositol-3,5-bisphosphate 3-phosphatase activity(GO:0052629) |
0.6 | 1.8 | GO:0001069 | regulatory region RNA binding(GO:0001069) |
0.6 | 4.2 | GO:0030169 | low-density lipoprotein particle binding(GO:0030169) |
0.6 | 13.2 | GO:0050321 | tau-protein kinase activity(GO:0050321) |
0.6 | 0.6 | GO:0008853 | exodeoxyribonuclease III activity(GO:0008853) |
0.6 | 66.4 | GO:0005070 | SH3/SH2 adaptor activity(GO:0005070) |
0.6 | 3.5 | GO:0030020 | extracellular matrix structural constituent conferring tensile strength(GO:0030020) |
0.6 | 2.3 | GO:0016404 | 15-hydroxyprostaglandin dehydrogenase (NAD+) activity(GO:0016404) |
0.6 | 2.3 | GO:0043515 | kinetochore binding(GO:0043515) |
0.6 | 1.2 | GO:0005127 | ciliary neurotrophic factor receptor binding(GO:0005127) |
0.6 | 5.8 | GO:0042975 | peroxisome proliferator activated receptor binding(GO:0042975) |
0.6 | 3.5 | GO:0003873 | 6-phosphofructo-2-kinase activity(GO:0003873) fructose-2,6-bisphosphate 2-phosphatase activity(GO:0004331) |
0.6 | 8.6 | GO:0019992 | diacylglycerol binding(GO:0019992) |
0.6 | 2.3 | GO:0070815 | peptidyl-lysine 5-dioxygenase activity(GO:0070815) |
0.6 | 16.4 | GO:0005035 | tumor necrosis factor-activated receptor activity(GO:0005031) death receptor activity(GO:0005035) |
0.6 | 2.3 | GO:0004060 | arylamine N-acetyltransferase activity(GO:0004060) |
0.6 | 3.9 | GO:0016494 | C-X-C chemokine receptor activity(GO:0016494) |
0.6 | 7.8 | GO:0019707 | protein-cysteine S-palmitoyltransferase activity(GO:0019706) protein-cysteine S-acyltransferase activity(GO:0019707) |
0.6 | 1.7 | GO:0097158 | pre-mRNA intronic pyrimidine-rich binding(GO:0097158) |
0.5 | 2.7 | GO:0005223 | intracellular cGMP activated cation channel activity(GO:0005223) |
0.5 | 5.3 | GO:0016176 | superoxide-generating NADPH oxidase activator activity(GO:0016176) |
0.5 | 11.1 | GO:0008157 | protein phosphatase 1 binding(GO:0008157) |
0.5 | 1.6 | GO:0035673 | oligopeptide transmembrane transporter activity(GO:0035673) |
0.5 | 1.5 | GO:0004616 | phosphogluconate dehydrogenase (decarboxylating) activity(GO:0004616) |
0.5 | 3.6 | GO:0016413 | O-acetyltransferase activity(GO:0016413) |
0.5 | 1.5 | GO:0031685 | adenosine receptor binding(GO:0031685) |
0.5 | 4.6 | GO:0015101 | organic cation transmembrane transporter activity(GO:0015101) |
0.5 | 2.0 | GO:0004530 | deoxyribonuclease I activity(GO:0004530) |
0.5 | 2.0 | GO:0004022 | alcohol dehydrogenase (NAD) activity(GO:0004022) |
0.5 | 4.6 | GO:0046975 | histone methyltransferase activity (H3-K36 specific)(GO:0046975) |
0.5 | 2.5 | GO:0002046 | opsin binding(GO:0002046) |
0.5 | 8.0 | GO:0097109 | neuroligin family protein binding(GO:0097109) |
0.5 | 1.5 | GO:0004142 | diacylglycerol cholinephosphotransferase activity(GO:0004142) |
0.5 | 3.0 | GO:0047685 | amine sulfotransferase activity(GO:0047685) |
0.5 | 2.9 | GO:0019869 | chloride channel inhibitor activity(GO:0019869) |
0.5 | 18.0 | GO:0017112 | Rab guanyl-nucleotide exchange factor activity(GO:0017112) |
0.5 | 2.4 | GO:0010484 | H3 histone acetyltransferase activity(GO:0010484) |
0.5 | 5.3 | GO:0015643 | toxic substance binding(GO:0015643) |
0.5 | 3.8 | GO:0017081 | chloride channel regulator activity(GO:0017081) |
0.5 | 1.4 | GO:0008332 | low voltage-gated calcium channel activity(GO:0008332) |
0.5 | 2.8 | GO:0039552 | RIG-I binding(GO:0039552) |
0.5 | 1.4 | GO:0004618 | phosphoglycerate kinase activity(GO:0004618) |
0.5 | 5.0 | GO:0051434 | BH3 domain binding(GO:0051434) |
0.4 | 1.3 | GO:0004983 | neuropeptide Y receptor activity(GO:0004983) |
0.4 | 1.3 | GO:0030627 | pre-mRNA 5'-splice site binding(GO:0030627) |
0.4 | 0.9 | GO:0050473 | arachidonate 15-lipoxygenase activity(GO:0050473) |
0.4 | 2.2 | GO:0031708 | endothelin B receptor binding(GO:0031708) |
0.4 | 4.8 | GO:0035381 | extracellular ATP-gated cation channel activity(GO:0004931) ATP-gated ion channel activity(GO:0035381) |
0.4 | 7.8 | GO:0015467 | G-protein activated inward rectifier potassium channel activity(GO:0015467) |
0.4 | 3.5 | GO:0005497 | androgen binding(GO:0005497) |
0.4 | 1.3 | GO:0050211 | procollagen galactosyltransferase activity(GO:0050211) |
0.4 | 3.0 | GO:0004035 | alkaline phosphatase activity(GO:0004035) |
0.4 | 9.4 | GO:0071837 | HMG box domain binding(GO:0071837) |
0.4 | 17.4 | GO:0017080 | sodium channel regulator activity(GO:0017080) |
0.4 | 1.7 | GO:0070735 | protein-glycine ligase activity(GO:0070735) |
0.4 | 6.4 | GO:0008519 | ammonium transmembrane transporter activity(GO:0008519) |
0.4 | 5.9 | GO:0019239 | deaminase activity(GO:0019239) |
0.4 | 2.1 | GO:0016300 | tRNA (uracil) methyltransferase activity(GO:0016300) |
0.4 | 10.9 | GO:0031489 | myosin V binding(GO:0031489) |
0.4 | 4.6 | GO:0004568 | chitinase activity(GO:0004568) chitin binding(GO:0008061) |
0.4 | 1.3 | GO:0042015 | interleukin-20 binding(GO:0042015) |
0.4 | 2.9 | GO:0070891 | lipoteichoic acid binding(GO:0070891) |
0.4 | 10.8 | GO:0004890 | GABA-A receptor activity(GO:0004890) |
0.4 | 1.2 | GO:0016899 | oxidoreductase activity, acting on the CH-OH group of donors, oxygen as acceptor(GO:0016899) |
0.4 | 1.2 | GO:0070697 | activin receptor binding(GO:0070697) |
0.4 | 0.8 | GO:0016019 | peptidoglycan receptor activity(GO:0016019) |
0.4 | 2.4 | GO:0017018 | myosin phosphatase activity(GO:0017018) |
0.4 | 3.2 | GO:0048273 | mitogen-activated protein kinase p38 binding(GO:0048273) |
0.4 | 5.6 | GO:0004065 | arylsulfatase activity(GO:0004065) |
0.4 | 1.2 | GO:0004967 | glucagon receptor activity(GO:0004967) |
0.4 | 7.2 | GO:0044548 | S100 protein binding(GO:0044548) |
0.4 | 0.4 | GO:0005159 | insulin-like growth factor receptor binding(GO:0005159) |
0.4 | 4.0 | GO:0015385 | sodium:proton antiporter activity(GO:0015385) potassium:proton antiporter activity(GO:0015386) |
0.4 | 2.0 | GO:0008035 | high-density lipoprotein particle binding(GO:0008035) |
0.4 | 9.8 | GO:0071949 | FAD binding(GO:0071949) |
0.4 | 59.9 | GO:0017137 | Rab GTPase binding(GO:0017137) |
0.4 | 2.7 | GO:0003909 | DNA ligase activity(GO:0003909) |
0.4 | 11.6 | GO:0004709 | MAP kinase kinase kinase activity(GO:0004709) |
0.4 | 3.1 | GO:0001042 | RNA polymerase I core binding(GO:0001042) |
0.4 | 5.4 | GO:0055056 | D-glucose transmembrane transporter activity(GO:0055056) |
0.4 | 1.9 | GO:0044736 | acid-sensing ion channel activity(GO:0044736) |
0.4 | 0.4 | GO:0051185 | coenzyme transporter activity(GO:0051185) |
0.4 | 3.4 | GO:0016724 | ferroxidase activity(GO:0004322) oxidoreductase activity, oxidizing metal ions, oxygen as acceptor(GO:0016724) |
0.4 | 5.7 | GO:0035591 | signaling adaptor activity(GO:0035591) |
0.4 | 1.1 | GO:0047275 | glucosaminylgalactosylglucosylceramide beta-galactosyltransferase activity(GO:0047275) |
0.4 | 2.2 | GO:0043015 | gamma-tubulin binding(GO:0043015) |
0.4 | 7.1 | GO:0016805 | dipeptidase activity(GO:0016805) |
0.4 | 1.5 | GO:0022865 | transmembrane electron transfer carrier(GO:0022865) |
0.4 | 2.2 | GO:0004447 | iodide peroxidase activity(GO:0004447) |
0.4 | 1.5 | GO:0003680 | AT DNA binding(GO:0003680) |
0.4 | 1.8 | GO:0034875 | oxidoreductase activity, acting on CH or CH2 groups, quinone or similar compound as acceptor(GO:0033695) caffeine oxidase activity(GO:0034875) |
0.4 | 5.0 | GO:0017110 | nucleoside-diphosphatase activity(GO:0017110) |
0.4 | 2.9 | GO:0005250 | A-type (transient outward) potassium channel activity(GO:0005250) |
0.4 | 4.6 | GO:0070001 | aspartic-type endopeptidase activity(GO:0004190) aspartic-type peptidase activity(GO:0070001) |
0.4 | 16.4 | GO:0004197 | cysteine-type endopeptidase activity(GO:0004197) |
0.4 | 1.8 | GO:0005052 | peroxisome matrix targeting signal-1 binding(GO:0005052) |
0.4 | 2.5 | GO:0086056 | voltage-gated calcium channel activity involved in AV node cell action potential(GO:0086056) |
0.4 | 2.5 | GO:0032138 | single base insertion or deletion binding(GO:0032138) |
0.4 | 2.5 | GO:0008271 | secondary active sulfate transmembrane transporter activity(GO:0008271) |
0.4 | 1.1 | GO:0004464 | leukotriene-C4 synthase activity(GO:0004464) |
0.4 | 12.8 | GO:0004683 | calmodulin-dependent protein kinase activity(GO:0004683) |
0.4 | 15.1 | GO:0005080 | protein kinase C binding(GO:0005080) |
0.3 | 5.2 | GO:0035925 | mRNA 3'-UTR AU-rich region binding(GO:0035925) |
0.3 | 3.8 | GO:0004062 | aryl sulfotransferase activity(GO:0004062) |
0.3 | 1.0 | GO:0004961 | thromboxane receptor activity(GO:0004960) thromboxane A2 receptor activity(GO:0004961) |
0.3 | 1.4 | GO:0042019 | interleukin-23 binding(GO:0042019) interleukin-23 receptor activity(GO:0042020) |
0.3 | 1.7 | GO:0004992 | platelet activating factor receptor activity(GO:0004992) |
0.3 | 1.3 | GO:0034481 | chondroitin sulfotransferase activity(GO:0034481) |
0.3 | 5.4 | GO:0031702 | type 1 angiotensin receptor binding(GO:0031702) |
0.3 | 1.0 | GO:0001665 | alpha-N-acetylgalactosaminide alpha-2,6-sialyltransferase activity(GO:0001665) |
0.3 | 9.8 | GO:0030544 | Hsp70 protein binding(GO:0030544) |
0.3 | 5.5 | GO:0042056 | chemoattractant activity(GO:0042056) |
0.3 | 2.0 | GO:0043855 | intracellular cyclic nucleotide activated cation channel activity(GO:0005221) cyclic nucleotide-gated ion channel activity(GO:0043855) |
0.3 | 1.3 | GO:0031716 | calcitonin receptor binding(GO:0031716) |
0.3 | 5.8 | GO:0099589 | serotonin receptor activity(GO:0099589) |
0.3 | 6.4 | GO:0004012 | phospholipid-translocating ATPase activity(GO:0004012) |
0.3 | 2.5 | GO:0052813 | phosphatidylinositol bisphosphate kinase activity(GO:0052813) |
0.3 | 3.5 | GO:0000150 | recombinase activity(GO:0000150) |
0.3 | 3.1 | GO:0030983 | mismatched DNA binding(GO:0030983) |
0.3 | 1.2 | GO:0005225 | volume-sensitive anion channel activity(GO:0005225) |
0.3 | 3.4 | GO:0016174 | NAD(P)H oxidase activity(GO:0016174) |
0.3 | 6.5 | GO:0008173 | RNA methyltransferase activity(GO:0008173) |
0.3 | 4.3 | GO:0031996 | thioesterase binding(GO:0031996) |
0.3 | 2.1 | GO:0034711 | inhibin binding(GO:0034711) |
0.3 | 0.6 | GO:0016634 | oxidoreductase activity, acting on the CH-CH group of donors, oxygen as acceptor(GO:0016634) |
0.3 | 0.6 | GO:0070568 | guanylyltransferase activity(GO:0070568) |
0.3 | 9.6 | GO:0048020 | CCR chemokine receptor binding(GO:0048020) |
0.3 | 1.5 | GO:0001609 | G-protein coupled adenosine receptor activity(GO:0001609) |
0.3 | 0.9 | GO:0003906 | DNA-(apurinic or apyrimidinic site) lyase activity(GO:0003906) |
0.3 | 6.4 | GO:0001223 | transcription coactivator binding(GO:0001223) |
0.3 | 1.5 | GO:0015056 | corticotrophin-releasing factor receptor activity(GO:0015056) |
0.3 | 1.7 | GO:0046935 | 1-phosphatidylinositol-3-kinase regulator activity(GO:0046935) |
0.3 | 1.2 | GO:0016520 | growth hormone-releasing hormone receptor activity(GO:0016520) |
0.3 | 9.1 | GO:0001786 | phosphatidylserine binding(GO:0001786) |
0.3 | 1.7 | GO:0070513 | death domain binding(GO:0070513) |
0.3 | 0.6 | GO:0097016 | L27 domain binding(GO:0097016) |
0.3 | 0.8 | GO:0034041 | sterol-transporting ATPase activity(GO:0034041) |
0.3 | 7.8 | GO:0005044 | scavenger receptor activity(GO:0005044) |
0.3 | 1.9 | GO:0008454 | alpha-1,3-mannosylglycoprotein 4-beta-N-acetylglucosaminyltransferase activity(GO:0008454) |
0.3 | 1.1 | GO:0004165 | dodecenoyl-CoA delta-isomerase activity(GO:0004165) |
0.3 | 2.1 | GO:0009008 | DNA-methyltransferase activity(GO:0009008) |
0.3 | 3.2 | GO:0032454 | histone demethylase activity (H3-K9 specific)(GO:0032454) |
0.3 | 1.6 | GO:0008948 | malate dehydrogenase (decarboxylating) (NAD+) activity(GO:0004471) malate dehydrogenase (decarboxylating) (NADP+) activity(GO:0004473) oxaloacetate decarboxylase activity(GO:0008948) |
0.3 | 3.4 | GO:0008331 | high voltage-gated calcium channel activity(GO:0008331) |
0.3 | 1.8 | GO:0015065 | uridine nucleotide receptor activity(GO:0015065) G-protein coupled pyrimidinergic nucleotide receptor activity(GO:0071553) |
0.3 | 2.1 | GO:0030172 | troponin C binding(GO:0030172) |
0.3 | 4.4 | GO:0004559 | alpha-mannosidase activity(GO:0004559) |
0.3 | 2.1 | GO:0032051 | clathrin light chain binding(GO:0032051) |
0.3 | 1.3 | GO:0015086 | cadmium ion transmembrane transporter activity(GO:0015086) cobalt ion transmembrane transporter activity(GO:0015087) lead ion transmembrane transporter activity(GO:0015094) ferrous iron uptake transmembrane transporter activity(GO:0015639) |
0.3 | 67.5 | GO:0030695 | GTPase regulator activity(GO:0030695) |
0.3 | 3.8 | GO:0004653 | polypeptide N-acetylgalactosaminyltransferase activity(GO:0004653) |
0.3 | 1.8 | GO:0004652 | polynucleotide adenylyltransferase activity(GO:0004652) |
0.2 | 15.0 | GO:0000149 | SNARE binding(GO:0000149) |
0.2 | 12.2 | GO:1990782 | protein tyrosine kinase binding(GO:1990782) |
0.2 | 1.2 | GO:0004995 | tachykinin receptor activity(GO:0004995) |
0.2 | 3.5 | GO:0097493 | structural molecule activity conferring elasticity(GO:0097493) |
0.2 | 1.0 | GO:0004619 | bisphosphoglycerate mutase activity(GO:0004082) phosphoglycerate mutase activity(GO:0004619) 2,3-bisphosphoglycerate-dependent phosphoglycerate mutase activity(GO:0046538) |
0.2 | 3.1 | GO:0030280 | structural constituent of epidermis(GO:0030280) |
0.2 | 1.2 | GO:0060002 | plus-end directed microfilament motor activity(GO:0060002) |
0.2 | 4.0 | GO:0001671 | ATPase activator activity(GO:0001671) |
0.2 | 0.9 | GO:0061769 | ribosylnicotinamide kinase activity(GO:0050262) ribosylnicotinate kinase activity(GO:0061769) |
0.2 | 17.4 | GO:0098811 | transcriptional activator activity, RNA polymerase II transcription factor binding(GO:0001190) transcriptional repressor activity, RNA polymerase II activating transcription factor binding(GO:0098811) |
0.2 | 2.7 | GO:0097371 | MDM2/MDM4 family protein binding(GO:0097371) |
0.2 | 4.0 | GO:0019104 | DNA N-glycosylase activity(GO:0019104) |
0.2 | 1.5 | GO:0016594 | glycine binding(GO:0016594) |
0.2 | 1.7 | GO:0001162 | RNA polymerase II intronic transcription regulatory region sequence-specific DNA binding(GO:0001162) |
0.2 | 1.3 | GO:0042834 | peptidoglycan binding(GO:0042834) |
0.2 | 10.6 | GO:0005089 | Rho guanyl-nucleotide exchange factor activity(GO:0005089) |
0.2 | 2.6 | GO:0003995 | acyl-CoA dehydrogenase activity(GO:0003995) |
0.2 | 5.1 | GO:0000993 | RNA polymerase II core binding(GO:0000993) |
0.2 | 1.3 | GO:0019870 | potassium channel inhibitor activity(GO:0019870) |
0.2 | 1.7 | GO:0004064 | arylesterase activity(GO:0004064) |
0.2 | 0.8 | GO:0038036 | sphingosine-1-phosphate receptor activity(GO:0038036) |
0.2 | 2.1 | GO:0015266 | protein channel activity(GO:0015266) |
0.2 | 5.2 | GO:0004602 | glutathione peroxidase activity(GO:0004602) |
0.2 | 2.0 | GO:0070679 | inositol 1,4,5 trisphosphate binding(GO:0070679) |
0.2 | 0.8 | GO:0015057 | thrombin receptor activity(GO:0015057) |
0.2 | 1.8 | GO:0043548 | phosphatidylinositol 3-kinase binding(GO:0043548) |
0.2 | 2.8 | GO:0005248 | voltage-gated sodium channel activity(GO:0005248) voltage-gated ion channel activity involved in regulation of postsynaptic membrane potential(GO:1905030) |
0.2 | 2.4 | GO:0001530 | lipopolysaccharide binding(GO:0001530) |
0.2 | 7.8 | GO:0032934 | cholesterol binding(GO:0015485) sterol binding(GO:0032934) |
0.2 | 0.6 | GO:0008195 | phosphatidate phosphatase activity(GO:0008195) |
0.2 | 5.7 | GO:0005184 | neuropeptide hormone activity(GO:0005184) |
0.2 | 1.6 | GO:0004873 | asialoglycoprotein receptor activity(GO:0004873) |
0.2 | 0.6 | GO:0004769 | steroid delta-isomerase activity(GO:0004769) |
0.2 | 0.8 | GO:0016888 | endodeoxyribonuclease activity, producing 5'-phosphomonoesters(GO:0016888) |
0.2 | 11.7 | GO:0030165 | PDZ domain binding(GO:0030165) |
0.2 | 2.6 | GO:0005245 | voltage-gated calcium channel activity(GO:0005245) |
0.2 | 0.6 | GO:0003828 | alpha-N-acetylneuraminate alpha-2,8-sialyltransferase activity(GO:0003828) |
0.2 | 1.5 | GO:0046703 | natural killer cell lectin-like receptor binding(GO:0046703) |
0.2 | 2.7 | GO:0005251 | delayed rectifier potassium channel activity(GO:0005251) |
0.2 | 2.1 | GO:0051011 | microtubule minus-end binding(GO:0051011) |
0.2 | 8.0 | GO:0004984 | olfactory receptor activity(GO:0004984) |
0.2 | 1.4 | GO:0035586 | purinergic receptor activity(GO:0035586) |
0.2 | 3.0 | GO:0004601 | peroxidase activity(GO:0004601) |
0.2 | 3.5 | GO:0004806 | triglyceride lipase activity(GO:0004806) |
0.2 | 1.9 | GO:0045236 | CXCR chemokine receptor binding(GO:0045236) |
0.2 | 2.6 | GO:0008191 | metalloendopeptidase inhibitor activity(GO:0008191) |
0.2 | 0.5 | GO:0019863 | IgE binding(GO:0019863) |
0.2 | 2.6 | GO:0008138 | protein tyrosine/serine/threonine phosphatase activity(GO:0008138) |
0.2 | 9.3 | GO:0005262 | calcium channel activity(GO:0005262) |
0.2 | 0.8 | GO:0008420 | CTD phosphatase activity(GO:0008420) |
0.2 | 0.7 | GO:0004886 | 9-cis retinoic acid receptor activity(GO:0004886) |
0.2 | 6.7 | GO:0005249 | voltage-gated potassium channel activity(GO:0005249) |
0.2 | 0.7 | GO:0030197 | extracellular matrix constituent, lubricant activity(GO:0030197) |
0.2 | 10.6 | GO:0001618 | virus receptor activity(GO:0001618) |
0.2 | 1.0 | GO:0030021 | extracellular matrix structural constituent conferring compression resistance(GO:0030021) structural constituent of tooth enamel(GO:0030345) |
0.2 | 0.8 | GO:0008140 | cAMP response element binding protein binding(GO:0008140) |
0.2 | 0.8 | GO:0015232 | heme transporter activity(GO:0015232) |
0.2 | 3.4 | GO:0008188 | neuropeptide receptor activity(GO:0008188) |
0.2 | 3.1 | GO:0070840 | dynein complex binding(GO:0070840) |
0.2 | 0.9 | GO:0005542 | folic acid binding(GO:0005542) |
0.2 | 1.5 | GO:0047498 | calcium-dependent phospholipase A2 activity(GO:0047498) |
0.2 | 1.7 | GO:0001206 | transcriptional repressor activity, RNA polymerase II distal enhancer sequence-specific binding(GO:0001206) |
0.2 | 1.8 | GO:0048018 | receptor agonist activity(GO:0048018) |
0.1 | 0.6 | GO:0004909 | interleukin-1, Type I, activating receptor activity(GO:0004909) |
0.1 | 0.4 | GO:0043422 | protein kinase B binding(GO:0043422) |
0.1 | 0.7 | GO:0004692 | cGMP-dependent protein kinase activity(GO:0004692) |
0.1 | 0.7 | GO:0008079 | translation release factor activity(GO:0003747) translation termination factor activity(GO:0008079) |
0.1 | 1.1 | GO:0003810 | protein-glutamine gamma-glutamyltransferase activity(GO:0003810) |
0.1 | 0.6 | GO:0030160 | GKAP/Homer scaffold activity(GO:0030160) |
0.1 | 0.4 | GO:0004937 | alpha1-adrenergic receptor activity(GO:0004937) |
0.1 | 1.3 | GO:0034483 | heparan sulfate sulfotransferase activity(GO:0034483) |
0.1 | 0.8 | GO:0010853 | cyclase activator activity(GO:0010853) guanylate cyclase activator activity(GO:0030250) |
0.1 | 7.5 | GO:0035064 | methylated histone binding(GO:0035064) |
0.1 | 1.2 | GO:0003708 | retinoic acid receptor activity(GO:0003708) |
0.1 | 0.7 | GO:0004095 | carnitine O-palmitoyltransferase activity(GO:0004095) O-palmitoyltransferase activity(GO:0016416) |
0.1 | 0.7 | GO:0032393 | MHC class I receptor activity(GO:0032393) |
0.1 | 13.9 | GO:0004222 | metalloendopeptidase activity(GO:0004222) |
0.1 | 2.1 | GO:0070412 | R-SMAD binding(GO:0070412) |
0.1 | 3.6 | GO:0002039 | p53 binding(GO:0002039) |
0.1 | 0.9 | GO:0035197 | siRNA binding(GO:0035197) |
0.1 | 0.9 | GO:0004467 | long-chain fatty acid-CoA ligase activity(GO:0004467) |
0.1 | 2.4 | GO:0031418 | L-ascorbic acid binding(GO:0031418) |
0.1 | 0.4 | GO:0005148 | prolactin receptor binding(GO:0005148) |
0.1 | 3.4 | GO:0005230 | extracellular ligand-gated ion channel activity(GO:0005230) |
0.1 | 2.1 | GO:0004535 | poly(A)-specific ribonuclease activity(GO:0004535) |
0.1 | 0.4 | GO:0043225 | anion transmembrane-transporting ATPase activity(GO:0043225) |
0.1 | 0.3 | GO:0099602 | acetylcholine receptor regulator activity(GO:0030548) neurotransmitter receptor regulator activity(GO:0099602) |
0.1 | 2.0 | GO:0015106 | bicarbonate transmembrane transporter activity(GO:0015106) |
0.1 | 0.3 | GO:0004814 | arginine-tRNA ligase activity(GO:0004814) |
0.1 | 3.6 | GO:0015459 | potassium channel regulator activity(GO:0015459) |
0.1 | 0.3 | GO:0052871 | tocopherol omega-hydroxylase activity(GO:0052870) alpha-tocopherol omega-hydroxylase activity(GO:0052871) 20-hydroxy-leukotriene B4 omega oxidase activity(GO:0097258) 20-aldehyde-leukotriene B4 20-monooxygenase activity(GO:0097259) |
0.1 | 0.5 | GO:0005381 | iron ion transmembrane transporter activity(GO:0005381) |
0.1 | 1.5 | GO:0008392 | arachidonic acid monooxygenase activity(GO:0008391) arachidonic acid epoxygenase activity(GO:0008392) |
0.1 | 2.0 | GO:0005086 | ARF guanyl-nucleotide exchange factor activity(GO:0005086) |
0.1 | 2.0 | GO:0004181 | metallocarboxypeptidase activity(GO:0004181) |
0.1 | 0.3 | GO:0050510 | N-acetylgalactosaminyl-proteoglycan 3-beta-glucuronosyltransferase activity(GO:0050510) |
0.1 | 1.2 | GO:0004089 | carbonate dehydratase activity(GO:0004089) |
0.1 | 0.8 | GO:0030742 | GTP-dependent protein binding(GO:0030742) |
0.1 | 0.3 | GO:0070139 | ubiquitin-like protein-specific endopeptidase activity(GO:0070137) SUMO-specific endopeptidase activity(GO:0070139) |
0.1 | 1.7 | GO:0043027 | cysteine-type endopeptidase inhibitor activity involved in apoptotic process(GO:0043027) |
0.1 | 1.1 | GO:0070008 | serine-type exopeptidase activity(GO:0070008) |
0.1 | 0.9 | GO:0043395 | heparan sulfate proteoglycan binding(GO:0043395) |
0.1 | 0.2 | GO:0004450 | isocitrate dehydrogenase (NADP+) activity(GO:0004450) |
0.1 | 0.5 | GO:0043546 | molybdopterin cofactor binding(GO:0043546) |
0.1 | 0.5 | GO:0004969 | histamine receptor activity(GO:0004969) |
0.1 | 0.2 | GO:0004833 | tryptophan 2,3-dioxygenase activity(GO:0004833) |
0.1 | 0.2 | GO:0016823 | hydrolase activity, acting on acid carbon-carbon bonds(GO:0016822) hydrolase activity, acting on acid carbon-carbon bonds, in ketonic substances(GO:0016823) |
0.1 | 3.2 | GO:0004713 | protein tyrosine kinase activity(GO:0004713) |
0.1 | 0.2 | GO:0004356 | glutamate-ammonia ligase activity(GO:0004356) ammonia ligase activity(GO:0016211) acid-ammonia (or amide) ligase activity(GO:0016880) |
0.1 | 81.8 | GO:0001071 | nucleic acid binding transcription factor activity(GO:0001071) transcription factor activity, sequence-specific DNA binding(GO:0003700) |
0.1 | 0.1 | GO:0034191 | apolipoprotein receptor binding(GO:0034190) apolipoprotein A-I receptor binding(GO:0034191) |
0.1 | 0.2 | GO:0016941 | natriuretic peptide receptor activity(GO:0016941) |
0.1 | 6.2 | GO:0008017 | microtubule binding(GO:0008017) |
0.1 | 0.2 | GO:0008384 | IkappaB kinase activity(GO:0008384) |
0.0 | 0.7 | GO:0017017 | MAP kinase tyrosine/serine/threonine phosphatase activity(GO:0017017) |
0.0 | 0.3 | GO:0035259 | glucocorticoid receptor binding(GO:0035259) |
0.0 | 7.3 | GO:0004252 | serine-type endopeptidase activity(GO:0004252) |
0.0 | 0.8 | GO:0008093 | cytoskeletal adaptor activity(GO:0008093) |
0.0 | 0.5 | GO:0016861 | intramolecular oxidoreductase activity, interconverting aldoses and ketoses(GO:0016861) |
0.0 | 0.5 | GO:0017034 | Rap guanyl-nucleotide exchange factor activity(GO:0017034) |
0.0 | 0.8 | GO:0051959 | dynein light intermediate chain binding(GO:0051959) |
0.0 | 2.9 | GO:0003730 | mRNA 3'-UTR binding(GO:0003730) |
0.0 | 0.1 | GO:0004703 | G-protein coupled receptor kinase activity(GO:0004703) |
0.0 | 1.2 | GO:0004129 | cytochrome-c oxidase activity(GO:0004129) heme-copper terminal oxidase activity(GO:0015002) oxidoreductase activity, acting on a heme group of donors, oxygen as acceptor(GO:0016676) |
0.0 | 1.3 | GO:0004198 | calcium-dependent cysteine-type endopeptidase activity(GO:0004198) |
0.0 | 0.3 | GO:0002151 | G-quadruplex RNA binding(GO:0002151) |
0.0 | 0.6 | GO:0005544 | calcium-dependent phospholipid binding(GO:0005544) |
0.0 | 0.4 | GO:0004767 | sphingomyelin phosphodiesterase activity(GO:0004767) |
0.0 | 0.2 | GO:0005436 | sodium:phosphate symporter activity(GO:0005436) |
0.0 | 4.9 | GO:0000287 | magnesium ion binding(GO:0000287) |
0.0 | 0.4 | GO:0003951 | NAD+ kinase activity(GO:0003951) |
0.0 | 0.0 | GO:0030343 | vitamin D3 25-hydroxylase activity(GO:0030343) vitamin D 25-hydroxylase activity(GO:0070643) |
0.0 | 0.3 | GO:0070742 | C2H2 zinc finger domain binding(GO:0070742) |
0.0 | 0.2 | GO:0008484 | sulfuric ester hydrolase activity(GO:0008484) |
0.0 | 0.1 | GO:0000285 | 1-phosphatidylinositol-3-phosphate 5-kinase activity(GO:0000285) |
0.0 | 0.1 | GO:0032404 | mismatch repair complex binding(GO:0032404) MutSalpha complex binding(GO:0032407) |
0.0 | 0.2 | GO:0001222 | transcription corepressor binding(GO:0001222) |
0.0 | 0.7 | GO:0003887 | DNA-directed DNA polymerase activity(GO:0003887) |
0.0 | 0.5 | GO:0051219 | phosphoprotein binding(GO:0051219) |
0.0 | 0.2 | GO:0030274 | LIM domain binding(GO:0030274) |
0.0 | 0.1 | GO:0003796 | lysozyme activity(GO:0003796) |
0.0 | 1.0 | GO:0008013 | beta-catenin binding(GO:0008013) |
0.0 | 0.1 | GO:0000035 | acyl binding(GO:0000035) |
0.0 | 0.2 | GO:0015174 | basic amino acid transmembrane transporter activity(GO:0015174) |
0.0 | 0.1 | GO:0004105 | choline-phosphate cytidylyltransferase activity(GO:0004105) |
0.0 | 0.1 | GO:0015095 | magnesium ion transmembrane transporter activity(GO:0015095) |
0.0 | 1.1 | GO:0002020 | protease binding(GO:0002020) |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
2.2 | 55.5 | PID TCR JNK PATHWAY | JNK signaling in the CD4+ TCR pathway |
2.2 | 62.8 | PID TCR PATHWAY | TCR signaling in naïve CD4+ T cells |
1.9 | 149.9 | PID CD8 TCR PATHWAY | TCR signaling in naïve CD8+ T cells |
1.6 | 6.3 | SA REG CASCADE OF CYCLIN EXPR | Expression of cyclins regulates progression through the cell cycle by activating cyclin-dependent kinases. |
1.5 | 60.2 | PID INTEGRIN CS PATHWAY | Integrin family cell surface interactions |
1.5 | 38.2 | PID PDGFRA PATHWAY | PDGFR-alpha signaling pathway |
1.4 | 7.0 | PID TCR RAS PATHWAY | Ras signaling in the CD4+ TCR pathway |
1.2 | 40.1 | PID NFKAPPAB CANONICAL PATHWAY | Canonical NF-kappaB pathway |
1.2 | 2.4 | ST STAT3 PATHWAY | STAT3 Pathway |
0.9 | 12.2 | PID SHP2 PATHWAY | SHP2 signaling |
0.9 | 1.9 | ST B CELL ANTIGEN RECEPTOR | B Cell Antigen Receptor |
0.9 | 34.4 | PID IL2 STAT5 PATHWAY | IL2 signaling events mediated by STAT5 |
0.9 | 28.9 | ST T CELL SIGNAL TRANSDUCTION | T Cell Signal Transduction |
0.9 | 9.9 | PID FAS PATHWAY | FAS (CD95) signaling pathway |
0.9 | 31.7 | ST WNT CA2 CYCLIC GMP PATHWAY | Wnt/Ca2+/cyclic GMP signaling. |
0.8 | 20.2 | PID INTEGRIN2 PATHWAY | Beta2 integrin cell surface interactions |
0.8 | 38.4 | PID IL8 CXCR2 PATHWAY | IL8- and CXCR2-mediated signaling events |
0.8 | 3.3 | SA CASPASE CASCADE | Apoptosis is mediated by caspases, cysteine proteases arranged in a proteolytic cascade. |
0.8 | 21.5 | PID CD40 PATHWAY | CD40/CD40L signaling |
0.8 | 23.1 | PID TOLL ENDOGENOUS PATHWAY | Endogenous TLR signaling |
0.8 | 38.3 | PID BCR 5PATHWAY | BCR signaling pathway |
0.7 | 37.6 | NABA PROTEOGLYCANS | Genes encoding proteoglycans |
0.6 | 8.4 | ST TYPE I INTERFERON PATHWAY | Type I Interferon (alpha/beta IFN) Pathway |
0.6 | 3.1 | PID EPHB FWD PATHWAY | EPHB forward signaling |
0.6 | 2.4 | ST PAC1 RECEPTOR PATHWAY | PAC1 Receptor Pathway |
0.6 | 13.1 | PID ERB GENOMIC PATHWAY | Validated nuclear estrogen receptor beta network |
0.6 | 4.0 | PID GLYPICAN 1PATHWAY | Glypican 1 network |
0.5 | 5.8 | PID PRL SIGNALING EVENTS PATHWAY | Signaling events mediated by PRL |
0.5 | 7.4 | SA PTEN PATHWAY | PTEN is a tumor suppressor that dephosphorylates the lipid messenger phosphatidylinositol triphosphate. |
0.5 | 2.0 | ST JAK STAT PATHWAY | Jak-STAT Pathway |
0.5 | 87.6 | NABA ECM AFFILIATED | Genes encoding proteins affiliated structurally or functionally to extracellular matrix proteins |
0.5 | 7.8 | PID TXA2PATHWAY | Thromboxane A2 receptor signaling |
0.5 | 8.6 | PID EPHRINB REV PATHWAY | Ephrin B reverse signaling |
0.5 | 10.8 | PID AMB2 NEUTROPHILS PATHWAY | amb2 Integrin signaling |
0.5 | 5.9 | ST GAQ PATHWAY | G alpha q Pathway |
0.5 | 16.3 | PID IL1 PATHWAY | IL1-mediated signaling events |
0.4 | 8.4 | ST GA12 PATHWAY | G alpha 12 Pathway |
0.4 | 7.0 | PID P38 GAMMA DELTA PATHWAY | Signaling mediated by p38-gamma and p38-delta |
0.4 | 5.3 | ST ERK1 ERK2 MAPK PATHWAY | ERK1/ERK2 MAPK Pathway |
0.4 | 8.1 | PID IL12 STAT4 PATHWAY | IL12 signaling mediated by STAT4 |
0.4 | 15.8 | PID FCER1 PATHWAY | Fc-epsilon receptor I signaling in mast cells |
0.4 | 1.7 | SA G2 AND M PHASES | Cdc25 activates the cdc2/cyclin B complex to induce the G2/M transition. |
0.4 | 2.5 | ST TUMOR NECROSIS FACTOR PATHWAY | Tumor Necrosis Factor Pathway. |
0.4 | 16.4 | PID ERBB1 DOWNSTREAM PATHWAY | ErbB1 downstream signaling |
0.4 | 3.8 | PID IL5 PATHWAY | IL5-mediated signaling events |
0.4 | 33.1 | PID CASPASE PATHWAY | Caspase cascade in apoptosis |
0.4 | 4.0 | SIG CD40PATHWAYMAP | Genes related to CD40 signaling |
0.3 | 8.7 | PID CXCR3 PATHWAY | CXCR3-mediated signaling events |
0.3 | 10.7 | PID ERBB1 INTERNALIZATION PATHWAY | Internalization of ErbB1 |
0.3 | 9.5 | PID TCR CALCIUM PATHWAY | Calcium signaling in the CD4+ TCR pathway |
0.3 | 5.3 | PID IL3 PATHWAY | IL3-mediated signaling events |
0.3 | 3.2 | PID ERBB1 RECEPTOR PROXIMAL PATHWAY | EGF receptor (ErbB1) signaling pathway |
0.3 | 4.4 | PID IL23 PATHWAY | IL23-mediated signaling events |
0.3 | 7.1 | PID SYNDECAN 3 PATHWAY | Syndecan-3-mediated signaling events |
0.3 | 3.4 | PID AR NONGENOMIC PATHWAY | Nongenotropic Androgen signaling |
0.3 | 3.2 | PID ERBB2 ERBB3 PATHWAY | ErbB2/ErbB3 signaling events |
0.3 | 8.5 | PID KIT PATHWAY | Signaling events mediated by Stem cell factor receptor (c-Kit) |
0.3 | 3.7 | ST ADRENERGIC | Adrenergic Pathway |
0.3 | 8.0 | PID MAPK TRK PATHWAY | Trk receptor signaling mediated by the MAPK pathway |
0.3 | 5.4 | PID SMAD2 3NUCLEAR PATHWAY | Regulation of nuclear SMAD2/3 signaling |
0.3 | 2.8 | PID RAS PATHWAY | Regulation of Ras family activation |
0.2 | 1.9 | PID TNF PATHWAY | TNF receptor signaling pathway |
0.2 | 3.1 | PID INTEGRIN A9B1 PATHWAY | Alpha9 beta1 integrin signaling events |
0.2 | 5.6 | PID IL12 2PATHWAY | IL12-mediated signaling events |
0.2 | 1.2 | PID IL27 PATHWAY | IL27-mediated signaling events |
0.2 | 4.8 | PID ARF6 TRAFFICKING PATHWAY | Arf6 trafficking events |
0.2 | 3.2 | ST GA13 PATHWAY | G alpha 13 Pathway |
0.2 | 4.4 | ST P38 MAPK PATHWAY | p38 MAPK Pathway |
0.2 | 21.6 | PID PDGFRB PATHWAY | PDGFR-beta signaling pathway |
0.2 | 3.4 | PID IL2 1PATHWAY | IL2-mediated signaling events |
0.2 | 2.7 | PID UPA UPAR PATHWAY | Urokinase-type plasminogen activator (uPA) and uPAR-mediated signaling |
0.2 | 2.6 | PID ATF2 PATHWAY | ATF-2 transcription factor network |
0.2 | 0.9 | PID ENDOTHELIN PATHWAY | Endothelins |
0.2 | 1.4 | PID ANTHRAX PATHWAY | Cellular roles of Anthrax toxin |
0.2 | 3.7 | PID CONE PATHWAY | Visual signal transduction: Cones |
0.2 | 3.2 | PID FAK PATHWAY | Signaling events mediated by focal adhesion kinase |
0.2 | 15.6 | PID MYC REPRESS PATHWAY | Validated targets of C-MYC transcriptional repression |
0.1 | 14.0 | PID CMYB PATHWAY | C-MYB transcription factor network |
0.1 | 1.9 | ST DIFFERENTIATION PATHWAY IN PC12 CELLS | Differentiation Pathway in PC12 Cells; this is a specific case of PAC1 Receptor Pathway. |
0.1 | 2.1 | PID IL6 7 PATHWAY | IL6-mediated signaling events |
0.1 | 31.6 | NABA ECM REGULATORS | Genes encoding enzymes and their regulators involved in the remodeling of the extracellular matrix |
0.1 | 7.2 | PID FANCONI PATHWAY | Fanconi anemia pathway |
0.1 | 4.8 | PID FGF PATHWAY | FGF signaling pathway |
0.1 | 3.8 | PID MTOR 4PATHWAY | mTOR signaling pathway |
0.1 | 1.2 | PID NFAT TFPATHWAY | Calcineurin-regulated NFAT-dependent transcription in lymphocytes |
0.1 | 0.3 | ST MYOCYTE AD PATHWAY | Myocyte Adrenergic Pathway is a specific case of the generalized Adrenergic Pathway. |
0.1 | 0.7 | NABA COLLAGENS | Genes encoding collagen proteins |
0.1 | 1.9 | PID HIF2PATHWAY | HIF-2-alpha transcription factor network |
0.1 | 0.3 | PID LYMPH ANGIOGENESIS PATHWAY | VEGFR3 signaling in lymphatic endothelium |
0.1 | 0.7 | PID RHODOPSIN PATHWAY | Visual signal transduction: Rods |
0.0 | 0.5 | PID P38 MKK3 6PATHWAY | p38 MAPK signaling pathway |
0.0 | 1.4 | PID ARF6 PATHWAY | Arf6 signaling events |
0.0 | 0.3 | PID FRA PATHWAY | Validated transcriptional targets of AP1 family members Fra1 and Fra2 |
0.0 | 0.7 | PID WNT CANONICAL PATHWAY | Canonical Wnt signaling pathway |
0.0 | 0.2 | PID INSULIN PATHWAY | Insulin Pathway |
0.0 | 0.7 | PID PTP1B PATHWAY | Signaling events mediated by PTP1B |
0.0 | 1.2 | PID LKB1 PATHWAY | LKB1 signaling events |
0.0 | 0.5 | PID ALPHA SYNUCLEIN PATHWAY | Alpha-synuclein signaling |
0.0 | 0.4 | PID NCADHERIN PATHWAY | N-cadherin signaling events |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
8.1 | 185.6 | REACTOME TRANSLOCATION OF ZAP 70 TO IMMUNOLOGICAL SYNAPSE | Genes involved in Translocation of ZAP-70 to Immunological synapse |
2.8 | 47.0 | REACTOME PLATELET ADHESION TO EXPOSED COLLAGEN | Genes involved in Platelet Adhesion to exposed collagen |
2.5 | 12.7 | REACTOME PHOSPHORYLATION OF CD3 AND TCR ZETA CHAINS | Genes involved in Phosphorylation of CD3 and TCR zeta chains |
2.2 | 29.2 | REACTOME REGULATION OF THE FANCONI ANEMIA PATHWAY | Genes involved in Regulation of the Fanconi anemia pathway |
2.0 | 170.6 | REACTOME IMMUNOREGULATORY INTERACTIONS BETWEEN A LYMPHOID AND A NON LYMPHOID CELL | Genes involved in Immunoregulatory interactions between a Lymphoid and a non-Lymphoid cell |
2.0 | 98.2 | REACTOME GPVI MEDIATED ACTIVATION CASCADE | Genes involved in GPVI-mediated activation cascade |
1.8 | 32.5 | REACTOME NOREPINEPHRINE NEUROTRANSMITTER RELEASE CYCLE | Genes involved in Norepinephrine Neurotransmitter Release Cycle |
1.6 | 4.8 | REACTOME ENDOSOMAL VACUOLAR PATHWAY | Genes involved in Endosomal/Vacuolar pathway |
1.6 | 33.4 | REACTOME OTHER SEMAPHORIN INTERACTIONS | Genes involved in Other semaphorin interactions |
1.5 | 21.9 | REACTOME ACTIVATION OF THE AP1 FAMILY OF TRANSCRIPTION FACTORS | Genes involved in Activation of the AP-1 family of transcription factors |
1.4 | 69.2 | REACTOME NOD1 2 SIGNALING PATHWAY | Genes involved in NOD1/2 Signaling Pathway |
1.3 | 5.4 | REACTOME SYNTHESIS OF PIPS AT THE LATE ENDOSOME MEMBRANE | Genes involved in Synthesis of PIPs at the late endosome membrane |
1.3 | 27.3 | REACTOME SYNTHESIS OF VERY LONG CHAIN FATTY ACYL COAS | Genes involved in Synthesis of very long-chain fatty acyl-CoAs |
1.3 | 25.4 | REACTOME P38MAPK EVENTS | Genes involved in p38MAPK events |
1.3 | 17.5 | REACTOME PASSIVE TRANSPORT BY AQUAPORINS | Genes involved in Passive Transport by Aquaporins |
1.2 | 7.3 | REACTOME PD1 SIGNALING | Genes involved in PD-1 signaling |
1.0 | 2.1 | REACTOME MRNA CAPPING | Genes involved in mRNA Capping |
1.0 | 20.5 | REACTOME PLATELET SENSITIZATION BY LDL | Genes involved in Platelet sensitization by LDL |
1.0 | 22.3 | REACTOME GENERATION OF SECOND MESSENGER MOLECULES | Genes involved in Generation of second messenger molecules |
1.0 | 54.2 | REACTOME NITRIC OXIDE STIMULATES GUANYLATE CYCLASE | Genes involved in Nitric oxide stimulates guanylate cyclase |
1.0 | 23.6 | REACTOME UNBLOCKING OF NMDA RECEPTOR GLUTAMATE BINDING AND ACTIVATION | Genes involved in Unblocking of NMDA receptor, glutamate binding and activation |
1.0 | 7.7 | REACTOME ETHANOL OXIDATION | Genes involved in Ethanol oxidation |
0.9 | 18.7 | REACTOME SYNTHESIS OF PIPS AT THE GOLGI MEMBRANE | Genes involved in Synthesis of PIPs at the Golgi membrane |
0.9 | 14.1 | REACTOME FGFR2C LIGAND BINDING AND ACTIVATION | Genes involved in FGFR2c ligand binding and activation |
0.9 | 29.8 | REACTOME INTERACTION BETWEEN L1 AND ANKYRINS | Genes involved in Interaction between L1 and Ankyrins |
0.9 | 11.2 | REACTOME IL 7 SIGNALING | Genes involved in Interleukin-7 signaling |
0.8 | 34.5 | REACTOME LIGAND GATED ION CHANNEL TRANSPORT | Genes involved in Ligand-gated ion channel transport |
0.8 | 11.6 | REACTOME FANCONI ANEMIA PATHWAY | Genes involved in Fanconi Anemia pathway |
0.8 | 9.8 | REACTOME GLUTAMATE NEUROTRANSMITTER RELEASE CYCLE | Genes involved in Glutamate Neurotransmitter Release Cycle |
0.8 | 34.6 | REACTOME MYOGENESIS | Genes involved in Myogenesis |
0.8 | 19.2 | REACTOME PROTEOLYTIC CLEAVAGE OF SNARE COMPLEX PROTEINS | Genes involved in Proteolytic cleavage of SNARE complex proteins |
0.8 | 29.1 | REACTOME ANTIGEN ACTIVATES B CELL RECEPTOR LEADING TO GENERATION OF SECOND MESSENGERS | Genes involved in Antigen Activates B Cell Receptor Leading to Generation of Second Messengers |
0.8 | 10.1 | REACTOME LATENT INFECTION OF HOMO SAPIENS WITH MYCOBACTERIUM TUBERCULOSIS | Genes involved in Latent infection of Homo sapiens with Mycobacterium tuberculosis |
0.8 | 10.6 | REACTOME TRYPTOPHAN CATABOLISM | Genes involved in Tryptophan catabolism |
0.8 | 48.6 | REACTOME CHEMOKINE RECEPTORS BIND CHEMOKINES | Genes involved in Chemokine receptors bind chemokines |
0.7 | 23.4 | REACTOME TRANSFERRIN ENDOCYTOSIS AND RECYCLING | Genes involved in Transferrin endocytosis and recycling |
0.7 | 13.9 | REACTOME NA CL DEPENDENT NEUROTRANSMITTER TRANSPORTERS | Genes involved in Na+/Cl- dependent neurotransmitter transporters |
0.7 | 2.0 | REACTOME SPRY REGULATION OF FGF SIGNALING | Genes involved in Spry regulation of FGF signaling |
0.6 | 16.3 | REACTOME RIP MEDIATED NFKB ACTIVATION VIA DAI | Genes involved in RIP-mediated NFkB activation via DAI |
0.6 | 15.7 | REACTOME SYNTHESIS OF PIPS AT THE PLASMA MEMBRANE | Genes involved in Synthesis of PIPs at the plasma membrane |
0.6 | 2.4 | REACTOME UNFOLDED PROTEIN RESPONSE | Genes involved in Unfolded Protein Response |
0.6 | 15.7 | REACTOME SIGNALING BY FGFR1 FUSION MUTANTS | Genes involved in Signaling by FGFR1 fusion mutants |
0.6 | 4.6 | REACTOME RETROGRADE NEUROTROPHIN SIGNALLING | Genes involved in Retrograde neurotrophin signalling |
0.6 | 4.0 | REACTOME CTLA4 INHIBITORY SIGNALING | Genes involved in CTLA4 inhibitory signaling |
0.6 | 15.8 | REACTOME CIRCADIAN REPRESSION OF EXPRESSION BY REV ERBA | Genes involved in Circadian Repression of Expression by REV-ERBA |
0.6 | 5.0 | REACTOME AMINE COMPOUND SLC TRANSPORTERS | Genes involved in Amine compound SLC transporters |
0.6 | 49.1 | REACTOME MEIOTIC SYNAPSIS | Genes involved in Meiotic Synapsis |
0.5 | 23.6 | REACTOME DARPP 32 EVENTS | Genes involved in DARPP-32 events |
0.5 | 7.6 | REACTOME DEFENSINS | Genes involved in Defensins |
0.5 | 11.9 | REACTOME INSULIN SYNTHESIS AND PROCESSING | Genes involved in Insulin Synthesis and Processing |
0.5 | 8.1 | REACTOME BILE SALT AND ORGANIC ANION SLC TRANSPORTERS | Genes involved in Bile salt and organic anion SLC transporters |
0.5 | 4.8 | REACTOME COMMON PATHWAY | Genes involved in Common Pathway |
0.5 | 3.7 | REACTOME TCR SIGNALING | Genes involved in TCR signaling |
0.5 | 9.4 | REACTOME IONOTROPIC ACTIVITY OF KAINATE RECEPTORS | Genes involved in Ionotropic activity of Kainate Receptors |
0.5 | 1.5 | REACTOME DESTABILIZATION OF MRNA BY BRF1 | Genes involved in Destabilization of mRNA by Butyrate Response Factor 1 (BRF1) |
0.5 | 4.0 | REACTOME CTNNB1 PHOSPHORYLATION CASCADE | Genes involved in Beta-catenin phosphorylation cascade |
0.5 | 5.8 | REACTOME THE ACTIVATION OF ARYLSULFATASES | Genes involved in The activation of arylsulfatases |
0.5 | 5.4 | REACTOME ABACAVIR TRANSPORT AND METABOLISM | Genes involved in Abacavir transport and metabolism |
0.5 | 14.5 | REACTOME CHONDROITIN SULFATE BIOSYNTHESIS | Genes involved in Chondroitin sulfate biosynthesis |
0.5 | 76.0 | REACTOME SIGNALING BY RHO GTPASES | Genes involved in Signaling by Rho GTPases |
0.5 | 18.3 | REACTOME EFFECTS OF PIP2 HYDROLYSIS | Genes involved in Effects of PIP2 hydrolysis |
0.5 | 3.3 | REACTOME TRAF6 MEDIATED IRF7 ACTIVATION IN TLR7 8 OR 9 SIGNALING | Genes involved in TRAF6 mediated IRF7 activation in TLR7/8 or 9 signaling |
0.5 | 0.9 | REACTOME ACTIVATED TAK1 MEDIATES P38 MAPK ACTIVATION | Genes involved in activated TAK1 mediates p38 MAPK activation |
0.5 | 8.8 | REACTOME INITIAL TRIGGERING OF COMPLEMENT | Genes involved in Initial triggering of complement |
0.5 | 7.7 | REACTOME ARMS MEDIATED ACTIVATION | Genes involved in ARMS-mediated activation |
0.4 | 3.9 | REACTOME SIGNAL ATTENUATION | Genes involved in Signal attenuation |
0.4 | 7.8 | REACTOME GABA RECEPTOR ACTIVATION | Genes involved in GABA receptor activation |
0.4 | 1.7 | REACTOME ER PHAGOSOME PATHWAY | Genes involved in ER-Phagosome pathway |
0.4 | 4.7 | REACTOME DIGESTION OF DIETARY CARBOHYDRATE | Genes involved in Digestion of dietary carbohydrate |
0.4 | 12.8 | REACTOME ACTIVATED AMPK STIMULATES FATTY ACID OXIDATION IN MUSCLE | Genes involved in Activated AMPK stimulates fatty-acid oxidation in muscle |
0.4 | 5.8 | REACTOME ACTIVATION OF BH3 ONLY PROTEINS | Genes involved in Activation of BH3-only proteins |
0.4 | 18.8 | REACTOME VOLTAGE GATED POTASSIUM CHANNELS | Genes involved in Voltage gated Potassium channels |
0.4 | 2.0 | REACTOME DOWNSTREAM SIGNALING EVENTS OF B CELL RECEPTOR BCR | Genes involved in Downstream Signaling Events Of B Cell Receptor (BCR) |
0.4 | 6.9 | REACTOME HIGHLY CALCIUM PERMEABLE POSTSYNAPTIC NICOTINIC ACETYLCHOLINE RECEPTORS | Genes involved in Highly calcium permeable postsynaptic nicotinic acetylcholine receptors |
0.4 | 5.6 | REACTOME IL RECEPTOR SHC SIGNALING | Genes involved in Interleukin receptor SHC signaling |
0.4 | 1.8 | REACTOME FORMATION OF INCISION COMPLEX IN GG NER | Genes involved in Formation of incision complex in GG-NER |
0.4 | 22.1 | REACTOME NCAM1 INTERACTIONS | Genes involved in NCAM1 interactions |
0.4 | 9.1 | REACTOME IL1 SIGNALING | Genes involved in Interleukin-1 signaling |
0.3 | 45.4 | REACTOME RESPONSE TO ELEVATED PLATELET CYTOSOLIC CA2 | Genes involved in Response to elevated platelet cytosolic Ca2+ |
0.3 | 1.4 | REACTOME DESTABILIZATION OF MRNA BY TRISTETRAPROLIN TTP | Genes involved in Destabilization of mRNA by Tristetraprolin (TTP) |
0.3 | 3.8 | REACTOME OPSINS | Genes involved in Opsins |
0.3 | 43.9 | REACTOME PEPTIDE LIGAND BINDING RECEPTORS | Genes involved in Peptide ligand-binding receptors |
0.3 | 4.6 | REACTOME ACYL CHAIN REMODELLING OF PG | Genes involved in Acyl chain remodelling of PG |
0.3 | 2.6 | REACTOME NOTCH HLH TRANSCRIPTION PATHWAY | Genes involved in Notch-HLH transcription pathway |
0.3 | 8.8 | REACTOME NGF SIGNALLING VIA TRKA FROM THE PLASMA MEMBRANE | Genes involved in NGF signalling via TRKA from the plasma membrane |
0.3 | 5.2 | REACTOME PLATELET CALCIUM HOMEOSTASIS | Genes involved in Platelet calcium homeostasis |
0.3 | 3.2 | REACTOME PRE NOTCH EXPRESSION AND PROCESSING | Genes involved in Pre-NOTCH Expression and Processing |
0.3 | 5.5 | REACTOME PRE NOTCH PROCESSING IN GOLGI | Genes involved in Pre-NOTCH Processing in Golgi |
0.3 | 4.5 | REACTOME REGULATION OF IFNG SIGNALING | Genes involved in Regulation of IFNG signaling |
0.3 | 14.7 | REACTOME GLUCONEOGENESIS | Genes involved in Gluconeogenesis |
0.3 | 15.9 | REACTOME OLFACTORY SIGNALING PATHWAY | Genes involved in Olfactory Signaling Pathway |
0.3 | 0.8 | REACTOME NFKB ACTIVATION THROUGH FADD RIP1 PATHWAY MEDIATED BY CASPASE 8 AND10 | Genes involved in NF-kB activation through FADD/RIP-1 pathway mediated by caspase-8 and -10 |
0.3 | 5.1 | REACTOME SYNTHESIS OF PE | Genes involved in Synthesis of PE |
0.3 | 6.0 | REACTOME ADHERENS JUNCTIONS INTERACTIONS | Genes involved in Adherens junctions interactions |
0.3 | 1.6 | REACTOME CROSS PRESENTATION OF SOLUBLE EXOGENOUS ANTIGENS ENDOSOMES | Genes involved in Cross-presentation of soluble exogenous antigens (endosomes) |
0.3 | 1.5 | REACTOME IL 6 SIGNALING | Genes involved in Interleukin-6 signaling |
0.3 | 13.2 | REACTOME NOTCH1 INTRACELLULAR DOMAIN REGULATES TRANSCRIPTION | Genes involved in NOTCH1 Intracellular Domain Regulates Transcription |
0.2 | 7.0 | REACTOME CYTOSOLIC SULFONATION OF SMALL MOLECULES | Genes involved in Cytosolic sulfonation of small molecules |
0.2 | 3.2 | REACTOME FGFR LIGAND BINDING AND ACTIVATION | Genes involved in FGFR ligand binding and activation |
0.2 | 5.5 | REACTOME RAP1 SIGNALLING | Genes involved in Rap1 signalling |
0.2 | 2.9 | REACTOME NEF MEDIATED DOWNREGULATION OF MHC CLASS I COMPLEX CELL SURFACE EXPRESSION | Genes involved in Nef mediated downregulation of MHC class I complex cell surface expression |
0.2 | 7.9 | REACTOME DEGRADATION OF THE EXTRACELLULAR MATRIX | Genes involved in Degradation of the extracellular matrix |
0.2 | 4.9 | REACTOME SYNTHESIS OF GLYCOSYLPHOSPHATIDYLINOSITOL GPI | Genes involved in Synthesis of glycosylphosphatidylinositol (GPI) |
0.2 | 4.9 | REACTOME AMINE DERIVED HORMONES | Genes involved in Amine-derived hormones |
0.2 | 4.8 | REACTOME NUCLEOTIDE LIKE PURINERGIC RECEPTORS | Genes involved in Nucleotide-like (purinergic) receptors |
0.2 | 2.8 | REACTOME SIGNALING BY HIPPO | Genes involved in Signaling by Hippo |
0.2 | 3.2 | REACTOME COSTIMULATION BY THE CD28 FAMILY | Genes involved in Costimulation by the CD28 family |
0.2 | 29.1 | REACTOME FACTORS INVOLVED IN MEGAKARYOCYTE DEVELOPMENT AND PLATELET PRODUCTION | Genes involved in Factors involved in megakaryocyte development and platelet production |
0.2 | 2.8 | REACTOME HORMONE SENSITIVE LIPASE HSL MEDIATED TRIACYLGLYCEROL HYDROLYSIS | Genes involved in Hormone-sensitive lipase (HSL)-mediated triacylglycerol hydrolysis |
0.2 | 3.1 | REACTOME REVERSIBLE HYDRATION OF CARBON DIOXIDE | Genes involved in Reversible Hydration of Carbon Dioxide |
0.2 | 7.6 | REACTOME CELL SURFACE INTERACTIONS AT THE VASCULAR WALL | Genes involved in Cell surface interactions at the vascular wall |
0.2 | 4.0 | REACTOME G0 AND EARLY G1 | Genes involved in G0 and Early G1 |
0.2 | 3.0 | REACTOME SLBP DEPENDENT PROCESSING OF REPLICATION DEPENDENT HISTONE PRE MRNAS | Genes involved in SLBP Dependent Processing of Replication-Dependent Histone Pre-mRNAs |
0.2 | 1.5 | REACTOME TRAF6 MEDIATED NFKB ACTIVATION | Genes involved in TRAF6 mediated NF-kB activation |
0.2 | 4.1 | REACTOME SIGNALING BY ROBO RECEPTOR | Genes involved in Signaling by Robo receptor |
0.2 | 0.8 | REACTOME ACETYLCHOLINE NEUROTRANSMITTER RELEASE CYCLE | Genes involved in Acetylcholine Neurotransmitter Release Cycle |
0.2 | 9.9 | REACTOME MHC CLASS II ANTIGEN PRESENTATION | Genes involved in MHC class II antigen presentation |
0.2 | 3.1 | REACTOME RNA POL I TRANSCRIPTION INITIATION | Genes involved in RNA Polymerase I Transcription Initiation |
0.2 | 1.9 | REACTOME ACYL CHAIN REMODELLING OF PC | Genes involved in Acyl chain remodelling of PC |
0.1 | 1.9 | REACTOME REGULATED PROTEOLYSIS OF P75NTR | Genes involved in Regulated proteolysis of p75NTR |
0.1 | 2.6 | REACTOME EICOSANOID LIGAND BINDING RECEPTORS | Genes involved in Eicosanoid ligand-binding receptors |
0.1 | 1.4 | REACTOME REGULATION OF INSULIN SECRETION BY ACETYLCHOLINE | Genes involved in Regulation of Insulin Secretion by Acetylcholine |
0.1 | 2.1 | REACTOME EGFR DOWNREGULATION | Genes involved in EGFR downregulation |
0.1 | 0.8 | REACTOME RECYCLING OF BILE ACIDS AND SALTS | Genes involved in Recycling of bile acids and salts |
0.1 | 1.0 | REACTOME GAMMA CARBOXYLATION TRANSPORT AND AMINO TERMINAL CLEAVAGE OF PROTEINS | Genes involved in Gamma-carboxylation, transport, and amino-terminal cleavage of proteins |
0.1 | 1.3 | REACTOME METABOLISM OF MRNA | Genes involved in Metabolism of mRNA |
0.1 | 0.5 | REACTOME NEPHRIN INTERACTIONS | Genes involved in Nephrin interactions |
0.1 | 3.0 | REACTOME MYD88 MAL CASCADE INITIATED ON PLASMA MEMBRANE | Genes involved in MyD88:Mal cascade initiated on plasma membrane |
0.1 | 3.9 | REACTOME O LINKED GLYCOSYLATION OF MUCINS | Genes involved in O-linked glycosylation of mucins |
0.1 | 7.6 | REACTOME NUCLEAR RECEPTOR TRANSCRIPTION PATHWAY | Genes involved in Nuclear Receptor transcription pathway |
0.1 | 0.6 | REACTOME INWARDLY RECTIFYING K CHANNELS | Genes involved in Inwardly rectifying K+ channels |
0.1 | 1.7 | REACTOME RESOLUTION OF AP SITES VIA THE SINGLE NUCLEOTIDE REPLACEMENT PATHWAY | Genes involved in Resolution of AP sites via the single-nucleotide replacement pathway |
0.1 | 4.8 | REACTOME ACTIVATION OF CHAPERONE GENES BY XBP1S | Genes involved in Activation of Chaperone Genes by XBP1(S) |
0.1 | 1.4 | REACTOME A TETRASACCHARIDE LINKER SEQUENCE IS REQUIRED FOR GAG SYNTHESIS | Genes involved in A tetrasaccharide linker sequence is required for GAG synthesis |
0.1 | 0.9 | REACTOME SIGNALING BY SCF KIT | Genes involved in Signaling by SCF-KIT |
0.1 | 18.0 | REACTOME GPCR DOWNSTREAM SIGNALING | Genes involved in GPCR downstream signaling |
0.1 | 0.6 | REACTOME ANDROGEN BIOSYNTHESIS | Genes involved in Androgen biosynthesis |
0.1 | 1.7 | REACTOME GLYCOGEN BREAKDOWN GLYCOGENOLYSIS | Genes involved in Glycogen breakdown (glycogenolysis) |
0.1 | 2.0 | REACTOME AMYLOIDS | Genes involved in Amyloids |
0.1 | 1.1 | REACTOME TIE2 SIGNALING | Genes involved in Tie2 Signaling |
0.1 | 2.8 | REACTOME TIGHT JUNCTION INTERACTIONS | Genes involved in Tight junction interactions |
0.1 | 1.3 | REACTOME SIGNALING BY NOTCH | Genes involved in Signaling by NOTCH |
0.1 | 16.9 | REACTOME GENERIC TRANSCRIPTION PATHWAY | Genes involved in Generic Transcription Pathway |
0.1 | 0.2 | REACTOME REGULATION OF KIT SIGNALING | Genes involved in Regulation of KIT signaling |
0.1 | 2.1 | REACTOME GLYCEROPHOSPHOLIPID BIOSYNTHESIS | Genes involved in Glycerophospholipid biosynthesis |
0.1 | 0.4 | REACTOME ROLE OF DCC IN REGULATING APOPTOSIS | Genes involved in Role of DCC in regulating apoptosis |
0.1 | 1.0 | REACTOME XENOBIOTICS | Genes involved in Xenobiotics |
0.1 | 0.6 | REACTOME CYTOKINE SIGNALING IN IMMUNE SYSTEM | Genes involved in Cytokine Signaling in Immune system |
0.1 | 0.3 | REACTOME REGULATION OF RHEB GTPASE ACTIVITY BY AMPK | Genes involved in Regulation of Rheb GTPase activity by AMPK |
0.1 | 0.5 | REACTOME PURINE CATABOLISM | Genes involved in Purine catabolism |
0.0 | 1.4 | REACTOME SPHINGOLIPID DE NOVO BIOSYNTHESIS | Genes involved in Sphingolipid de novo biosynthesis |
0.0 | 1.1 | REACTOME RNA POL III TRANSCRIPTION INITIATION FROM TYPE 2 PROMOTER | Genes involved in RNA Polymerase III Transcription Initiation From Type 2 Promoter |
0.0 | 0.8 | REACTOME MEIOSIS | Genes involved in Meiosis |
0.0 | 0.4 | REACTOME TRIGLYCERIDE BIOSYNTHESIS | Genes involved in Triglyceride Biosynthesis |
0.0 | 0.8 | REACTOME INTERFERON ALPHA BETA SIGNALING | Genes involved in Interferon alpha/beta signaling |